September 2020 – World Solutions – Economy, Politics, Technology, and The Earth

California Vol.27 (corporations: Illumina)

What do you learn when you sequence #DNA from 442 ancient bone fragments? For one thing, it’s that the Vikings weren’t blond. https://t.co/k1VRHIo4AW pic.twitter.com/1T8IAxAYIz

— Illumina (@illumina) September 27, 2020

We are excited to announce new library kits to help enhance research in rare genetic diseases: https://t.co/HjfcNFXJbN pic.twitter.com/K06OIBQSUK

— Illumina (@illumina) September 26, 2020

https://twitter.com/illumina/status/1309145623975911425

With the installation of @Bloom_Energy fuel cells at our San Diego HQ, we helped keep 3,600 metric tons of CO2 out of the air which is equivalent to taking 4,500 cars off the road for a year! #ClimateWeek https://t.co/NrxkU7yC0h pic.twitter.com/iBSQRiKE8c

— Illumina (@illumina) September 23, 2020

For #ClimateWeek, we are reaffirming our support for climate action and reflecting on our recent efforts. https://t.co/R2pS0FDeHI pic.twitter.com/kXOXPHQrfy

— Illumina (@illumina) September 22, 2020

Our sequencing and software analysis are best in class for accuracy with #DRAGEN shining at @PrecisionFDA Truth Challenge. Congratulations to the team! https://t.co/LgyNEDJLid pic.twitter.com/EdeDJfW7eM

— Illumina (@illumina) September 22, 2020

Learn more about how with @GRAILbio, we have the opportunity to revolutionize cancer testing & support our mission to improve human health: https://t.co/odIKxdvlVt pic.twitter.com/RiTxVqjA28

— Illumina (@illumina) September 21, 2020

We are excited to announce our agreement to acquire @GRAILbio, the company detecting cancer early with a simple blood test.

Beating cancer begins with finding it. Together we are poised to transform cancer detection.https://t.co/UZvG6cj63N pic.twitter.com/RD1WgHdMq7

— Illumina (@illumina) September 21, 2020

Our final episode in the four part mini series on clinical whole genome sequencing talks about how using WGS in the clinic can help doctors diagnose genetic diseases in days – not years. Listen here: https://t.co/zmCrjPObfF pic.twitter.com/XZkntcNyKm

— Illumina (@illumina) September 19, 2020

Targeted multigene panels help researchers conduct efficient variant discovery while trying to understand neurological and metabolic disorders. https://t.co/MvqnLErvGr pic.twitter.com/RXA6viRhvk

— Illumina (@illumina) September 16, 2020

We believe that every diagnosis matters. Despite most of our employees working remotely, we still came together to collectively walk over 100 million steps and raise $25,000 in donations to 5 rare disease organizations around the world. #IlluminaProud https://t.co/llmiczBYXn pic.twitter.com/7CZ9BGzCsA

— Illumina (@illumina) September 16, 2020

Hear more on how #NGS is helping to drive a new paradigm in healthcare from our Chief Product Officer, @SusanTousi’s recent presentation at @KAISTpr. https://t.co/SnX7Xu1jFY

— Illumina (@illumina) September 15, 2020

Alongside @UNSW, @UniMelbMDHS, and @TheDohertyInst, we are proud to be part of Australia's groundbreaking effort to track all positive #COVID19 cases.

Read more: https://t.co/bnThkMqF9S pic.twitter.com/TF5x7zEHVR

— Illumina (@illumina) September 15, 2020

Our researchers have shown that sequencing C-RNA can detect molecular signals of preeclampsia in the blood. This could drive early diagnoses and provide info about the health of the placenta and organs. https://t.co/Nnk70ecncx pic.twitter.com/emF47T5OjC

— Illumina (@illumina) September 10, 2020

In a groundbreaking study published in @Nature, researchers at Toronto’s @SickKidsNews used data primarily from Illumina instruments to show, for the first time, that many different tandem repeat expansions can contribute to ASD. #asd #autism https://t.co/5BxJcbjeiW pic.twitter.com/oMO8oJ1FKp

— Illumina (@illumina) September 9, 2020

Real-time NGS can, for the first time in history, enable effective contact tracing and outbreak management, and highlight viral changes that could impact diagnostic and vaccine efficacy. https://t.co/S80IsJUZ3i

— Illumina (@illumina) September 3, 2020

The African genome contains more genetic diversity than any other, but < than 3% of genomes analyzed come from Africans. The new genomics facility in Nigeria created by @weare54Gene is an important step in the right direction. https://t.co/hkHhgh6kUN pic.twitter.com/BJokXjumqh

— Illumina (@illumina) September 3, 2020

We are proud to have been awarded a contract from the National Institutes of Health (NIH) as part of its Rapid Acceleration of Diagnostics (#RADx) program to increase and accelerate #COVID19 testing capacity in the U.S. https://t.co/NTJWVgZXHv

— Illumina (@illumina) September 2, 2020

We applaud @myESMO for new guidelines that recommend using #NGS for advanced cancers. These genome testing approaches will help accelerate the use of precision medicine, ensuring individual patients receive the right medicine for their cancer. https://t.co/GVuco0lGS5

— Illumina (@illumina) August 28, 2020

A little more than three years after debuting the NovaSeq 6000, we installed our 1,000th system at @WhiteheadInst. Our most powerful sequencer continues to make deeper discoveries on an increasing scale. https://t.co/Prdu78V9nj pic.twitter.com/UM6rZE8atz

— Illumina (@illumina) August 26, 2020

Expanding access to more customers, the @US_FDA has amended the Emergency Use Authorization for COVIDSeq, our sequencing-based #COVID19 diagnostic test.

Read more here: https://t.co/Ag2RlnYe8d pic.twitter.com/n44Hft3FGp

— Illumina (@illumina) August 21, 2020

We are thrilled to see @ACOG guidelines recommending #NIPT for all pregnancies regardless of risk.https://t.co/RnBIy1PPC3

— Illumina (@illumina) August 18, 2020

To help tackle the nearly 2.4MM #COVID19 cases in India, @IGIBsocial is tapping into the COVIDSeq assay on our NovaSeq 6000.

Learn more on how this could help frontline testing on our News Center: https://t.co/EhqZaM5rLm pic.twitter.com/3My4SgGd5n

— Illumina (@illumina) August 14, 2020

We are thrilled to support the great work of @GeneticsSociety to connect with our communities and expand the reach of genomics. https://t.co/P6FnTMiKAp pic.twitter.com/pl6F7qNheg

— Illumina (@illumina) August 12, 2020

Announcing the NovaSeq6000 v1.5 Reagent Kit offering accelerated access to exceptional discovery power and operating efficiency, unlocking a promising number of applications for labs of all sizes.https://t.co/wQ6innDbky pic.twitter.com/0b4E8yX2JA

— Illumina (@illumina) August 10, 2020

It’s #InternationalBeerDay! Next-generation sequencing yeast could be the future to making better beers. What does your perfect beer look like?https://t.co/PmNj93kMbb pic.twitter.com/hvYF5wwnyu

— Illumina (@illumina) August 7, 2020

Genomic insights can potentially transform human health and everyone should have the opportunity to benefit from the power of precision medicine. How are we breaking down barriers to ensure access for all?

Read more: https://t.co/uMKoVnx32Q pic.twitter.com/q6G4Qxi65F

— Illumina (@illumina) August 7, 2020

#COVID19 testing is a vital part of a confident return-to-school plan, and we are proud to be involved in Testing for America's work to bring students back to HBCUs this fall.https://t.co/XUGeDFTDdo https://t.co/LEPmNwvz4i

— Illumina (@illumina) July 28, 2020

Minutes matter. The new Illumina DNA PCR-Free Prep kit expedites whole-genome sequencing by improving prep times to a mere 90-minutes.

Read more: https://t.co/k6wgDGArJc pic.twitter.com/KDm4eSmfCm

— Illumina (@illumina) July 27, 2020

Welcome to the Illumina family, Enancio. Together with this genomic compression software company, we will reduce data storage and transfer costs associated with today’s data deluge.https://t.co/dC6woFwwUs pic.twitter.com/LwcnUWRLtJ

— Illumina (@illumina) July 14, 2020

Sawyer was diagnosed with TRIP12. His journey to a diagnosis was 8-years. “I was so excited I could finally move forward,” said his mom, Hillary. “I couldn’t believe it, I was shocked.” https://t.co/hZqY2uBG31 pic.twitter.com/5e68iHV47T

— Illumina (@illumina) July 10, 2020

We’ve released a new collaboration environment for studying #COVID19 host response, which leverages the BaseSpace Correlation Engine. Learn more here:

— Illumina (@illumina) July 9, 2020

Carson and Chase were diagnosed with MEPAN. “We got the diagnosis through whole-genome sequencing, and that was after 6-yrs of searching.” Their message to other families – do not give up!https://t.co/hZqY2uBG31 pic.twitter.com/jSMcmwX06N

— Illumina (@illumina) July 9, 2020

We are excited to launch our new curbside-recyclable packaging for shipping frozen reagents. The insulated shipping containers are made with plant-based renewable materials and require less energy to make.

Learn more: https://t.co/9kjF7cLcfq pic.twitter.com/7AWD7C2oLW

— Illumina (@illumina) June 24, 2020

Our noninvasive prenatal screening kit (NIPT) has received regulatory approval in South Korea. Learn more: https://t.co/xBZr2fxHei pic.twitter.com/EPAes5ngE6

— Illumina (@illumina) June 24, 2020

Illumina Accelerator has selected seven early-stage companies to join its first global cohort of breakthrough genomics startups in Cambridge, UK, and the San Francisco Bay Area.

Learn more: https://t.co/Zw4f5xYuiL pic.twitter.com/bIBhvzvJgU

— Illumina (@illumina) June 23, 2020

We are excited to announce the new RNA library preparation product portfolio, including Stranded Total RNA for whole transcriptomes, Stranded mRNA or poly(A) mRNA, and RNA with Enrichment for targeted transcriptomes.

Learn more: https://t.co/Iiq5bwt46t pic.twitter.com/nolxjQKHC9

— Illumina (@illumina) June 23, 2020

“@idtdna has a great history of partnership with @BlueBeeGenomics, so we are pleased to learn their innovative platform will join the industry-leading sequencing technology provided by our strategic partner Illumina.” pic.twitter.com/kN8OdxV6vy

— Illumina (@illumina) June 18, 2020

“Having these two partners now as part of one company will allow all parties to accelerate growth, expand our offering and, most importantly, help women with breast cancer around the world.” pic.twitter.com/vsb9SfpZsh

— Illumina (@illumina) June 18, 2020

“Our team is encouraged at the prospect of joining Illumina where we believe we can merge high power computing and advanced data science technologies to help propel genomics forward and deliver on its clinical promise.” pic.twitter.com/xgAjkMVtU4

— Illumina (@illumina) June 18, 2020

Welcome to the Illumina family, @BlueBeeGenomics. Together we will provide the most scalable, efficient, and extensible genomic analysis solutions for both clinical and translational research use cases. https://t.co/SIEv5HDInN pic.twitter.com/svELutNwOi

— Illumina (@illumina) June 17, 2020

COVIDSeq leverages the performance of NGS to help address the global need for diagnostic testing to fight the #COVID19 pandemic.

— Illumina (@illumina) June 10, 2020

We are pleased to support @Ginkgo in finding innovative ways to leverage NGS for #COVID19 testing. https://t.co/bHFAqyW7FZ

— Illumina (@illumina) May 28, 2020

Since many students are currently at home, we are bringing the classroom to you. Learn more about DNA with our new Genomics 101: At Home video series: https://t.co/Fz4RAZw2ZE #distancelearning #DNA #STEMeducation pic.twitter.com/fLyF6Al3z5

— Illumina (@illumina) May 26, 2020

Congratulations Illumina CEO @fdesouza for being recognized by The Healthcare Technology Report as a Top Healthcare Technology CEO of 2020 https://t.co/n2558L7r3R pic.twitter.com/dI5nzt8RkY

— Illumina (@illumina) May 21, 2020

We are proud to announce our $10 million commitment toward #COVID19 response and research efforts.

Read more:

— Illumina (@illumina) May 18, 2020

While #COVID19 has dramatically increased the challenges that already face the #RareDisease community, Illumina’s mission to help patients with rare diseases by unlocking the power of the genome has not slowed down, and our message is still one of never-ending hope.

— Illumina (@illumina) May 14, 2020

The UK is relying on whole human genome and viral sequencing to get a clearer picture of #COVID19.

Learn more: https://t.co/oxYem8q73x pic.twitter.com/SzZ8UV8tvu

— Illumina (@illumina) May 13, 2020

We’re pleased to welcome Alex Aravanis back to Illumina as our new Chief Technology Officer, leading our research and technology development functions.

— Illumina (@illumina) May 4, 2020

Our CEO @fdesouza spoke with Mike Milken at the @MilkenInstitute about how Illumina is working toward new applications that can help fight the #COVID19 pandemic.

Listen here: https://t.co/GfBlcmPkgj

— Illumina (@illumina) May 1, 2020

We have donated sequencing systems and related consumables to the @AfricaCDC for their #COVID19 efforts to help provide access in 10 countries.

Read more here:

— Illumina (@illumina) April 28, 2020

We are proud to be ranked as one of the Best Employers in #Singapore & #1 in the Health Care Equipment and Services Industry. In this time of social distancing, we are honored that our employees rallied together to recognize us. #illuminaproud
https://t.co/wBkygkTEYq pic.twitter.com/BtxWkSqUoY

— Illumina (@illumina) April 28, 2020

We believe in the advancement of personalized medicine guided by comprehensive genomic profiling to improve patient outcomes. We’re one step closer to helping make this the standard of care in oncology.

Now shipping TSO 500 ctDNA & TSO 500 HT. #AACR20 https://t.co/7Zy00Q1FIg

— Illumina (@illumina) April 27, 2020

Our commitment to diversity, inclusion and respect for all is a core part of our culture. But, there is still so much to do to create a fair and inclusive society. https://t.co/j9O2v6QuFE

— Illumina (@illumina) June 3, 2020

https://twitter.com/illumina/status/1253805405701984256

Registration is open for our second webcast on July 21st featuring @EricTopol and @PhilFebboMD_CMO discussing the role #genomics plays in reimagining #healthcare. Register here: https://t.co/pMKlg6qb7P pic.twitter.com/VMpcrIqXHo

— SPARK Genomics (@sparkgenomics) July 20, 2020

In response to #COVID19, we have seen unprecedented collaboration among the medical and scientific communities. @PhilFebboMD_CMO shares his perspective: https://t.co/3uG8w4lxTz pic.twitter.com/4PesDuwhcj

— SPARK Genomics (@sparkgenomics) June 8, 2020

#DYK: Viral mutations can help a virus spread, but can also be used to stop the spread. Give your students the tools to step in the role of Data Scientist and understand the transmission of viruses with NEW virtual activities from @Illumina: https://t.co/m76cIpMYKw pic.twitter.com/5u1OMe5s3G

— Discovery Education (@DiscoveryEd) September 18, 2020

You can help your students adjust to a new world of #virtuallearning through the lens of genomics!

Inspire students with dynamic resources from #DNADecoded that explore how our genes interact with one another and the environment: https://t.co/JOExDrhoRc @Illumina pic.twitter.com/TV3dEcgZ2f

— Discovery Education (@DiscoveryEd) May 5, 2020

Last week I hosted a #BackToSchool Kids Chat with @illumina employees and their kids to talk about #COVID19 and staying safe the school year starts. Special thanks to the families that joined and the kids who asked great questions! https://t.co/GpvgiwdfDB

— Phillip Febbo, MD (@PhilFebboMD_CMO) September 14, 2020

I'm very excited to be a part of this study that demonstrates the role of repeat expansions in autism and also demonstrates how repeat expansions can be integrated in studies of complex disorders. Great working with @RKCYuen and researchers at @SickKidsNews and @UofT https://t.co/rcymdmyQbo

— Mike Eberle (@MikeEberle) July 27, 2020

https://twitter.com/SequencingQueen/status/1260568131287818243

Congratulations to the DRAGEN team on this impressive result and to our customers and collaboraters around the world who motivate us to push the envelope! https://t.co/d8SkRhaOBZ

— Susan Tousi (@susantousi) August 4, 2020

It has been a great first two years for #DRAGEN on board at @illumina. #innovationliveshere #illuminaproud https://t.co/ByI8ECQlvs pic.twitter.com/OMs3eCmj2j

— Susan Tousi (@susantousi) May 19, 2020

Today we celebrate the 20th anniversary of the publication of the first human genome by the Human Genome Project, ushering in a new era of science and benefitting human health #HumanGenome20 https://t.co/mh6OtWus41 @JCVenter @NIHDirector @BillClinton pic.twitter.com/ihWJn3tbe9

— Francis deSouza (@fdesouza) June 26, 2020

“I have never seen a diagnostic tool that’s made such a huge
impact in intensive care medicine in all my years.” Powerful data from @RadyGenomics, #ProjectBabyBear showing value of genome sequencing for infants with genetic diseases #raredisease #rWGS https://t.co/he3xoiGVfa pic.twitter.com/LbfneXQAQE

— Francis deSouza (@fdesouza) June 18, 2020

Genomic sequencing is key to understanding the influence of genetics on patient susceptibility to #COVID19 , informing treatments and future global outbreak response. @Illumina is proud our support longtime partner @GenomicsEngland on this important study. https://t.co/ecD2KwsFS9

— Francis deSouza (@fdesouza) May 13, 2020

Today, on #DNADay2020, I’d like to recognize the scientists, researchers and health care professionals who are using genomic sequencing to study the virus, understand different human responses and develop therapies and vaccines for #COVID19 https://t.co/Cg0PEyZmg3

— Francis deSouza (@fdesouza) April 25, 2020

Great article by @hannahkuchler on the importance of start-up investment during the pandemic – exactly what we believe at the Illumina Accelerator. https://t.co/IaPfchwYTQ

— Paula Dowdy (@PaulaDowdy) August 4, 2020

Well-deserved recognition of @AnnaSchuh3 's important and novel work to bring NGS analysis to benefit children with blood diseases in sub-Saharan Africa. https://t.co/fX8AQ8j3wh

— Paula Dowdy (@PaulaDowdy) July 28, 2020

We @illumina are proud to support @genomicmedswe, @karolinskainst & @KarolinskaUnsju. Whole genome/transcriptome sequencing could potentially change the standard of care for diagnosing certain blood cancers in Sweden #WorldBloodCancerDay https://t.co/vCwG1ODGfB

— Paula Dowdy (@PaulaDowdy) May 28, 2020

Illumina is proud to support Genomics Medicine Ireland in its offer of free genome sequencing services to scientists in Ireland working to identify protective and risk-bearing genetic factors for COVID-19 https://t.co/QrcrphgmYc pic.twitter.com/9lWCNlxURS

— Paula Dowdy (@PaulaDowdy) April 27, 2020

Dr. Stephen Kingsmore shares the success of #ProjectBabyBear, our CA-funded program providing #rWGS for critically ill infants enrolled in MediCal. rWGS should be standard of care for all babies & children with undiagnosed rare genetic diseases. https://t.co/HZb9IL5HM5 #genomics

— Rady Genomics (@RadyGenomics) June 24, 2020

Genetic experts analysing COVID-19 have made some interesting discoveries about the disease and how it attacks the human body.

They've found the virus is changing as it sweeps around the world and an individual's vulnerability could depend on blood type. @benavery9 #9News pic.twitter.com/FFiYYNZycI

— 9News Sydney (@9NewsSyd) June 13, 2020

#AirQualityAwarenessWeek may be coming to a close, but our work to bring about positive change doesn’t stop here. This is how one clean energy project has already made a difference in the local San Diego community. #TogetherWeCan protect air quality @illumina #BeTheSolution pic.twitter.com/3SlPObyQ1V

— Bloom Energy (@Bloom_Energy) May 9, 2020

Massachusetts Vol.21 (corporations: Thermo Fisher Scientific)

#NGS is helping researchers track the spread of #COVD19. @PKennyLab shares how he used our SARS-CoV-2 Research Panel to track the spread of one strain of the virus across three states to its origin at a meatpacking plant in Iowa with the @washingtonpost. https://t.co/yBvgkY4e6A

— Thermo Fisher (@ThermoFisherPR) September 25, 2020

Researchers at @BristolUni have made a significant #COVID19 drug target discovery using Thermo Fisher's #CryoEM technology. These findings will be valuable in building out a pharmacological arsenal against COVID-19 and other viruses or future pandemics. https://t.co/wylNgx03R9

— Thermo Fisher (@ThermoFisherPR) September 24, 2020

Senate #COVID19 hearing: HHS Assistant Secretary Admiral Brett Giroir answers Senator Jerry Moran about open call for labs who'd increase testing if the feds provide Thermo Fisher Scientific instruments & tests. pic.twitter.com/Nz9xDkF5R7

— Thermo Fisher (@ThermoFisherPR) September 17, 2020

We are investing over $140 million to further expand our laboratory plastics consumables production to support the global demand for #COVID19testing. https://t.co/bsDIu6sqEn pic.twitter.com/U8Ej4DupDA

— Thermo Fisher (@ThermoFisherPR) September 15, 2020

#TheJustProject is increasing #COVID19 testing capacity of #HBCUs across the country. @NBCNews shows how leadership is utilizing Thermo Fisher-donated equipment to protect students. https://t.co/UFzYKcnQ9V @HowardU @Morehouse @MSM_GME @MeharryMedical @XULA1925 @_HamptonU

— Thermo Fisher (@ThermoFisherPR) September 15, 2020

We are happy to be a part of @xprize Rapid COVID Testing, a competition that brings together leaders in health and tech to develop frequent, fast, cheap and easy #COVID19 testing. https://t.co/MtsAFYh92V

— Thermo Fisher (@ThermoFisherPR) September 3, 2020

New protocols published in @Clin_Chem_AACC by @blood_pac will help define industry standards in the development of liquid biopsy diagnostic tests and accelerate development of #NGS-based circulating tumor DNA (NGS-based ctDNA) diagnostic tests. https://t.co/I1a7pJlXGr

— Thermo Fisher (@ThermoFisherPR) September 2, 2020

Breath testing is a non-invasive way to monitor our biology, providing a potential tool for the early detection of diseases through #precisionmedicine. https://t.co/Qs7rCY0vmZ

— Thermo Fisher (@ThermoFisherPR) August 20, 2020

As part of our continued efforts to support transplant patients during the pandemic, we've developed a new serological assay targeted towards #transplant candidates and recipients that can detect #antibodies directed against #COVID19. https://t.co/pYdIaDLCDE

— Thermo Fisher (@ThermoFisherPR) August 13, 2020

Our cGMP-compatible CTS Series Laboratory Equipment is designed to minimize the challenges #cellandgenetherapy manufacturers face so they can focus on using science to save patient lives. https://t.co/C45Y6h7qjG

— Thermo Fisher (@ThermoFisherPR) August 6, 2020

To help alleviate some of the constraints #oncology labs are facing under #COVID19, we are expanding our GlobalAccess Sequencing Program to include these labs. https://t.co/RLG8IUKQGr #NGSRedefined pic.twitter.com/fXuJga3ZEM

— Thermo Fisher (@ThermoFisherPR) July 30, 2020

Dr. Paraic Kenny says genetic analysis of SARS-CoV-2, including his research @gundersenhealth using Thermo Fisher's #NGS assay, can provide a "warning of when to anticipate a surge in cases.” @AliceParkNY covers the quest to trace #COVID19 for @TIME. https://t.co/QbHhZfUn41

— Thermo Fisher (@ThermoFisherPR) July 27, 2020

Inovio has partnered with Thermo Fisher Scientific to manufacture its in-development COVID-19 vaccine. We're grateful for their efforts to meet demand for the vaccine once it's available. https://t.co/Mh7AnjpEdv pic.twitter.com/JJUJOKc4sd

— MasterControl (@MCMasterControl) September 22, 2020

IOM deployed Thermo Fisher (TF) system for testing truck drivers at @icrhk_official laboratory located at Coast General Hospital. The semi-automated RNA extraction instrumentation and fast RT-PCR allows testing of 300-400 specimens within a day. @DimancheSh @sidchat1 @IOM_DRD pic.twitter.com/J2NYkMbfwY

— IOM Kenya (@IOMKenya) September 22, 2020

INOVIO is excited to have @ThermoFisher join our Manufacturing Consortium for our #COVID19 #DNAVaccine candidate, INO-4800. Read more here: https://t.co/xtdG7Ydcpd pic.twitter.com/6gTjCq7Q6C

— INOVIO Pharmaceuticals (@InovioPharma) September 8, 2020

We had an all-star lineup of @thermofisher's Marc Casper, @cardinalhealth's Mike Kaufmann, @GEHealthcare's @KieranMurphyCEO and former Cardinal CEO and Chair, George Barrett to talk about one of the biggest issues of #COVID19: supply chain operations. https://t.co/um3c8wGmLN

— Health Evolution (@TheHealthSummit) September 3, 2020

With #Covid19 disproportionately affecting the Black community, historically Black colleges and universities (HBCUs) are beginning to increase #coronavirus screenings.

It's part of @thermofisher's Just Project initiative pic.twitter.com/jVAs9ZL6ag

— Bloomberg QuickTake (@QuickTake) September 2, 2020

@verilylifesci has developed its own CLIA-certified #lab focused on #COVID19 testing. The lab will be based in South #SF and uses @thermofisher technology. @amazon has its own labs to test its warehouse workers. https://t.co/hfPlmBZHBQ

— Amine Korchi MD (@AmineKorchiMD) August 12, 2020

The PCR test is known to be extremely sensitive, as well as specific, for the virus. The PCR tests for the Governor, First Lady, and staff were run twice. They came back negative the first time and came back negative when they were run on a second diagnostic platform.

— Governor Mike DeWine (@GovMikeDeWine) August 7, 2020

Academic labs considering a new SEM should choose one that addresses current and future needs, can save time and money, and accelerates research programs. Read our latest blog for details on the four criteria to consider. https://t.co/1Opzr5wox6

— Microscopy & Spectroscopy (@thermosciEMSpec) September 22, 2020

Molecular biologists use spectrophotometers for protein quantitation quality control so downstream experiments deliver accurate results. Read our blog to learn how our NanoDrop identifies sample contaminants to more accurately measure protein concentration.https://t.co/OQiB02pxGs

— Microscopy & Spectroscopy (@thermosciEMSpec) September 17, 2020

Congratulations for uncovering how thyroid hormone synthesis works at a molecular level. We’re glad to see @DiamondILO making worldwide cryo-EM collaborations like this possible, accelerating drug discovery research. https://t.co/AvCD44Y1Nk

— Microscopy & Spectroscopy (@thermosciEMSpec) September 16, 2020

Dr. Beth Mason, Verschuren Centre at Cape Breton University, and her team of researchers are looking at ways to embed compounds into plastic packaging that kill the coronavirus. Read more about their research in our latest blog. https://t.co/rbXFYlhLtU

— Microscopy & Spectroscopy (@thermosciEMSpec) September 10, 2020

Steel helps power the global economy. Read how our Phenom ParticleX Steel SEM provides manufacturers the info needed to produce high-quality steel by quickly analyzing the size & location of inclusions and getting necessary elemental composition. https://t.co/1ysj2bYqOZ

— Microscopy & Spectroscopy (@thermosciEMSpec) September 8, 2020

.@OutsourcPharma interviewed our senior director of pharma and shared how our new cryo-EM access program enables our pharmaceutical and biotech customers to improve their drug discovery process. https://t.co/hhgbgGs9c7

— Microscopy & Spectroscopy (@thermosciEMSpec) September 4, 2020

Companies are turning to additive manufacturing to develop new parts with polymer materials or metallic powders. XRD is ideal to examine the 3D crystalline structures of these materials because it's non-destructive and fast. Learn more in our latest blog. https://t.co/d6f38drISJ

— Microscopy & Spectroscopy (@thermosciEMSpec) September 3, 2020

We know about the promises of 5G. But did you know ceramic materials can be used to construct 5G antenna arrays? Read our latest blog to see how X-ray diffractometers & X-ray fluorescence spectrometers provide the capabilities to analyze these materials. https://t.co/RZhWfGBPQk

— Microscopy & Spectroscopy (@thermosciEMSpec) August 27, 2020

Why IEDs are considered one of the most prevalently used explosive device employed by criminals worldwide…https://t.co/cQRkOl5jxf #safety #security #borderprotection pic.twitter.com/R5svK1I53t

— Thermo Scientific (@thermosci) August 20, 2020

Watch the video to see how the Prima Process Mass Spectrometer reports respiratory gases including inerts and volatiles in seconds, with extremely high levels of precision. https://t.co/emprLMJVhd pic.twitter.com/m0px6DKB21

— Thermo Scientific (@thermosci) August 20, 2020

What happens when the carbon content of #steel is increased? Learn the important characteristics that are strengthened or reduced. https://t.co/hub8M4ZTbn pic.twitter.com/Qz6Zx2EAeK

— Thermo Scientific (@thermosci) August 19, 2020

Did you know 75% of #copper produced since 1900 is still in use? For best re-use, XRF analysis should be done on #recycled #metals. https://t.co/0hvDBnuP4J pic.twitter.com/oZkmiXFxjV

— Thermo Scientific (@thermosci) August 18, 2020

For #CBRNE professionals every second counts when needing to accurately identify illicit substances. Gemini LowDose Analyzer provides ease of use and improved accuracy when testing low distribution substances. Learn more on @cbrne World. https://t.co/rVMDVjB8nq pic.twitter.com/bDkdIeqPtl

— Thermo Scientific (@thermosci) August 14, 2020

New public #safety challenge: Low, distributed concentrations of #narcotics making identifying illicit substances difficult. Gemini Analyzer with LowDoseID can help. Read @spectroscopyeurope. https://t.co/88SH0Bgstv

— Thermo Scientific (@thermosci) August 14, 2020

Enjoy Your July 4th Holiday and the Metals Helping You BBQ! https://t.co/vct5P4wKdM pic.twitter.com/volHyT1mgP

— Thermo Scientific (@thermosci) June 30, 2020

9 Facts About Fireworks and the Minerals They Containhttps://t.co/NttRmv1StW pic.twitter.com/mewtLuYHUd

— Thermo Scientific (@thermosci) June 30, 2020

Why TIME matters?
When it comes to #sepsis, TIME matters. For every hour treatment is delayed, the risk of death increases by as much as 8%. As many as 80% of sepsis deaths could be prevented with rapid diagnosis and treatment. https://t.co/vyr8WQQbEx pic.twitter.com/NG6zsEr4kp

— Thermo Fisher (@thermofisher) September 25, 2020

Now upgraded to contain full length genomic RNA!
Ultra-Low #COVID19 control enables you to monitor your assay where it is most critical to avoid reporting false-negative results #SARSCoV2 #coronavirus https://t.co/8Dn6VeuO6Z pic.twitter.com/WEc8R7MLqR

— Thermo Fisher (@thermofisher) September 25, 2020

Learn to solve your most challenging patient assessment decisions with experts Drs. Gluck and Broyles as they discuss the role of #PCT in #COVID19 patients in their podcast with @emnews #Procalcitonin https://t.co/BMPgTv70Ho pic.twitter.com/TnVvcLceC0

— Thermo Fisher (@thermofisher) September 24, 2020

Only assays specifying "B·R·A·H·M·S PCT" in their product name are based on B·R·A·H·M·S antibodies and can refer to established clinical #PCT cut-offs. https://t.co/jecixuN3uS #Procalcitonin #antibioticstewardship https://t.co/lllmfgZAJE pic.twitter.com/hmKVNLYvhT

— Thermo Fisher (@thermofisher) September 23, 2020

New AcroMetrix SARs-CoV-2 RUO Control! Mimics patient sample and compatible with most #COVID19 molecular testing assays on the market as it contains inactivated #SARSCoV2. https://t.co/4NMX0zO36m #coronavirus pic.twitter.com/9qkbJVuW5L

— Thermo Fisher (@thermofisher) September 23, 2020

We are excited to announce the launch of our Oncomine Clinical Research Grant program to support oncology and reproductive health studies. Awardees will have access to our cutting-edge Genexus System. https://t.co/AwfFZy2LZQ #NGS #NGSRedefined

— Thermo Fisher (@thermofisher) September 23, 2020

Rio Tinto Bell Bay Aluminium is following a simple, three-step plan to transform its mining operations with Thermo Scientific™ SampleManager LIMS™ software. https://t.co/MieR6owvVg

— Thermo Fisher (@thermofisher) September 23, 2020

Did you know that Thermo Fisher Scientific offers a large menu of FDA-cleared drugs of abuse reagents for urine, oral fluid and serum samples and four sample validity assays to detect adulteration? https://t.co/vfswcre3f3 #drugsofabusetesting pic.twitter.com/OFKmZpX0nf

— Thermo Fisher (@thermofisher) September 22, 2020

Reduce cost and optimize your lab workflow with improved turnaround time. Learn how B·R·A·H·M·S #KRYPTOR compact PLUS can improve the operational efficiency in your lab. https://t.co/NaNaLNv3Lj #brahms #immunoanalyzer #clinicallab #powerfulprecision pic.twitter.com/vI0NYuCzfV

— Thermo Fisher (@thermofisher) September 21, 2020

See how Laboratory Information Management Systems (LIMS) help food testing laboratories maintain data integrity, protect product quality and comply with updated ISO 17025 requirements. https://t.co/v3kIQHWXwE

— Thermo Fisher (@thermofisher) September 21, 2020

ALL-IN-ONE autoimmunity resource. Get a complete overview of EliA™ autoimmune tests and Phadia™ Laboratory Sytems in a few clicks. Searchable product catalog. Easy-to-find lab documentation. And a lot more. Go to the source: https://t.co/ROxvglMthY pic.twitter.com/zbjBQDXKPo

— Thermo Fisher (@thermofisher) September 16, 2020

Read the feature article “Elucidate the underlying mechanisms of Parkinson's disease” in the latest #BioProbes journal. #Connect2Science https://t.co/Oud7tssJ0N pic.twitter.com/5Paptrl0kS

— Thermo Fisher (@thermofisher) September 11, 2020

We’ve been hearing about the potential timing of a vaccine for #COVID19 since the beginning of the pandemic. Listen to this episode of #ScienceWithATwist to learn about vaccine development and the three main methods being pursued by drug companies. https://t.co/YCB5QRcycs pic.twitter.com/b3y75wdCB1

— Thermo Fisher (@thermofisher) September 10, 2020

Which vaccine type is missing? It involves something being separated out to create an immune response to that particular part. Not sure? Download the #vaccinedevelopment infographic to learn more. https://t.co/vM4wqCA7J0 pic.twitter.com/T3zYEvJBtw

— Thermo Fisher (@thermofisher) September 9, 2020

For many labs, it’s easier to run an autoimmune test than to find all the documentation for ordering, instrument operation, and audits. We fixed that. Go to the source for labs at: https://t.co/cUcaGXvSNQ pic.twitter.com/2xIlAEv0UX

— Thermo Fisher (@thermofisher) September 9, 2020

Now FBI NDIS-approved: RapidHIT ID System #RapidDNA #SafetySpeaks #EveryMinuteCounts https://t.co/3H7Ty42LMr

— Thermo Fisher (@thermofisher) September 8, 2020

Market conditions have hindered adoption of digital transformation initiatives in the oil and gas sector. See why digitization is more essential than ever, with three key areas to help your lab get started. https://t.co/a4QFYH3he9

— Thermo Fisher (@thermofisher) September 7, 2020

We have partnered with @NanoimagingS to increase access to cryoelectron microscopy (cryoEM) technology for the global pharmaceutical and biotechnology community. #Cryoem technology uses electrons to study samples frozen at cryogenic temperatures. https://t.co/Cis2DcXTjK

— Thermo Fisher (@thermofisher) September 3, 2020

Awesome! <3 https://t.co/82QU8oy7H1

— Thermo Fisher (@thermofisher) September 3, 2020

We are proud to launch this historic #COVID19 testing partnership with @Morehouse @HowardU @XavierU @MeharryMedical and @_HamptonU with the goal of expanding to every #HBCU in the country. Read more about #TheJustProject from @Wright_One on @TheUndefeated https://t.co/NUWTS71HKM

— Thermo Fisher (@thermofisher) September 2, 2020

Pinpointing an autoimmune diagnosis can be difficult. Our new online lab resource is not. Find over 50 clinically relevant tests, a full product catalog, and product documentation all on one site. Go to the source for autoimmune diagnostics: https://t.co/vsdlaJHMpX pic.twitter.com/y3fSjmWl1l

— Thermo Fisher (@thermofisher) September 2, 2020

Do you spend a lot of time imaging? Find out about social distancing solutions such as Invitrogen™ EVOS™ Imaging Systems. Connect with a specialist like Mike Howren for a #virtualdemo. #BacktotheLab #ScienceComeback https://t.co/D5pMNwybOR pic.twitter.com/5vl7S3PfUF

— Thermo Fisher (@thermofisher) August 31, 2020

What you need to know about loading control #antibodies. DOWNLOAD the infographic for help in choosing the right ones for assessing #westernblotting efficiencies. #Connect2Science https://t.co/RZ2m4oXsdp pic.twitter.com/30JhBsoAde

— Thermo Fisher (@thermofisher) August 31, 2020

See how SampleManager LIMS software helps Codelco, the world's main copper producer, improve extraction and processing efficiency while supporting Good Laboratory Practice (GLP). https://t.co/wgwjvjdECo

— Thermo Fisher (@thermofisher) August 31, 2020

We are excited to welcome @GovLauraKelly @JerryMoran @SecretaryToland @KansasCommerce @dinah_sykes @Woodard4Kansas and @cityoflenexa to our manufacturing site opening in Lenexa, KS as we rapidly expand to meet demand for #COVID testing. https://t.co/woYivxlSh6 @ThermoFisherDC

— Thermo Fisher (@thermofisher) August 28, 2020

Built in just 6 weeks, our new Lenexa, KS site is increasing production of #COVID19 sample collection products and has created 300+ jobs. Ahead of our ribbon cutting tomorrow, thank you to our Lenexa colleagues for your hard work to meet a national need. https://t.co/9YK7g6mCm0

— Thermo Fisher (@thermofisher) August 27, 2020

How can we use less plastic? We're focused on reducing waste — for ourselves and for our customers. https://t.co/Ea3VJQRlli Learn about our #GreenLab solutions for less waste in #LifeintheLab pic.twitter.com/VQinCTnAyv

— Thermo Fisher (@thermofisher) August 27, 2020

Need to ramp up and optimize your #westernblots? Find out about a solution for imaging challenges by connecting with a specialist like Lisa Saad for a #virtualdemo. #BacktotheLab #ScienceComeback https://t.co/Xiz2qnE5Dh pic.twitter.com/5tkgBsJyad

— Thermo Fisher (@thermofisher) August 25, 2020

See how LIMS software can help you get ahead of the latest FDA mandate and achieve ISO 17025 accreditation for food safety testing. https://t.co/Z7pTcFyEGX

— Thermo Fisher (@thermofisher) August 24, 2020

In #hematologyoncology, understanding the genetics driving acute malignancies is important to determine how to best address them. Our new portfolio of assays for the Genexus System is enabling a future where #NGS turnaround times can be reduced to 24 hours https://t.co/0cq0nrilIl

— Thermo Fisher (@thermofisher) August 20, 2020

Did you know that Thermo Fisher Scientific offers a large menu of FDA-cleared drugs of abuse reagents for urine, oral fluid and serum samples and four sample validity assays to detect adulteration? #drugsofabusetesting https://t.co/kUNtLFMYMQ https://t.co/Jjws7M3F4N pic.twitter.com/A91F9WpPpB

— Thermo Fisher (@thermofisher) August 20, 2020

Find the essential lab products you need to keep moving your experiments moving forward. #ScienceMustGoOn https://t.co/3F8CAcqkpy pic.twitter.com/0QzALwC6tG

— Thermo Fisher (@thermofisher) August 20, 2020

See how LIMS software can help you get ahead of the latest FDA mandate and achieve ISO 17025 accreditation for food safety testing. https://t.co/41dqHM1ehY https://t.co/qv4ILtLpXe

— Thermo Fisher (@thermofisher) August 19, 2020

We’re excited to announce a new companion diagnostic agreement for #oncology w/ Hengrui Therapeutics, Inc., which will leverage our Oncomine Precision Assay and Ion Torrent Genexus System to help match patients with targeted therapies faster https://t.co/smEZf6e8y2 #NGSRedefined

— Thermo Fisher (@thermofisher) August 17, 2020

Learn how Thermo Scientific™ SampleManager LES™ software helps laboratories drive process compliance and enable electronic management of SOPs. https://t.co/ST0xjxX1tF

— Thermo Fisher (@thermofisher) August 17, 2020

Learn how Thermo Scientific™ SampleManager LES™ software helps laboratories drive process compliance and enable electronic management of SOPs. https://t.co/S0PB0uEsWP

— Thermo Fisher (@thermofisher) August 13, 2020

Accelerate your SARS-CoV-2 research
Helping to accelerate national, multi-institutional efforts focused on mapping SARS-CoV-2 transmission and epidemiological studies with data to be shared among the scientific community partners.
Request details>> https://t.co/zYOOzYYnND pic.twitter.com/07d5BFjHoH

— Thermo Fisher (@thermofisher) August 12, 2020

Does your lab test for sample adulteration on your urine drugs of abuse specimens. It's easy to perform sample validity tests on many chemistry analyzers. #drugsofabusetesting https://t.co/7jNSpxNbac pic.twitter.com/bxHwjYyY6E

— Thermo Fisher (@thermofisher) August 6, 2020

Through our partnership with FCS Express Software, we are able to create an even more seamless workflow for #laboratories using our Invitrogen Attune NxT Acoustic Flow Cytometer System. https://t.co/TmfR4g71ei pic.twitter.com/hh86dUMxN3

— Thermo Fisher (@thermofisher) August 6, 2020

With new Thermo Scientific™ SampleManager LIMS™ software cloud services, labs can benefit from one of the world’s most deployed LIMS, hosted on AWS and managed by Thermo Fisher Scientific, the world leader in serving science. https://t.co/k8bqjpQXJ3 pic.twitter.com/OPqeK1loZg

— Thermo Fisher (@thermofisher) August 6, 2020

Our response to #covid19testing continues to expand with a new highly automated, real-time PCR solution designed to analyze up to 6,000 samples a day. https://t.co/QFrDqF3x1K pic.twitter.com/oHM2tGnbog

— Thermo Fisher (@thermofisher) August 5, 2020

Have you seen our recyclable #papercooler boxes? Learn more about our #sustainablescience efforts in #LifeintheLab https://t.co/Ba6Fs7Ipmy pic.twitter.com/LWxOJPXXcB

— Thermo Fisher (@thermofisher) August 3, 2020

I joined @SecretaryToland to celebrate @thermofisher's brand new site in Lenexa. They've been producing COVID-19 testing products since the onset of this pandemic, and their new facility will further support our efforts to strengthen the economy and protect public health. pic.twitter.com/HHaHZc6Bbc

— Governor Laura Kelly (@GovLauraKelly) August 28, 2020

World Vol.48 (mainly on U.S.)

The @WAFarmBureau the @IDFarmBureau and the @OreFarmBureau all support the Emergency Wildfire and Public Safety Act of 2020.https://t.co/8Bj7Bj4idt pic.twitter.com/hNV4GAg4WF

— PNWAgNetwork (@PNWAgNetwork) September 17, 2020

OSU is now offering analysis of smoke impacted grapes and wine for free smoke phenol compounds. Find out how you can take part with Oregon Wine Research Institute. #oregonwine #foodscience https://t.co/txneYK4BhO pic.twitter.com/7Dq6o94sKf

— OSU Ag Sciences (@OSUAgSci) September 21, 2020

“The masks that we wear are cloth masks with no filters. We take them home to wash them because they are not disposable.” For many West Coast farm workers, wildfire season represents another crisis compounding the current coronavirus emergency: https://t.co/gKi8Kipmo6

— The Counter (@TheCounter) September 17, 2020

Washington State University gets $3 million for endowment to bolster food security https://t.co/1SqgEHxn8t

— Fruit Growers News (@FGNews) September 17, 2020

“We are Pasco-grown kids and have a Pasco-grown family — we want to source from Pasco,” said James Alford who is a third-generation farmer and owner of Alford Farms, Inc. with about 2,000 acres north of Pasco.https://t.co/2s313xfn1l

— Washington Farm Bureau (@WAFarmBureau) August 4, 2020

Ever heard of a Cosmic Crisp? It’s a new type of apple hitting supermarkets near you next month and growers are betting big on its success.

Our @KevTibs taste tests the fruit in Washington State and meets its developers to learn more. Watch more tonight on @NBCNightlyNews. pic.twitter.com/RCVXjsuFUC

— NBC Nightly News with Lester Holt (@NBCNightlyNews) November 23, 2019

The apple harvest is getting underway, and the Washington State Tree Fruit Association estimates this year's crop will be be slightly larger. https://t.co/USEyxUz2cp

— The Seattle Times (@seattletimes) August 11, 2020

Investment firms are starting to purchase Washington state tree fruit companies, including ones with a presence in the Yakima Valley. That’s prompted some family farmers to ask, “Do I hold on for more gains, or do I cash out?” https://t.co/uMurY7FZ6X

— The Seattle Times (@seattletimes) February 25, 2019

https://twitter.com/seattletimes/status/1027421720129486848

Wineries in California, Oregon and Washington have survived severe wildfires before, but the smoke from this year’s blazes has been especially bad — thick enough to obscure vineyards drooping with clusters of grapes almost ready for harvest. https://t.co/4aYWgdRThJ

— 4 News Now (@kxly4news) September 24, 2020

The 2020 Washington fresh apple crop will be similar to last year with an estimated harvest of 134 million 40-pound boxes, the Washington State Tree Fruit Association said. https://t.co/l2CjtguUBi

— Yakima Herald (@Yakima_Herald) August 10, 2020

Marionberries, known for their flavor and aroma, are named for Marion County. They’re called the “Cabernet of Blackberries” and are one of Oregon’s signature fruits.https://t.co/YcrPZDFKis

— KOIN News (@KOINNews) July 14, 2020

Anticipation of ripe #pears and #apples peaks in fall as fruits hang heavily from branches and begin their gravity-aided trip to the ground.

But how do you know when it’s prime picking time?https://t.co/wlkkyRHrvW #gardening #gardeningtips

— OregonStateUnivExt (@OregonStateExt) September 21, 2020

Sales of Oregon wine were up almost 13% in 2019 over 2018. ⁦@oregonwineboard⁩ https://t.co/4klk04WSzf

— Jill Barth (@jillbarth) September 23, 2020

2019 Troon Vineyards Kubli Bench Amber Applegate Valley ($30): A blend of biodynamically farmed Riesling, Vermentino, and Marsanne https://t.co/jJhicrQirq #wine #OregonWine #ORWine #ApplegateValley

— Craig Camp (@CraigCamp) September 25, 2020

If you're interested in how the Oregon wildfires have affected Oregon vineyards and what we're doing to support harvest and the Oregon Wine Industry as a whole, check out this piece by @KGWNews! https://t.co/6FOeEjRK28 #oregonwine #oregonharvest2020 #drinkoregon

— Willamette Valley Vineyards (@WillametteVV) September 18, 2020

Michigan Secretary of State Jocelyn Benson says it could take days after Election Day to tabulate ballots.

“We’re going to prioritize that full tabulation, that accuracy, over everything else,” she tells @brikeilarCNN. https://t.co/YuxCoKJYSj pic.twitter.com/NhV6ZoBJ3Q

— CNN Newsroom (@CNNnewsroom) September 24, 2020

Detection of COVID-19 has been one of the pandemic's biggest challenges. Infrared technology is fast becoming the preferred method for detecting symptoms in areas where people congregate. https://t.co/4koRMBP7ui pic.twitter.com/isOEmG9V1A

— CNBC (@CNBC) September 24, 2020

With COVID cases rising, foot traffic to restaurants is slowing throughout the Ninth District. See all current Ninth District COVID data on our dashboard: https://t.co/5e2Az0dEbX #dataviz pic.twitter.com/5eshwKQ88p

— Minneapolis Fed (@MinneapolisFed) September 23, 2020

https://twitter.com/DallasFed/status/1304048510355021824

Gov. Gavin Newsom is calling for California to ban new gasoline-fueled vehicles within 15 years in a bid to combat climate change and make the state the first in the nation to stop sales of internal combustion engines https://t.co/TQUMS43Jb4

— POLITICO (@politico) September 23, 2020

Will there be enough electric cars and trucks available?

There will. Automakers are getting serious about moving past combustion engines. There will be dozens and then hundreds of models available between now and 2035. https://t.co/j2OENFlD67

— Los Angeles Times (@latimes) September 23, 2020

Our local & state governments are locked in a dysfunctional marriage.

Our cities adopt laws that increase motor vehicle trips & pollution. Our state government then passes regulations to undo the damage – but falls short.

Here are 4 ways to fix this.
1/nhttps://t.co/b2lXdvgo4w

— Patrick Siegman (@PatrickSiegman) September 23, 2020

https://twitter.com/NRDC/status/1308923733772566530

This is awesome – kudos @GavinNewsom! Note that this is consistent with the national zero-emissions vehicle sales standard (reaching 100% of new car sales by 2035) in the House Democrats' @ClimateCrisis Committee Plan.https://t.co/CWGPn6kLjD

— Dana Nuccitelli (@dana1981) September 23, 2020

Purdue University research is driving clean air changes in California and could lead to landmark vehicle emissions changes across the United States. https://t.co/hO2XusV2OM

— Purdue OIGP (@PU_OIGP) September 16, 2020

https://twitter.com/ToyotaPolicy/status/1307786878385614848

President Trump has made dismantling federal climate policies a centerpiece of his administration.

At least 100 environmental regulations have been repealed or weakened over the past four years. https://t.co/7PjUYDUBZ8

— The New York Times (@nytimes) September 17, 2020

Just like the US where California is leading in the terms of future vehicle policies,

with Kejriwal Govt's latest commitment to promoting EVs, Delhi can be a pioneer in promoting environment – friendly policies in India.
https://t.co/mSbVQQ1nvO

— AAP (@AamAadmiParty) September 23, 2020

An eerie orange smoke billows across the Oregon sky amid a disastrous wildfire season in the West. So far in 2020, #wildfires have burned almost 7 million acres in the US. @NOAA says wildfires in California were one of four weather disasters costing $1 billion or more last month. pic.twitter.com/FOxzuobZ9Q

— Pattrn (@pattrn) September 17, 2020

Smoke, ash affect crops and livestock in wildfires’ wake – #AgAlert coverage https://t.co/rc97aMYEVc #agchat #AgTwitter #cawildfires pic.twitter.com/wmo1TKMua7

— California Farm Bureau (@CAFarmBureau) September 22, 2020

#Farmers and #Farmworkers: Protecting our Food Supply and Sustaining our Industry in Times of Crisis https://t.co/JmaQOz9itq #Agriculture #COVID19 #FoodSecurity #Wildfires

— Calif Food and Ag (@CDFAnews) September 21, 2020

California farmer Vince Bernard, who saw more than 3,000 boxes of oranges rot when the coronavirus pandemic hit, is worried his citrus farm will wither before his eyes https://t.co/ni79QkQrGA pic.twitter.com/0YTy3QfGk6

— Reuters (@Reuters) August 24, 2020

https://twitter.com/calwater/status/1308452002570084353

And the bears were very happy. pic.twitter.com/gY4dFEysP5

— John Fusco (@JohnFusco12) September 24, 2020

We were warned: A key U.S. election software company says it’s been hacked by unknown parties https://t.co/d0EO4kjyuN

— The Daily Beast (@thedailybeast) September 24, 2020

Map shows the richest person in each US state. Wonder who will have lost most due to COVID19. Surely not Jeff… Source: https://t.co/MSzkYwpCg3 pic.twitter.com/ZBWhuVhv0H

— Simon Kuestenmacher (@simongerman600) May 30, 2020

https://twitter.com/Millenarian22/status/1304873134349152256
https://twitter.com/Millenarian22/status/1305245214135726087
https://twitter.com/Millenarian22/status/1305209971139698694
https://twitter.com/Millenarian22/status/1297582604296663040
https://twitter.com/mcimaps/status/1270812233686290432
https://twitter.com/mcimaps/status/1270794357478735879

Strong testimony by @dbongino, former U.S. Secret Service agent: “Please stop this ‘Defund the Police’ abomination before someone gets hurt.” pic.twitter.com/bnlnRP8UEL

— Senator Ted Cruz (@SenTedCruz) June 10, 2020

https://twitter.com/GovernorTomWolf/status/1259543729435807746

Why is America’s covid-19 death toll so high? https://t.co/QhXt11p4GS

— The Economist (@TheEconomist) April 22, 2020

In which countries is covid-19’s death toll higher than official counts suggest? Data from Sweden, Belgium, Austria and Turkey have been added to our tracker https://t.co/hBxsZwbv93

— The Economist (@TheEconomist) April 22, 2020

NEW: Inside the White House Situation Room yesterday, economic adviser Peter Navarro got into a heated dispute with infectious disease expert Dr. Anthony Fauci over the efficacy of the antimalarial drug hydroxychloroquine. Details here: https://t.co/lvpf9HRxy5

— Jonathan Swan (@jonathanvswan) April 5, 2020

"Why is Jared Kushner in charge of anything?": Trump’s son-in-law sparks outcry, confusion after coronavirus briefing debut https://t.co/TJgF2u2H6s

— The Washington Post (@washingtonpost) April 3, 2020

BREAKING: New report documents the many ties between the oil industry and the private prosecutor (Rita Glavin) who detained me — including that her spouse was a lawyer for Exxon and her own firm had @Chevron as a client.https://t.co/QMKDRSYmTh

— Steven Donziger (@SDonziger) September 25, 2020

https://twitter.com/urbgardenersrep/status/967176199188500481

Nutritional psychiatry: Your brain on food: https://t.co/x3Cbj7TeSf #HarvardHealth pic.twitter.com/R0ao9wmO3v

— Harvard Health (@HarvardHealth) September 24, 2020

https://twitter.com/WHO/status/1309120129733722113

We may be able to track and contain the spread of #COVID19 thanks to its mutations pic.twitter.com/473megjoPS

— Tech Insider (@techinsider) May 4, 2020

Salmon farmers have been hit by restrictions in China, where a new outbreak of the coronavirus was blamed on imported fish https://t.co/t9BKKLZ0Ll

— Bloomberg (@business) June 16, 2020

BREAKING: United Airlines says it will have to furlough 2,850 pilots if there is no new aid package. https://t.co/jn8limUSe7 pic.twitter.com/TNTNqygzkQ

— CNBC Now (@CNBCnow) August 27, 2020

A chemical fire erupted at a manufacturing plant in Westlake, Louisiana, in the wake of #HurricaneLaura. Officials warned residents to stay inside, close their doors and turn off air conditioning, describing the fire as "a hazardous material incident." https://t.co/zgBDWyYP1N pic.twitter.com/WYr0ibrLiN

— ABC News (@ABC) August 28, 2020

Coast Guard aerial video shows flooding along Highway 82 in southwest Louisiana after #HurricaneLaura made landfall in the area with maximum sustained wind speeds of 150 mph. https://t.co/mvx2siZsEG pic.twitter.com/dnbv0KJa10

— ABC News (@ABC) August 28, 2020

A message from Acting U.S. Ambassador to Canada Richard Mills on U.S.-Canada cooperation to repatriate citizens, facilitate essential trade across our shared border, and protect our hardest-hit communities during the #COVID19 pandemic. pic.twitter.com/2s3aZgXQL1

— U.S. Embassy Ottawa (@usembassyottawa) April 9, 2020

Prime Minister Justin Trudeau says there's 'exemplary' co-operation between Canada and the U.S. He says it will be many weeks before we can talk about relaxing Canada-U.S. border restrictions: 'There is a need to protect our citizens as every country is doing.'

— CBC News Alerts (@CBCAlerts) April 16, 2020

Oil investors stampede for the exit as price falls to minus $37.63 US a barrel. The negative price, a first, reflects the pessimistic outlook for demand. Oil is traded on the futures market; investors gamble on whether they can make money on the spread. https://t.co/I2hfjmjcaE

— CBC News Alerts (@CBCAlerts) April 20, 2020

Oil’s unprecedented price decline is a function of how commodities futures market operate. So gas stations won’t be paying American’s to drive any time soon. https://t.co/Ln7ISjFzUy

— Barron's (@barronsonline) April 20, 2020

“The internet is emerging as a technology of control, not just communication. Whoever runs the global Internet of Things, connecting billions of devices, will have a geostrategic advantage. And China is strengthening its position” https://t.co/Xmdi6waC52

— John Hemmings (@JohnHemmings2) June 16, 2020

"China-linked hackers are targeting US coronavirus vaccine research, FBI warns" https://t.co/PsRFgjGW4w

— John Hemmings (@JohnHemmings2) May 14, 2020

Australian politicians criticize the PRC for lying about the Coronavirus and allowing it to go abroad. https://t.co/nY04lJjxls

— John Hemmings (@JohnHemmings2) April 5, 2020

Official Chinese statistics put Wuhan’s coronavirus death toll at 2,563. Evidence coming out of the city suggests it was actually more than 40,000. Our latest: https://t.co/6D2zHtAd17

— Anna Fifield (@annafifield) April 3, 2020

Australia is hardly alone in having its exports threatened by the Chinese government. In the @smh, James Carouso & I suggest several ways for Australian businesses to become more resilient in the face of ongoing disruptions caused by #Covid_19 & China. https://t.co/BY7uJGDmYs

— Charles Edel (@CharlesEdel) May 11, 2020

https://twitter.com/EUatUN/status/1259121980051271681

If you open your streets, they will come.
It really is as simple (and cheap) as that!

~Paris, Rue de Rivoli, May 2020 (by @Diego_cdc)pic.twitter.com/1iKwX280FR

— Cycling Professor (@fietsprofessor) May 18, 2020

Scotland, Wales and Northern Ireland have all called for a Brexit extension https://t.co/mqbUy3Bd3g

— The New European (@TheNewEuropean) June 4, 2020

“Maybe our biggest strength in Germany,” said Professor Kräusslich, “is the rational decision-making at the highest level of government combined with the trust the government enjoys in the population.” https://t.co/GV7ZnU2IvM

— Eli Stokols (@EliStokols) April 4, 2020

China should be sued under international law for trillions of dollars for its initial cover-up of the coronavirus pandemic which has caused more than 60,000 deaths and trillions of dollars in economic damage, a new report says | @latikambourke https://t.co/GuR8YAtoiR

— The Sydney Morning Herald (@smh) April 5, 2020

https://twitter.com/MFATNZ/status/1251028832141717504

New York Vol.37 (corporations: Regeneron)

See how #antibody and vaccine approaches for #COVID19 compare and how each is manufactured: https://t.co/t1YQv1suNL pic.twitter.com/5tkIvblrjQ

— Regeneron (@Regeneron) August 20, 2020

We are collaborating with @Roche to significantly increase global supply of Regeneron’s investigational antibody cocktail for #COVID19: https://t.co/A4i6ZZh482 pic.twitter.com/N1lEfTrKmO

— Regeneron (@Regeneron) August 19, 2020

Watch: Drew Murphy, PhD, EVP of Research, explains the #science behind how novel #antibody medicines can emulate the natural disease-fighting process. For more: https://t.co/VtwzW1XHKg pic.twitter.com/9Kd1M934rN

— Regeneron (@Regeneron) August 11, 2020

Congrats to Raquel Deering, PhD, who was named one of @INVIVOnow’s Rising Leaders in Life Sciences for her work using next-gen sequencing methods to “outsmart cancer.” https://t.co/yh52K7DvBt

— Regeneron (@Regeneron) May 13, 2020

#COVID19 program update: We have moved our top SARS-CoV-2-neutralizing antibodies into preclinical- and clinical-scale cell production lines & remain on track to have supply available for clinical studies in June. Read on: https://t.co/w3wjPjXlmB pic.twitter.com/GEcO3ClFVe

— Regeneron (@Regeneron) April 16, 2020

Congrats to our Prez and CEO (& @uvamedalum) Len Schleifer for being recognized with the Walter Reed Distinguished Achievement Award for his leadership and commitment to innovation: https://t.co/FGHkql59Ng pic.twitter.com/TDmiPnqz2u

— Regeneron (@Regeneron) September 25, 2020

During #DPharm2020, David Weinreich, MD, SVP and Head of Global Clinical Development, shared how we are rapidly responding to #COVID19 while maintaining our high-science principles and quality standards. For more: https://t.co/yKKW8dOoY9 pic.twitter.com/4DP5HwDIrB

— Regeneron (@Regeneron) September 25, 2020

We second that! Congrats to @mayaajmera on the @NSF_NSB 2020 Public Service Award for inspiring generations of young people to be #STEM leaders and innovators through her work with @Society4Science: https://t.co/vAhKAaZiSN https://t.co/dvKlcWtXlD

— Regeneron (@Regeneron) September 23, 2020

Regeneron is top 10 on the @fortunemagazine #ChangeTheWorld list for applying our technologies and expertise to diseases like Ebola and COVID-19. See the list and all the orgs that are #DoingWellByDoingGood: https://t.co/7LF3XiiDU8

— Regeneron (@Regeneron) September 21, 2020

Read about our second late-breaking #ESMO20 presentation with @Sanofi featuring pivotal trial data for an investigational #immunotherapy in first-line advanced #NonSmallCellLungCancer (#NSCLC): https://t.co/VeJykCRPgp pic.twitter.com/tnG6eZxKQP

— Regeneron (@Regeneron) September 21, 2020

Today at #ESMO20: We shared late-breaking pivotal trial data for an investigational #immunotherapy in locally advanced #BasalCell #Carcinoma (BCC). Read more about our presentation with @Sanofi: https://t.co/ygrvPrHBXY pic.twitter.com/cFifC5z8mB

— Regeneron (@Regeneron) September 18, 2020

Watch: #RegeneronScientist Alina Baum, PhD, shares how #antibodies work to protect the healthy human cells against pathogens. Learn about antibody medicines: https://t.co/msL7mRf6WS pic.twitter.com/Y0Dj7e9P6c

— Regeneron (@Regeneron) September 17, 2020

Uncertainty can have a big impact on people with #AtopicDermatitis and those in their lives. Help us #ChangeAD by submitting your idea at https://t.co/2pzIIgYNIw. https://t.co/JoW12TLs7g

— Regeneron (@Regeneron) September 14, 2020

#Breaking: Our investigational #COVID19 anti-viral antibody cocktail will be evaluated as part of the @UniofOxford Phase 3 RECOVERY trial: https://t.co/nilVh0LZVR pic.twitter.com/swaGGtwQZm

— Regeneron (@Regeneron) September 14, 2020

Announcing with @Sanofi, the FDA has granted Breakthrough Therapy designation for our investigational medicine in #EosinophilicEsophagitis. Learn more: https://t.co/jNAYVGWE2b pic.twitter.com/xylZ3i4Zmz

— Regeneron (@Regeneron) September 14, 2020

We’re sharing new long-term data (up to three years) for our moderate-to-severe #asthma medicine at #ERSCongress. This includes safety and the impact of some of asthma’s most debilitating symptoms. Find out more: https://t.co/sZbJpPdvUB CC: @Sanofi

— Regeneron (@Regeneron) September 8, 2020

From his time playing football, Wilson learned at a young age that even when things are broken, they can be fixed. Watch his story and learn how this lead him to a career in clinical trial development. pic.twitter.com/VehwHTDb0I

— Regeneron (@Regeneron) September 3, 2020

#ESMO20: Announcing the acceptance of late-breaking oral presentations on our pivotal immunotherapy trials in advanced #basalcell #carcinoma (BCC) and advanced #NonSmallCellLungCancer (#NSCLC): https://t.co/7glgFBDvKj CC: @Sanofi pic.twitter.com/kiekMgoaoK

— Regeneron (@Regeneron) September 3, 2020

.@YonkersPartners Regeneron Science Research enables students from the Yonkers school district to participate in an after-school #science research program. Recent graduates of the Regeneron-supported initiative reflect on their experiences: https://t.co/nLHKINRsYc

— Regeneron (@Regeneron) September 2, 2020

Thanks to our colleagues who have volunteered 1.7K+ hours over three years to maintain Westchester County Parks, we’ve been recognized with the Business Impact Award by @FriendsofParks: https://t.co/0tKveSmT87 #ResponsibleRegeneron

— Regeneron (@Regeneron) August 28, 2020

#RegeneronIreland is growing its team by 40% to support the production of our existing life-changing medicines. Learn more: https://t.co/GSypUPXmGs pic.twitter.com/9f1m1ZUG3I

— Regeneron (@Regeneron) August 27, 2020

Doing what’s right has always been core to how we run our business. In April, we announced our 2025 global responsibility goals to help further our efforts. Read more from @halamirza, SVP, Corp Comms & Citizenship: https://t.co/qNVKVL1Nnb #ResponsibleRegeneron

— Regeneron (@Regeneron) August 26, 2020

We have been recognized by @Forbes as one of America’s Best-in-State Employers for another year. Find out more about us: https://t.co/AC6iWsPPA2 pic.twitter.com/PL3csXCcuE

— Regeneron (@Regeneron) August 25, 2020

Today @NEJM published positive Phase 3 results for our investigational medicine in patients with #HoFH, an ultra-rare inherited form of high cholesterol. #FHcommunity #RareDisease More: https://t.co/49keEeIgPx

— Regeneron (@Regeneron) August 19, 2020

At Regeneron, we’re building a more sustainable future. By 2035, our goal is to match 100% of our electricity consumption with electricity from certified renewable energy sources.⚡ Read more: https://t.co/PXmKYebc1O #ResponsibleRegeneron pic.twitter.com/xo7LnxbwMK

— Regeneron (@Regeneron) August 14, 2020

Thanks to all who submitted a proposal to the 2019 ‘Agents of Change’ AD Challenge. Your ideas will help us support the #AtopicDermatitis community. Learn about the initiative and grant recipients at https://t.co/obIdYb9cT1 pic.twitter.com/gypordlWIU

— Regeneron (@Regeneron) August 7, 2020

For the second consecutive year, we have been named as one of @FastCompany's 2020 Best Workplaces for Innovators. Learn how we foster a collaborative culture driven by #science: https://t.co/UMGQRAs2TM #FCBestWorkplaces pic.twitter.com/E56AIguWsc

— Regeneron (@Regeneron) July 29, 2020

#Ebola update: @BARDA has procured our investigational Ebola cocktail treatment for national preparedness. Learn more: https://t.co/ZMxtV3LQne

— Regeneron (@Regeneron) July 29, 2020

Watch: #STEM influencer @FascinateSci recently spoke with Alina Baum, PhD, of our infectious diseases team about our approach to researching potential #antibody medicines for #COVID19 and what it’s like being a scientist during the pandemic: https://t.co/jTkQGokcTr

— Regeneron (@Regeneron) July 22, 2020

The #RGC is partnering with @Ancestry to advance current understanding of #COVID19 susceptibility, severity and outcomes. For more on this new collaboration: https://t.co/5uzYgGlCOw

— Regeneron (@Regeneron) July 15, 2020

https://twitter.com/Regeneron/status/1283064845491937282

Regeneron immunology expert, Jamie Orengo, PhD, sees firsthand the impact #asthma and #allergies have on everyday life. Learn how her team is exploring the use of #antibody medicines for allergic diseases: https://t.co/msL7mRf6WS pic.twitter.com/UzMxyv9jYm

— Regeneron (@Regeneron) July 13, 2020

Announcing large-scale manufacturing & supply agreement of our investigational #COVID19 medicine for @BARDA & @JPEOCBRND @DeptofDefense: https://t.co/b1YYy8P0Sq

— Regeneron (@Regeneron) July 7, 2020

We have initiated a Phase 3 prevention trial for our investigational #COVID19 dual-antibody medicine in collaboration with @NIAIDNews (a part of @NIH). Read more: https://t.co/4GkTXzDRMM pic.twitter.com/DAYjFIPhzl

— Regeneron (@Regeneron) July 6, 2020

Together with @Sanofi we’ve provided an update from our Phase 3 U.S. clinical trial for #COVID19 patients with our IL-6 receptor antibody. Learn more: https://t.co/ckHhKkEahw

— Regeneron (@Regeneron) July 2, 2020

Last year, nearly 60% of our colleagues worldwide volunteered their time to local non-profit organizations. Learn how we support our communities through programs such as #RegeneronD4DG, in our 2019 Responsibility Report: https://t.co/Z9NblB6qzq pic.twitter.com/ewdc5XVDkg

— Regeneron (@Regeneron) June 24, 2020

Congrats to the recipients of the eighth annual Regeneron Prize for Creative Innovation, which celebrates and rewards cutting-edge thinking from the next generation of young #scientists. Read about their winning proposals here: https://t.co/8iABqWz64Q pic.twitter.com/RkxkkNLamI

— Regeneron (@Regeneron) June 22, 2020

The FDA has approved a new option for administering one of our medicines. Find out how this innovation can help patients: https://t.co/CnM6lkD4t1 pic.twitter.com/XPgbrAxjgQ

— Regeneron (@Regeneron) June 19, 2020

The second defines the protective value of a multiple-#antibody approach against #SARSCoV2 ‘viral escape’ mutations: https://t.co/anSXRfg92V via @ScienceMagazine

— Regeneron (@Regeneron) June 15, 2020

Today, we’re announcing @ScienceMagazine will publish two manuscripts which highlight the potential of our investigational anti-viral antibody cocktail to protect against #SARSCoV2 ‘viral escape’ mutations: https://t.co/boN2i5OF8S pic.twitter.com/bYDVtps4Nn

— Regeneron (@Regeneron) June 11, 2020

Today, we announce the initiation of clinical trials for our investigational anti-viral antibody cocktail for the treatment and prevention of COVID-19: https://t.co/PetA4EsQGf pic.twitter.com/ba1wDlJEUu

— Regeneron (@Regeneron) June 11, 2020

Yesterday at #BIODigital, our President and CSO, George Yancopoulos, discussed the importance of a united effort amongst our biopharma peers in the fight against #COVID19. Learn about our COVID-19 response efforts: https://t.co/h2dc05EGF0 https://t.co/HZyFtn4if2

— Regeneron (@Regeneron) June 9, 2020

Regeneron & @IntelliaTweets expand collaboration to develop CRISPR/Cas9-based treatments: https://t.co/HsJpVdyvPB

— Regeneron (@Regeneron) June 1, 2020

Check out our latest #immunooncology research in advanced #NonMelanoma #SkinCancer (NMSC) with @Sanofi, including results from the largest and most mature prospective dataset in advanced Cutaneous #SquamousCellCarcinoma (CSCC). #ASCO20

— Regeneron (@Regeneron) May 29, 2020

Announcing with @Sanofi at #ASCO20: longer-term outcomes and first post-hoc quality-of-life results from our pivotal Phase 2 trial in advanced Cutaneous #SquamousCellCarcinoma (CSCC). Learn more: https://t.co/1zQIvrGMQQ pic.twitter.com/0SVo3rDdgm

— Regeneron (@Regeneron) May 29, 2020

Our growing #RegeneronIreland team at our IOPS site in Limerick is officially 1,000 people strong! In six years, they’ve built the largest biologics production facility in Ireland and formed a strong community. Learn more about our growing team: https://t.co/u7xBR2Ilod pic.twitter.com/lMSU87JmMK

— Regeneron (@Regeneron) May 27, 2020

Our newly published research with @DukeU provides an atlas of the cells that regulate eye pressure — crucial information that may lead to future #glaucoma treatments approaches. #DYK there are 12 cells types in a space about half as thick as a penny? https://t.co/0dQj1XK8Xz pic.twitter.com/3ZXEF1f7RN

— Regeneron (@Regeneron) May 26, 2020

The FDA has approved our medicine for children aged 6-11 years with uncontrolled moderate-to-severe #AtopicDermatitis. Read more: https://t.co/9IEHlTHY8y CC: @Sanofi pic.twitter.com/KFTA2qA0rX

— Regeneron (@Regeneron) May 26, 2020

With @Sanofi, we are announcing positive results from our trial in adults and adolescents with #EosinophilicEsophagitis. Read more: https://t.co/lS0FMYybsA

— Regeneron (@Regeneron) May 22, 2020

Yesterday at #RegeneronISEF, Regeneron infectious disease experts, Christos Kyratsous, Leah Lipsich and Serge Monpoeho, shared a behind-the-scenes look at our efforts to combat #COVID19. For more about our efforts: https://t.co/QZZc3YBBeZ CC: @Society4Science https://t.co/qqhH5FWQsc

— Regeneron (@Regeneron) May 20, 2020

Our Prez & CEO Len Schleifer sat down with @MegTirrell during @CNBC’s #HealthyReturns virtual event to discuss how we’re applying our core technologies to fight infectious diseases like #COVID19. https://t.co/rAxLeXyolb

— Regeneron (@Regeneron) May 15, 2020

In partnership with the Colorado Center for Personalized Medicine at @CUAnschutz, the #RGC will sequence 450,000 DNA samples from patients at @uchealth. Read more about how we're advancing the field of #genetics and precision medicine: https://t.co/5hG8FNf4TW pic.twitter.com/q6mGg5gmP8

— Regeneron (@Regeneron) May 11, 2020

Facing unprecedented health crises, our team has responded with urgency, applying our core technologies to fight infectious diseases. To learn more about our efforts, read our 2019 Annual Report: https://t.co/2yBJUeBkEU pic.twitter.com/VqZkwWeS6k

— Regeneron (@Regeneron) May 8, 2020

We are joining the @AmDiabetesAssn to focus on an often-overlooked complication for the 30m+ American adults living with #diabetes: eye disease. Stay tuned for more on how we plan to help raise awareness. More: https://t.co/O19L7Rfpnf pic.twitter.com/l3OoBPyBKV

— Regeneron (@Regeneron) May 6, 2020

With @Sanofi, we're announcing clinically meaningful results from a pivotal Phase 2 clinical trial for our #immunotherapy in advanced #basalcell #carcinoma (BCC). Learn more: https://t.co/dFCrEbLuai

— Regeneron (@Regeneron) May 5, 2020

We continue to tap into our collective expertise, technology and resources to do what's right. Hala Mirza, SVP, Corp Comms & Citizenship, introduces our new global responsibility goals in our latest #RegeneronPerspectives blog:

— Regeneron (@Regeneron) April 27, 2020

With @Sanofi, we're announcing the pivotal Phase 3 trial for our #immunotherapy in first-line advanced #NonSmallCellLungCancer (#NSCLC) was stopped early due to highly significant results. https://t.co/8duu67iYPY

— Regeneron (@Regeneron) April 27, 2020

Regeneron and @Sanofi provide update on U.S. Phase 2/3 trial of repurposed IL-6 inhibitor medicine (currently approved for rheumatoid arthritis) in hospitalized COVID-19 patients https://t.co/8KAZob0Nfd pic.twitter.com/ZuyQ4DFqfd

— Regeneron (@Regeneron) April 27, 2020

At Regeneron, we are committed to following the #science to help people with serious diseases. Today on FOP Awareness Day learn how we apply our technologies and novel approaches to investigate #rarediseases like fibrodysplasia ossificans progressiva.

— Regeneron (@Regeneron) April 23, 2020

The PALM clinical trial is the recipient of @SCTorg’s David Sackett Trial of the Year Award, recognizing the amazing collaboration behind this important study. We’re currently applying lessons from our #Ebola research and development to find a potential medicine for #COVID19.

— Regeneron (@Regeneron) April 22, 2020

FDA accepts the biologics license application for our investigational antibody medicine for Ebola: https://t.co/I3UkEXEfcy

— Regeneron (@Regeneron) April 16, 2020

Announcing a new collaboration with Zai Lab for our investigational bispecific antibody for B-cell non-Hodgkin #lymphoma. Read more: https://t.co/LEtydrJisb

— Regeneron (@Regeneron) April 8, 2020

Join us by supporting @CommFound518’s Capital Region Community Response Fund to help rapidly deploy resources to community-based organizations at the front lines of the #COVID19 outbreak: https://t.co/WkQW3hIDiV

— Regeneron (@Regeneron) April 7, 2020

New announcement on our @Sanofi restructuring and changes in Regeneron’s accounting presentation. Read more: https://t.co/0NBVMuPlbu

— Regeneron (@Regeneron) April 6, 2020

Read the latest #RegeneronPerspectives blog for more from #RegeneronIOPS leadership: https://t.co/85IRZc5XoB

— Regeneron (@Regeneron) April 1, 2020

We’ve treated the first ex-US severe #COVID19 patient in our global clinical program w/ @Sanofi with our IL-6 receptor antibody. Learn more: https://t.co/srR5JmlJN1

— Regeneron (@Regeneron) March 30, 2020

Our CSO George Yancopoulos discussed on @CNNi how we’re applying lessons from our #Ebola research to finding a potential medicine for #COVID19. Watch via w/ @jchatterleyCNN https://t.co/98CZw8bBRy

— Regeneron (@Regeneron) March 27, 2020

Healthcare workers at the front lines of the #COVID19 pandemic critically need medical supplies. We’re supporting @AfyaFoundation’s efforts to get supplies to NY-based qualified health centers. Learn more: https://t.co/UVKcTlmxCo

— Regeneron (@Regeneron) March 18, 2020

Update on our #COVID19 novel antibody program: We’ve identified hundreds of virus-neutralizing antibodies from our VelocImmune technology and are now selecting the top candidates for clinical testing. Learn more: https://t.co/JhkedKl8yM

— Regeneron (@Regeneron) March 17, 2020

If you or someone you know is sick, call your doctor and visit this resource from @CDCgov for more info: https://t.co/cYReu4Y7vz

— Regeneron (@Regeneron) March 16, 2020

We’ve initiated a global clinical program w/ @Sanofi for people hospitalized with severe #COVID19, testing our IL-6 receptor antibody. Read on: https://t.co/uKmBRgSBf3

— Regeneron (@Regeneron) March 16, 2020

It’s #ExomeDay! #ICYMI: The #RGC has sequenced one million exomes, making it the largest database of its kind. Learn more about this genomic research initiative:

— Regeneron (@Regeneron) March 11, 2020

We shared our current timeline for COVID-19 drug discovery/development yesterday at #CowenHealthCare and the White House: pic.twitter.com/pa1PCpyKTz

— Regeneron (@Regeneron) March 3, 2020

We are excited to join communities around the world to recognize #RareDiseaseDay. At Regeneron, we are on a journey to understand the #science behind these serious diseases to develop meaningful medicines. Learn why this day is so important: https://t.co/cmVZeQpCSs

— Regeneron (@Regeneron) February 29, 2020

We're proud to support this important legislation & the leadership of @NYGov in fighting intolerance, ignorance & hate. https://t.co/I9r0543cBZ

— Regeneron (@Regeneron) February 27, 2020

Thanks to our dedicated colleagues, for another year we’ve been recognized on @FortuneMagazine and @GPTW_US's list of #100BestCos! #GreatPlaceToWork https://t.co/PiLtMdVBNO

— Regeneron (@Regeneron) February 18, 2020

We’re committed to celebrating these hard-working students in the manner they deserve, and look forward to meeting them in person later this year when they will compete, receive prizes and share their important research with the public. #RegeneronSTS https://t.co/nWqffTLVeY

— Regeneron (@Regeneron) March 3, 2020

.@Society4Science recently announced the recipients of this year’s STEM Action Grant Program. This Regeneron-supported initiative provides funding to organizations working to increase participation of underrepresented and underserved populations in #STEM fields. Learn more: https://t.co/Pua34Yp2VO

— Regeneron (@Regeneron) July 8, 2020

For the first time in the competition's history, the @Regeneron Science Talent Search went virtual this year. Relive some of the amazing memories! #RegeneronSTS pic.twitter.com/88EfzXZO39

— Society for Science (@Society4Science) September 1, 2020

For the first time in its 79-year history, the Science Talent Search went virtual. Read more about how we did it in @sciam. via @SchamandaBaker #RegeneronSTS https://t.co/q8oiSeuju6

— Society for Science (@Society4Science) August 19, 2020

We're grateful for our #SSPalumni who are leading & tackling the most urgent scientific & humanitarian crisis of our time. See what George Yancopoulos, Len Schleifer & the @Regeneron team are doing & why we're so proud to partner with these leaders in #STEM! #COVID19 pic.twitter.com/QQKZEGK2rV

— Society for Science (@Society4Science) May 1, 2020

As companies race to find treatments and vaccines for coronavirus, @JNJNews’s Paul Stoffels and @Regeneron’s George Yancopoulos join @GStephanopoulos to give the latest on their research. See it on @ThisWeekABC https://t.co/sRvHtXTwAz pic.twitter.com/RyIhRqimdH

— This Week (@ThisWeekABC) May 9, 2020

It's all-hands-on-deck at pharmaceutical companies around the world as the coronavirus spreads. I visited Regeneron, a company that's racing to develop a drug and has been successful in the past at treating Ebola. https://t.co/uHBRkmkIfU

— Lester Holt (@LesterHoltNBC) March 10, 2020

We are proud to partner with @Regeneron to develop a potential therapeutic needed to #SaveLives from #COVID19. BARDA is supporting the Phase 2/3 clinical trial for this product. https://t.co/IweZ9P3DnB pic.twitter.com/e684tTf27I

— BARDA (@BARDA) March 22, 2020

https://twitter.com/GPTW_Ireland/status/1232796927797932034

Pennsylvania Vol.11 (corporations: CSL Behring) / Australia Vol.29

Our response to #COVID-19 starts with the health and safety of our employees, donors and patients. Learn more about what we’re doing in this rapidly evolving situation. https://t.co/KhYeJQ877t pic.twitter.com/l9q1bhdyOw

— CSL Behring (@CSLBehring) March 23, 2020

Watch: virtual #golf lessons from pro Perry Parker stepped up w/video lessons after the pandemic postponed #CSLBehringJNC sports competition for the #bleedingdisorders community. He shares his tips for a great golf game & living with #hemophilia https://t.co/9vl7GDE3zV

— CSL Behring (@CSLBehring) September 25, 2020

https://twitter.com/CSLBehring/status/1308772688744402945

THANK YOU to all the recovered #COVID-19 patients donating their plasma to help us make a potential treatment! Visit https://t.co/gmG1K6qd9X to join them! #donateplasma pic.twitter.com/VUoQTjyOgu

— CSL Behring (@CSLBehring) September 19, 2020

Our with @TheEIU ‘Suffering in Silence: Assessing Rare Disease Awareness and Management in Asia-Pacific’ finds delays in diagnosis, inadequate access to best evidence-based care and more issues to tackle for #raredisease patients. Details: https://t.co/GWdRntzEXQ pic.twitter.com/25TogvMHT5

— CSL Behring (@CSLBehring) September 19, 2020

Ventilation is now seen as a key strategy to prevent the spread of #COVID19. https://t.co/TBPO5NRjIR

— CSL Behring (@CSLBehring) September 17, 2020

Newborn screening is a lifeline for the tiniest #raredisease patients. Find out how it can catch rare diseases before babies leave the hospital. https://t.co/cRGUSdOTAX @RareDiseases

— CSL Behring (@CSLBehring) September 16, 2020

Will it be safe for someone with a primary immunodeficiency to get the #COVID19 vaccine? https://t.co/L0a5k94Y3q #PI @IDFCommunity

— CSL Behring (@CSLBehring) September 15, 2020

As many parents and children living with a #raredisease begin another week of working or learning from home, here is some expert advice on how to make it all work: https://t.co/3m7GpOj977 #MotivationMonday

— CSL Behring (@CSLBehring) September 14, 2020

https://twitter.com/CSLBehring/status/1304796954166210561

Looking for a new job? Our Chief Medical Officer and Head of R&D Bill Mezzanotte recently offered some lessons he's learned in his biotech journey in @Biopharma_asia. https://t.co/Zhy3bT31jA #careeradvice

— CSL Behring (@CSLBehring) September 10, 2020

Our partnership with @BaseLaunch gives us an inside look at cutting edge treatments and therapies under development, primarily in Europe. Learn more about it here: https://t.co/egSsuErou0

— CSL Behring (@CSLBehring) September 9, 2020

Our #Respiratory team is attending #ERSCongress this week sharing some of the great work we support, like this innovative research from @OSIC. Read more about their @Kaggle artificial intelligence approach in the fight against interstitial lung disease. https://t.co/D1jEmgAbp5

— CSL Behring (@CSLBehring) September 8, 2020

About a third of rare disease patients have experienced cancelled medical appointments due to #COVID19. Learn more about a survey conducted by @RareDiseases. https://t.co/m96j1henX4

— CSL Behring (@CSLBehring) September 4, 2020

#COVID19 isn't the only campus health concern. Get tips for how to manage a rare disease while at college. https://t.co/mBTFedWpKg #backtoschool

— CSL Behring (@CSLBehring) September 3, 2020

How well do you Zoom? At our patient summit, patient advocates received some expert advice on how to give an effective virtual presentation. https://t.co/BzI4GDn1C5

— CSL Behring (@CSLBehring) September 2, 2020

Our @CSL Chief Scientific Officer, Andrew Nash, got his start at @unimelb. Hear his advice for young #scientists who are just beginning their careers. https://t.co/JqIZxaksn7

— CSL Behring (@CSLBehring) August 30, 2020

https://twitter.com/CSLBehring/status/1298024868483563520

As we head into fall and winter, public health officials are urging vaccinations against the flu while #COVID19 continues to circulate, according to @nytimes. https://t.co/24EKWAHoKA

— CSL Behring (@CSLBehring) August 20, 2020

We're back to sponsor the @UCScienceCenter Nucleus Awards, which celebrate leaders and groundbreakers in innovation! Congrats to #Nucleus2020 Honorees Benjamin Doranz, @auroraarcher and @sylvestermobley. More here: https://t.co/ijOnWyNrGu pic.twitter.com/TTgxWltrU9

— CSL Behring (@CSLBehring) August 20, 2020

THANK YOU to all plasma donors donating during the #COVID19 pandemic. https://t.co/8AIgQn7TAL

— CSL Behring (@CSLBehring) August 15, 2020

This year, learning went online for everyone, including doctors. Learn about a series of webinars about immunoglobulin offered by CSL Behring in Taiwan. https://t.co/ZOHnKHFvSK #COVID19

— CSL Behring (@CSLBehring) August 13, 2020

It's #backtoschool time during a global pandemic. Get expert advice on how to adapt to uncertainty and changing conditions. https://t.co/7vikWwnKqP #COVID19

— CSL Behring (@CSLBehring) August 12, 2020

Our work on developing potential therapeutics to address #COVID19 is progressing around the world. https://t.co/VAbz3XlLdC

— CSL Behring (@CSLBehring) August 11, 2020

https://twitter.com/CSLBehring/status/1291147027003445250
https://twitter.com/CSLBehring/status/1288602726654455808
https://twitter.com/CSLBehring/status/1286722903405408256

We are one step closer to the development of a potential therapy with the CoVIg-19 Plasma Alliance. Our Bern facility successfully manufactured the clinical trial materials and now they are being sent to our Marburg location for packaging. #COVID19 https://t.co/wPrCYQwoLM pic.twitter.com/VBjX8Zq8on

— CSL Behring (@CSLBehring) July 22, 2020

This accomplished hiker @AlphaFriend just started a 3,100-mile journey to raise awareness about #Alpha1. https://t.co/EqrAWRLIg3 #Hikingforacure

— CSL Behring (@CSLBehring) July 20, 2020

With #COVID19 precautions in place, scientists have returned to the lab at sitem-insel in Bern, Switzerland. Get a peek behind the scenes with this photo gallery. https://t.co/lNfpUTnPJ5

— CSL Behring (@CSLBehring) July 17, 2020

https://twitter.com/CSLBehring/status/1284088067146620928

How can people living with a #raredisease or chronic illness cope with the long haul of the #COVID19 pandemic? This expert advice can help. https://t.co/N0ApKvIwSt

— CSL Behring (@CSLBehring) July 16, 2020

#ClinicalTrials can be an important potential resource for those living with a #raredisease. We're supporting @ACRPDC and @GGIgreatergift in the VOICE Campaign to raise awareness of clinical trials as a treatment option. More here: https://t.co/rPrc5ekOLS

— CSL Behring (@CSLBehring) July 15, 2020

We shouldn't underestimate the complexity of developing vaccines for #COVID19, which must be rigorously tested to prove they are safe and effective, says our @CSL CEO and Managing Director, Paul Perreault. https://t.co/wYUz9P6sAm

— CSL Behring (@CSLBehring) July 14, 2020

First-time donor? Find out 3 things to know about donating plasma. #donateplasma https://t.co/lPfSM7byLQ

— CSL Behring (@CSLBehring) July 12, 2020

Little is known about #COVID19 and #rarediseases. A patient with #HAE recently shared experience with @US_HAEA. https://t.co/nOoj8jY43E

— CSL Behring (@CSLBehring) July 10, 2020

After recovering from #COVID19, @SenBobCasey from Pennsylvania donated plasma recently at @CSLPlasma's Taylor, Pennsylvania, collection center. Learn more and find out how you can #donateplasma today- https://t.co/xGcwPcr0nz

— CSL Behring (@CSLBehring) July 9, 2020

As we gear up for #ISTH2020 we are proud to announce the 2020 recipients of our Prof. Heimburger Awards for #bleedingdisorders #research Learn more: https://t.co/PlUYSlDIyM pic.twitter.com/XN2wiYjoAm

— CSL Behring (@CSLBehring) July 9, 2020

#CSLBehring made three recent announcements about monoclonal antibodies. What are they? Here are 10 facts about "mAbs." https://t.co/xqX8gvW3Dn

— CSL Behring (@CSLBehring) July 7, 2020

Sharing medical data is a balancing act, according to an @eurordis survey of 2,000 #raredisease patients. https://t.co/JmFsOLybyU

— CSL Behring (@CSLBehring) July 6, 2020

“Everybody wants to get everybody to speed up and try to get rid of red tape. A reason that some of that tape is there is for safety purposes, when you know you're going to have to be giving billions of doses of this vaccine, you want to make sure you're doing the right thing.” https://t.co/ty12i1jMSL

— CSL Behring (@CSLBehring) July 6, 2020

Today we announce another important step in the fight against #COVID-19. The 1st patient is enrolled in study to assess our monoclonal antibody to treat patients suffering from severe respiratory distress. Learn more here: https://t.co/3MQXCABaXH pic.twitter.com/FCVTwBokpL

— CSL Behring (@CSLBehring) July 6, 2020

❓❓❓ Can you pass this quiz from from @UNICEF about #COVID19? https://t.co/0XH2qsW9Wv

— CSL Behring (@CSLBehring) July 5, 2020

When the weather heats up, how can you keep your meds cool? We offer 3 tips: https://t.co/JOrDMCAVcb

— CSL Behring (@CSLBehring) July 3, 2020

⭐⭐⭐Star power: "You've got a lot of fight in you" if you survived COVID-19, says Dame Helen Mirren. If you’ve recovered from #COVID19, find out how you can #donateplasma. https://t.co/CZ1fJCKmTh

— CSL Behring (@CSLBehring) July 1, 2020

Did you know there is more than one type of hemophilia? Learn about #HemophiliaB: https://t.co/VJp4YeJ7iU

— CSL Behring (@CSLBehring) June 29, 2020

Despite the #COVID19 pandemic, #CSLBehring remains on track with an expansion project in Bern, Switzerland, that will serve an additional 90,000 patients. https://t.co/34KbOFyohp

— CSL Behring (@CSLBehring) June 25, 2020

Today we are announcing an agreement to acquire @uniQure_NV’s phase 3 gene therapy product, currently being studied to treat hemophilia B. Learn more here: https://t.co/HSPge0kg4R pic.twitter.com/wlIt4XqYFt

— CSL Behring (@CSLBehring) June 24, 2020

How do you decide if it's safe to do this or that amid the evolving #COVID19 pandemic? Dr. Kate Sullivan of @ChildrensPhila offers guidance for people who have #primaryimmunodeficiencies. https://t.co/pHAt1JZXrD @IDFCommunity

— CSL Behring (@CSLBehring) June 22, 2020

Today is #WorldSickleCellDay Patients have been waiting a long time for a breakthrough. Read our expert's thoughts on what’s next for those who face the prospect of pain, organ damage and shortened life spans. https://t.co/SVNbU269Up #CSLBehring pic.twitter.com/2jrrYhRRJj

— CSL Behring (@CSLBehring) June 19, 2020

Educate. Empower. Inform. 3 important pieces to being a caregiver for a loved one with #SickleCellDisease. Friday is #WorldSickleCellDay Learn more here: https://t.co/BIafJp6wKc pic.twitter.com/Y5pMw4Es0G

— CSL Behring (@CSLBehring) June 18, 2020

The CoVIg-19 Plasma Alliance is now part of a nationwide coalition in an effort to further encourage recovered #COVID19 patients to #donateplasma. Learn more about the initiative: https://t.co/3jsboOi91V #TheFightIsInUs https://t.co/yAzjfYmXYl

— CSL Behring (@CSLBehring) June 17, 2020

From crucial catches in the @NFL to crucial support for sickle cell families. Listen to former @SuperBowl MVP Santonio Holmes’ story here https://t.co/O4GMwVgLvu @IIIandLong #GreaterThanSickleCell #WorldSickleCellDay

— CSL Behring (@CSLBehring) June 16, 2020

Surfer Arran Strong rides waves and spreads a message of hope to people who have respiratory diseases like #Alpha1. https://t.co/WWpbtvnpHJ

— CSL Behring (@CSLBehring) June 15, 2020

What do spoons have to do with chronic illness? Find out how it became a symbol for those who must manage their health and their daily energy. https://t.co/COakx1eAKl

— CSL Behring (@CSLBehring) June 14, 2020

“Our commitment to delivering innovative treatments for people with #bleedingdisorders is stronger than ever,” says Antti Kourula, VP, Hematology ahead of #WFHVirtualSummit. Read the full release: https://t.co/nhLJ9t1Urp @wfhemophilia pic.twitter.com/YhgTERQYI3

— CSL Behring (@CSLBehring) June 12, 2020

Together with @seattlechildren, #CSLBehring plans to develop treatment options for two, rare, life-threatening #primaryimmunodeficiency diseases. https://t.co/hp3p5RXys7 #PI @IDFCommunity

— CSL Behring (@CSLBehring) June 11, 2020

Our latest #podcast dives into how clinical trials play an important role in developing therapies for patients, and why as the #COVID-19 pandemic continues to impact people around the world, clinical trials are more important than ever. https://t.co/hN647CrmAL pic.twitter.com/D88tTw4nUx

— CSL Behring (@CSLBehring) June 10, 2020

Employees are exemplifying #PatientFocus by donating plasma for our necessary therapies. https://t.co/EeUvIP9ECd

— CSL Behring (@CSLBehring) June 10, 2020

If you're new to wearing a face mask, here are 5 tips for making it work. https://t.co/fIn67zQYk3 #COVID19

— CSL Behring (@CSLBehring) June 8, 2020

Today, we take an important next step in growing our portfolio of promising products in late-stage development to address the significant unmet needs of #transplant recipients. @vitaerisbio is now part of #CSLBehring https://t.co/lSDciA8qfA pic.twitter.com/E46SQPk5a5

— CSL Behring (@CSLBehring) June 8, 2020

Organ #transplants continue despite #COVID19. This week, CSL Behring awarded two grants in transplant medicine during #ATC2020 to @Paulo_MartinsMD of @UMassMedical and @umassmemorial and Dr. Yang Yang of @UTHealth. https://t.co/NRJgLDB1q5 @ATCMeeting @ASTSChimera @AST_info

— CSL Behring (@CSLBehring) June 3, 2020

"The plasma they have is rich in these antibodies and can save the lives of other individuals down the road. So it is a chance to pay it forward," Bill Mezzanotte, Executive Vice President, Head Research & Development told @AliciaNews8 @CBS8 #COVID19 https://t.co/uFo4LDQhRV

— CSL Behring (@CSLBehring) May 29, 2020

@CSLBehring, medical researchers & other groups making up a nationwide coalition in the fight against coronavirus have joined forces. If you’ve recovered from #COVID19, find out how you can #donateplasma. https://t.co/WhvJcBqW8g https://t.co/R4WcYpP1jB

— HemophiliaFederation (@hemophiliafed) June 18, 2020

We're delighted to strengthen our partnership with @DrexelCCI and @CSLBehring with Yi Deng and Bill Mezzanotte joining our Board. https://t.co/lPuXAyl1Or pic.twitter.com/giGRxCQ5KP

— Science Center (@UCScienceCenter) June 19, 2020

#PennStateBiotechDay @InventPennState @CSLBehring CSL Behring Fermentation Facility @PennState highlighted as a critical resource for Penn State's innovative research @PSUresearch pic.twitter.com/fM7DxhucoE

— Center of Excellence in Industrial Biotechnology (@huckcenters) June 12, 2020

In response to the global emergency precipitated by COVID-19, CSL has announced three agreements to secure supply of two COVID-19 vaccines for Australia, should the vaccines prove successful in clinical trials. Read more here https://t.co/6C5GGL6BUQ #COVID19 pic.twitter.com/QCu0xdMm6o

— CSL (@CSL) September 7, 2020

Sir Frank was one of the most distinguished figures in biological sciences in Australia. His pioneering research & discoveries left a lasting legacy. Our library in Parkville is proudly named in honour of his significant contribution to CSL as a long-term friend & collaborator. https://t.co/oAQfW1E0VR

— CSL (@CSL) September 4, 2020

Announcing CSL’s FY results, Mr Paul Perreault, CEO & MD said, “Our result is a reflection of the focus we have to deliver our strategy and on our promise to provide innovative medicines for patients and public health around the world.” pic.twitter.com/uhRiW5OPJI

— CSL (@CSL) August 18, 2020

Work is now underway at the Broadmeadows facility to develop a hyperimmune globulin to assist in treating COVID-19. Read more about the treatment here https://t.co/3ECCKiapM4 #covid19

— CSL (@CSL) August 12, 2020

Commenting on a new collaboration with @UniQuestUQ, CSL’s Chief Scientific Officer, Dr Andrew Nash, said “This is another example of Australian research excellence, harnessing the strengths of both industry and academia to address an important area of unmet medical need.” https://t.co/80qsWHshOb

— CSL (@CSL) July 20, 2020

CSL’s Prof. Andrew Cuthbertson explains why it’s important to test safety and efficacy in the development of a COVID-19 vaccine candidate. #covid19 https://t.co/MrpTSq5l85

— CSL (@CSL) July 20, 2020

Congratulations to the University of Queensland, who have today commenced the first human trials of their COVID-19 vaccine. This is an exciting milestone for #UQ and we look forward to continuing to work together on this important project. https://t.co/dkSBCpIuRs

— CSL (@CSL) July 13, 2020

Applications for the CSL Centenary Fellowship are now open. Here is Dr Daniel Pellicci, one of the 2019 fellowship recipients, talking about his research recruiting specialist white blood cells to help fight tuberculosis (TB) #CSLcentenaryfellowship https://t.co/fqafIhHrIg

— CSL (@CSL) July 7, 2020

Ever wondered what happens to a #COVID19 swab test? This video explains the journey of a swab test and highlights the important role of #science in addressing the current pandemic. https://t.co/T543DgVnRz

— CSL (@CSL) July 3, 2020

.@AAMRI_Aus share a video highlighting the efforts of Australian medical researchers throughout the #COVID19 pandemic. #medicalresearch https://t.co/MnPUAySj7z

— CSL (@CSL) June 30, 2020

CSL is excited to be part of @WEHI_research led Australian consortium focused on finding new anti-viral medicines to treat COVID-19. Thank you to @GregHuntMP, who earlier this month announced MRFF funding for the program. https://t.co/bwRw9V1q2C

— CSL (@CSL) June 18, 2020

Listen to a recent podcast with Deirdre BeVard, @CSLBehring ’s Senior Vice President of R&D Strategic Operations, who discusses the importance of #clinicaltrials and how they benefit patients. https://t.co/7SQS1OiDR5

— CSL (@CSL) June 10, 2020

CSL, @CEPIvaccines and #UQ today announced a partnering agreement to accelerate the development, manufacture and distribution of a #COVID19 vaccine candidate, utilising #UQ’s “molecular clamp” enabled vaccine. #UQ aim to commence phase 1 clinical trials in July. pic.twitter.com/OeVshf9wDO

— CSL (@CSL) June 5, 2020

A new rapid research brief on the evidence for how long the SARS-CoV-2 virus remains viable on different surfaces, particularly clothes, cardboard, plastic, stainless steel, and copper. https://t.co/vSPbcwJApI

— CSL (@CSL) May 29, 2020

Damian got coronavirus. Now he's part of the quest to outwit it https://t.co/2kwvGHatbB via @ABCNews @davidantibiotic @syctong @TheDohertyInst @lifebloodau @CSL @WEHI_research

— Dr Catherine Hanrahan (@CathHanrahan1) August 5, 2020

#Didyouknow Nobel Laureate Karl Landsteiner, who discovered and classified ABO human blood groups, also discovered the virus that causes polio?

Today thanks to a worldwide effort, two out of the three wild poliovirus strains have been completely eradicated.

Image: Polio vaccine pic.twitter.com/966hzuV7dU

— The Nobel Prize (@NobelPrize) June 14, 2020

CSL Plasma App Takes Donors on a Plasma Journey: App offers a personalized experience for plasma donors. https://t.co/y2FXRblkXr

— CSL Plasma (@CSLPlasma) September 2, 2020

We do have a few requirements for our donors, and it’s all to ensure we keep you safe to come back and continue giving more.
Learn more: https://t.co/GhXdnlxeWO pic.twitter.com/Zh450NMCdV

— CSL Plasma (@CSLPlasma) July 23, 2020

Donations are needed more than ever. Become a donor today!
Help people around the world while earning up to $400.
Learn more by going to: https://t.co/X3SvsTeEIx pic.twitter.com/IniTGEku2J

— CSL Plasma (@CSLPlasma) May 19, 2020

Illinois Vol.12 (corporations: Abbott Laboratories)

BREAKING: We’re launching an innovative COVID-19 rapid antigen test and mobile app. BinaxNOW is fast and reliable for frequent mass testing, and results pair with the NAVICA app’s digital pass to help get back to life with a bit more confidence. https://t.co/LKefDGEx3f pic.twitter.com/SL7SWdrj9t

— Abbott (@AbbottNews) August 26, 2020

A new study published in the Journal of Neurotrauma shows that a rapid blood test for concussions we’re developing is a reliable indicator of traumatic brain injuries. https://t.co/0tVhjcq4Ux pic.twitter.com/OSv8XpoJ7G

— Abbott (@AbbottNews) September 23, 2020

We’re proud to be named to @FortuneMagazine’s #ChangeTheWorld list for expanding access to care in Rwanda, and work to advance COVID-19 testing.

Learn more: https://t.co/TwAxofeAy3 #SharedValue pic.twitter.com/D8xQTgs3xq

— Abbott (@AbbottNews) September 22, 2020

Heart tech that helps people live healthier. Our fourth-generation MitraClip G4 device received CE Mark, offering an enhanced approach for mitral valve repair in the EU: https://t.co/vuEEwBVIht

Important Safety Info: https://t.co/yQ2GUvJVHM pic.twitter.com/GTjBS39QBy

— Abbott (@AbbottNews) September 22, 2020

Backed by our pioneering track record of innovation, medical firsts, and clinical credibility, Libre Sense Glucose Sport Biosensor—when used with a compatible partner app—allows athletes to correlate their nutrition choices to their athletic performance: https://t.co/hSUFkUPJuk pic.twitter.com/lzYvWEP3Is

— Abbott (@AbbottNews) September 22, 2020

NEWS: Our next-generation MitraClip G4 received CE Mark and is now approved in the EU to treat patients with mitral regurgitation: https://t.co/vuEEwBVIht

Important Safety Info: https://t.co/yQ2GUvJVHM pic.twitter.com/UCEGkKUd57

— Abbott (@AbbottNews) September 21, 2020

One size does not fit all, especially for cardiovascular diseases.

Read our Beyond Intervention white paper findings on how technology could create tailored, patient-centric care: https://t.co/b96X3cLCzv pic.twitter.com/AU0CseP0MN

— Abbott (@AbbottNews) September 18, 2020

Today we declared a quarterly #dividend of 36 cents per share. As a member of the S&P 500 Dividend Aristocrats Index, we’ve increased our dividend payout for 48 consecutive years: https://t.co/xAxPweYdZZ #DividendAristocrat pic.twitter.com/zN6ooNJT7M

— Abbott (@AbbottNews) September 17, 2020

Proud to be on this list for the 20th-straight time.

Thanks to all of our working parents for showing perseverance and passion this year. https://t.co/zbsAmPAE4y

— Abbott (@AbbottNews) September 15, 2020

Balancing family and career and times of uncertainty. We’re thankful for the perseverance and commitment of our working parents who enable us to continue to deliver our life-changing health technologies when they’re needed most. https://t.co/xCaWDNThko pic.twitter.com/cGlFdSGlyJ

— Abbott (@AbbottNews) September 15, 2020

60% of people across Africa live in rural areas with limited access to care.

We're helping @RwandaHealth and @SFHRwanda to bring more comprehensive care and testing closer to home through the power of innovation: https://t.co/x50Xe1Ask5 #SharedValue pic.twitter.com/8V8Gl5bnCt

— Abbott (@AbbottNews) September 14, 2020

Sustainability is central to our purpose of helping people live fully.

Find out how in our global sustainability report: https://t.co/uWFD1Okbb1

— Abbott (@AbbottNews) September 8, 2020

ICYMI: Our Freestyle Libre 2 system is now covered by Medicare. Meeting the highest level of accuracy standard*, every minute. https://t.co/Na9CZGhgtp

Important safety info: https://t.co/w2niXXYyAj
*Based on FDA iCGM special controls pic.twitter.com/zhTxJ0PbJF

— Abbott (@AbbottNews) September 4, 2020

First enrollments have begun for the first clinical trial in the U.S. to evaluate a fully resorbable device to treat blocked arteries in people with critical limb ischemia. https://t.co/01JDZe668B pic.twitter.com/Vtd0tRggt4

— Abbott (@AbbottNews) September 4, 2020

ANNOUNCEMENT: The first patient has been enrolled in a clinical trial to evaluate the new Esprit BTK drug-eluting resorbable scaffold: https://t.co/01JDZe668B

*Investigational device only in the U.S. pic.twitter.com/SME8Ptz31H

— Abbott (@AbbottNews) September 3, 2020

Now covered by Medicare: Our FreeStyle Libre 2 system, the only iCGM that measures glucose levels every minute, so people can make the right decisions at the right time about their health: https://t.co/Na9CZGhgtp

Important safety info: https://t.co/w2niXXYyAj pic.twitter.com/KcI8RJwrqT

— Abbott (@AbbottNews) September 1, 2020

Bringing accessible diagnostics testing to more people in more places. Our BinaxNOW COVID-19 Ag Card is a rapid antigen test with no equipment required that delivers results in 15 minutes: https://t.co/r0vSNE20ul pic.twitter.com/xmR6uNKHRd

— Abbott (@AbbottNews) August 28, 2020

To fight COVID-19, diagnostics are a powerful tool to help us navigate daily life. Our BinaxNOW rapid antigen test and NAVICA mobile app pair fast, reliable test results with a digital pass to help facilitate entry into organizations like work, schools: https://t.co/LW8LjdvUby pic.twitter.com/OweknZ5QEy

— Abbott (@AbbottNews) August 27, 2020

"We intentionally designed the BinaxNOW test and NAVICA app so we could offer a comprehensive testing solution to help Americans feel more confident about their health and lives." – Robert B. Ford, president and chief executive officer, Abbott. https://t.co/gn5PoryN1o

— Abbott (@AbbottNews) August 27, 2020

Addressing the unmet needs of babies with congenital heart defects: our Masters 15mm valve and Amplatzer Piccolo. We’re honored to be recognized by @TCBmag for manufacturing excellence.

Important safety info: https://t.co/dvqDD0xs0A & https://t.co/poUDFD30q0 pic.twitter.com/eivjAhut7h

— Abbott (@AbbottNews) August 20, 2020

True. Authentic. Real.

That’s how we want all 107,000 of our employees to feel at our workplaces around the world. We’re proud our diversity and inclusion efforts have been recognized by @_workingmother_ #DBPInclusionIndex: https://t.co/gN7aopRaMI pic.twitter.com/Iqbti8I8cq

— Abbott (@AbbottNews) August 18, 2020

Here’s why @RomanchukDaniel trusts our therapeutic nutrition drink, Juven, to support wound healing while pushing over 100 miles a week. pic.twitter.com/yA8nLfF4X6

— Abbott (@AbbottNews) August 17, 2020

In true champion form, @RomanchukDaniel is always ready to adapt, even during COVID-19.

In the midst of a pandemic, he organized a virtual marathon that brought together over 60 athletes from a dozen countries. Here’s his story: https://t.co/Hmeoovdq5T pic.twitter.com/58Xuf0Ryr5

— Abbott (@AbbottNews) August 13, 2020

People recovering from serious illnesses like COVID-19 can struggle to regain strength, energy and immune health.

Here’s 5 things you can do to support your muscle and overall health via @usnews: https://t.co/iU4hwmxTPZ

— Abbott (@AbbottNews) August 14, 2020

The role that nutrition plays in supporting would healing can sometimes be overlooked.

Here’s how Juven, a therapeutic nutrition drink, can help: https://t.co/nyIQwES1O8

— Abbott (@AbbottNews) August 12, 2020

Advancing emergency medicine in Africa when it’s needed most.

We’re working with @afemafrica to provide 8 months of virtual trainings on COVID-19 care to 2,000 frontline providers in Africa.

Here’s how: https://t.co/mVrhm9hT0Y pic.twitter.com/OKhulyP9OV

— Abbott (@AbbottNews) August 7, 2020

Our innovative spirit drives us to create health technologies that help people around the world live their best lives. Thanks for recognizing us @FastCompany #FCBestWorkplaces https://t.co/6lkaxD8JSc

— Abbott (@AbbottNews) July 29, 2020

Smartphones. They’ve seamlessly integrated into our daily lives.

We’re using that integration to take an innovative approach to deep brain stimulation: https://t.co/XYtnr7XhzR

Imp safety info: https://t.co/s6bEuReMwR pic.twitter.com/ds5DyAHVzf

— Abbott (@AbbottNews) July 28, 2020

Life-changing tests and diagnostics tools that enable smarter, faster decisions to better manage your health. Thank you @SelectScience for recognizing us as Clinical Company of the Year. https://t.co/yQ7IZG5123

— Abbott (@AbbottNews) July 23, 2020

COVID-19 infection: past or present? There are different types of tests for each. pic.twitter.com/xZHJaSSrCT

— Abbott (@AbbottNews) July 23, 2020

Community health centers are on the front lines of the COVID-19 fight in vulnerable communities. Thanks to @DirectRelief for the partnership to help advance COVID-19 testing. https://t.co/hblaRPOz5v

— Abbott (@AbbottNews) July 21, 2020

We exceeded expectations in Q2, topping analyst estimates for EPS and sales growth: https://t.co/K2ULlDBug7 $ABT #earnings pic.twitter.com/XNz9ez2ahV

— Abbott (@AbbottNews) July 16, 2020

How do our coronavirus tests differ?

Learn more: https://t.co/sAf2CQayYY pic.twitter.com/uiy8efZOJu

— Abbott (@AbbottNews) July 13, 2020

Millions of people served globally, every day.

Here’s how our quality and assurance teams in our nutrition business utilize resilience to deliver needed products to families who depend on them, especially during a pandemic: https://t.co/onrjYn8G2C

— Abbott (@AbbottNews) July 13, 2020

Wondering if that “flu” or really bad cold from the winter was COVID-19? Find out for sure. Get an antibody test. Learn how here: https://t.co/vuRVCRotHO pic.twitter.com/vFRDq8zCG1

— Abbott (@AbbottNews) July 9, 2020

Our interns are our future leaders.

That’s why it’s important for us to make sure they’re having valuable and engaging experiences this summer. Thanks @SHRMHRNews for highlighting our efforts. https://t.co/fOeBP61osV

— Abbott (@AbbottNews) July 9, 2020

Blood and plasma is needed now more than ever. Your donation could save the lives of up to 3 people. #BETHE1Donor https://t.co/9EvPnOdwzE pic.twitter.com/X5wzRmi4Tr

— Abbott (@AbbottNews) July 6, 2020

Caring. It’s in our DNA. It’s seen in the efforts our team members make, both at work and in their communities, like our colleague here in India who’s sewing masks and providing essential products to families in his area. pic.twitter.com/9AQCnVDKzu

— Abbott (@AbbottNews) July 1, 2020

No one knows how long this pandemic will last, but we do know that we’re committed to help fight it until the end. Our colleagues at this diagnostics site are working around the clock to deliver the critical tests needed for our m2000 laboratory system. https://t.co/euNbOD9bnI pic.twitter.com/NIKtURUGFr

— Abbott (@AbbottNews) June 30, 2020

By combining our glucose sensing technology with @TandemDiabetes proven insulin delivery systems, we will be able to create a cohesive ecosystem for people with diabetes that can fit easily into their daily lives: https://t.co/fgWVLyN8FE pic.twitter.com/kidtNakuTV

— Abbott (@AbbottNews) June 29, 2020

ANNOUNCEMENT: New research finds our optical coherence tomography imaging changed treatment decisions in 88% of artery blockages. Learn more: https://t.co/YguTyWpeH1 pic.twitter.com/3dHUbTyvHO

— Abbott (@AbbottNews) June 26, 2020

NEWS: Late-breaking data highlight impact of our minimally invasive therapies for people with structural heart diseases https://t.co/2dxqBHZ6i8 pic.twitter.com/wZDI1HoqZD

— Abbott (@AbbottNews) June 25, 2020

The research community is trying to better understand what antibody responses to COVID-19 mean. @Time covers what is known to date: https://t.co/yaDF4M95pB

— Abbott (@AbbottNews) June 24, 2020

COVID-19 antibody questions? Get answers: https://t.co/JlrD1RCq8G pic.twitter.com/3YgcQyd0g5

— Abbott (@AbbottNews) June 18, 2020

A sustainable future depends on environmental, social, and governance transparency and leadership.

We're honored to be one of the few on this list for 12 consecutive years. #100BestCC https://t.co/itiGdj2WOJ

— Abbott (@AbbottNews) June 17, 2020

Blood and plasma are needed more than ever. See how you could save lives: https://t.co/3F57uwvE2O #BETHE1Donor pic.twitter.com/Qi6PSbhQwr

— Abbott (@AbbottNews) June 14, 2020

We depend on frontline health workers providing critical care. And they can depend on us to do everything we can to fight this evolving threat. That’s why our colleagues here are working tirelessly to produce millions of our antibody tests each month. pic.twitter.com/Tdaa6wCqxp

— Abbott (@AbbottNews) May 28, 2020

NEWS: We’ve received FDA Emergency Use Authorization for our COVID-19 antibody blood test on our Alinity i System.

Data shows reliable results with 99.6% specificity and 100% sensitivity for patients tested 14 days after symptoms began: https://t.co/lN1DZihA4K pic.twitter.com/fYI8DdoFm9

— Abbott (@AbbottNews) May 11, 2020

We’re tackling COVID-19 head-on.

Recently, we announced our third COVID-19 test, an antibody test that can help determine if a person has had the novel coronavirus and whether they have developed antibodies: https://t.co/1GpMRKakpz pic.twitter.com/tL1bccE76x

— Abbott (@AbbottNews) April 17, 2020

We’re expanding COVID-19 testing options, launching an antibody test that runs on our ARCHITECT i1000SR and i2000SR lab instruments. We’ll start shipping this week and will ship 4 million tests in April, ramping to 20 million in the U.S. per month in June: https://t.co/bdXSrdd0YD pic.twitter.com/kv24A7NW35

— Abbott (@AbbottNews) April 15, 2020

BREAKING: We’re launching a COVID-19 antibody test that can help determine if a person has been previously infected.

We’ll supply 4 million tests in April, ramping up capacity to 20 million in the U.S. per month in June and beyond. Learn more: https://t.co/sxVOVgegMT pic.twitter.com/6xS1LjbaRB

— Abbott (@AbbottNews) April 15, 2020

With the combination of our lab and molecular point-of-care COVID-19 testing capabilities, we will supply about 5 million tests per month: https://t.co/mgOdVzMT3E pic.twitter.com/3oPMaNqkQe

— Abbott (@AbbottNews) March 30, 2020

https://twitter.com/cheddar/status/1299373636323872771

Highlight: “We’re providing a reliable and affordable rapid test at massive scale,” @AbbottGlobal R&D Divisional Vice President Dr. John Hackett says. “This is so portable… and so it allows health care providers to be able to test a lot more people.” Full interview: pic.twitter.com/YYrCK2OP4t

— Yahoo Finance (@YahooFinance) August 27, 2020

Abbott Laboratories new rapid test for the Coronavirus strain Covid-19 should expand much-needed access and help fill in gaps where U. S. testing has been slow and still unavailable months into the pandemic.https://t.co/BZbrFnMluf pic.twitter.com/BOByDOEI9Y

— Forbes Science (@ForbesScience) August 31, 2020

$5 rapid Covid-19 test from Abbott Labs gets emergency FDA approvalhttps://t.co/9JM6clFNuE By @DanielCassady pic.twitter.com/kw07QO4YkK

— Forbes Tech (@ForbesTech) August 27, 2020

Abbott’s rapid COVID-19 test: Here’s how it’s different from the rest https://t.co/TUzAUTsTf0

— Fast Company (@FastCompany) August 27, 2020

The first rapid coronavirus test that doesn't need any special computer equipment to produce results has been approved by the FDA. Its maker reports that it will sell for $5. https://t.co/JlI5ranEaJ pic.twitter.com/EppNfDTt3S

— WebMD (@WebMD) August 27, 2020

FDA authorizes Abbott’s fast $5 COVID-19 test https://t.co/ShGXqlztsz pic.twitter.com/qK789Xkinm

— The Verge (@verge) August 27, 2020

The FDA granted emergency-use authorization to Abbott Laboratories for a $5 rapid-response Covid-19 antigen test https://t.co/rLRXJpYDUl

— The Wall Street Journal (@WSJ) August 26, 2020

The US Food and Drug Administration issued an emergency use authorization to BinaxNOW Covid-19 Ag Card – a rapid antigen test made by Abbott that can detect Covid-19 infection in 15 minutes.

It uses the same type of technology as a flu test. https://t.co/306d6ZxEwo

— CNN (@CNN) August 27, 2020

A 15-minute Covid test that will be priced at just $5 has been granted emergency authorization for use in the U.S. and could ease a major bottleneck https://t.co/5amsOKePuQ

— Bloomberg (@business) August 26, 2020

BREAKING: U.S. Approves Abbott Labs $5 ‘Mass Scale’ Covid-19 Test via @forbes https://t.co/pKYTutRquY

— Bruce Japsen (@brucejapsen) August 26, 2020

@ScottGottliebMD Doc, i think this is the big one.. first large scale test that can make us be able to travel, go to work, test test test without the maddening delay…I am calling it big.. You??? https://t.co/Pml0qXGuyH

— Jim Cramer (@jimcramer) August 26, 2020

Bingo! Abbott with the game-changer–a 15 minute test ready next week!! $5 i think it's the real deal… because it's 98% accurate and it is ready in scale by the millions…Think pregnancy test . Time to travel again?

— Jim Cramer (@jimcramer) August 26, 2020

#WaitJustaMinute, what is antibody testing and why is it important?

Watch as Abbott's principal scientist and #VirusHunter, Mary Rodgers, explain the importance of #antibodytesting and what we've learned so far.https://t.co/CXMOi4EpQh

— The Chicago Council (@ChicagoCouncil) July 13, 2020

https://twitter.com/cheddar/status/1266049375387648000

From a new implant to keep babies' hearts healthy, to fighting malaria, to advancing the careers of underrepresented people in STEM, @AbbottGlobal's range of entries to #FCWorldChangingIdeas made it our selection for World Changing Company of the Year. https://t.co/HwqdoE0TNw

— Fast Company (@FastCompany) April 29, 2020

Breaking: Abbott just announced they have been given emergency use authorization for a rapid antigen test. They say: 15 minutes. 5 dollars. Greater than 95% sensitivity and no machine or lab required, adding they have the ability to make 50 million tests per month by October. pic.twitter.com/Ap7UBAn2UW

— Dr. Sanjay Gupta (@drsanjaygupta) August 26, 2020

Today's Special:
A potential game-changer in COVID-19 testing. Don't miss @megtirrell's exclusive interview with @AbbottNews CEO Robert Ford as they'll discuss the company's $5 rapid test. $ABT pic.twitter.com/xOnFYyyLtc

— Power Lunch (@PowerLunch) August 28, 2020

#WomensEqualityDay is not only intended to commemorate the passage of the 19th Amendment in 1920, but to also exemplify women’s hard work and accomplishments throughout the years. Learn how @AbbottNews are diversifying the #FutureOfSTEM with women in #STEM https://t.co/wKGHnOfcmP

— STEMconnector (@STEMconnector) August 26, 2020

There should be #NoCeilings for women who want to help others live their healthiest, fullest lives. That’s why we’re proud to be on the 2020 NAFE list of Top Companies for Executive Women for 12 straight years. #NAFETop https://t.co/vVE5xKgaoP

— Abbott (@AbbottGlobal) March 3, 2020

Is your toddler eating enough of these important nutrients? https://t.co/XI4VKyX5ST pic.twitter.com/oc5gnhjfXZ

— Abbott (@AbbottGlobal) March 3, 2020

Massachusetts Vol.20 (corporations: Biogen)

Today Biogen announced @US_FDA acceptance of the BLA filing for our investigational #Alzheimers disease therapy with Priority Review. Learn more about what this milestone means for the Alzheimer’s community.

— Biogen (@biogen) August 7, 2020

#Alzheimers disease has a significant impact on patients, care partners and society. Hear from Samantha Budd Haeberlein, SVP, Head of Neurodegeneration Development Unit, on how she is feeling about today’s milestone and why we are so passionate about this #PublicHealth crisis.

— Biogen (@biogen) July 8, 2020

#ClimateChange demands our attention. We're committed to advancing the science of how #FossilFuels impact health. We're investing $250M in our Healthy Climate, Healthy Lives initiative as we aim to be #FossilFuelFree and work with leaders like @MITGlobalChange & @HarvardCCHange.

— Biogen (@biogen) September 14, 2020

#Alzheimers is a growing public health crisis. This #WorldAlzMonth we stand with patients, caregivers, healthcare providers and advocates around the world in the fight against this disease. #LetsTalkAboutDementia https://t.co/XdSfqotKte

— Biogen (@biogen) September 23, 2020

Today Biogen CEO Michel Vounatsos spoke at @BostonGlobe’s “Accelerating the Next Generation of Climate Policy & Protecting Human Health” event. Thank you to participants: @CharlieBakerMA @Linda_Pizzuti @gibbonset @EnviroLeagueMA @MindyLubber @DrAriBernstein @The_BMC @EEASecretary pic.twitter.com/BDAzSbzb7y

— Biogen (@biogen) September 21, 2020

Dementia is not a normal part of aging. Together, let’s break down these misconceptions and encourage more discussions with doctors to understand dementia and #Alzheimers disease. Learn more from @AlzDisInt:

— Biogen (@biogen) September 21, 2020

#DYK that #NeuropathicPain, which can be chronic, unpredictable, and severe, is caused by nerve damage that affects millions of Americans every year? #PainAwarenessMonth pic.twitter.com/zgDQPfkbN7

— Biogen (@biogen) September 21, 2020

Our journey to becoming #fossilfuelfree includes supporting our suppliers. Three of our key suppliers, @VetterPharma, @ViforPharma and @Sharp_Services, have announced they’re joining us on our #fossilfuelfree journey. Learn more:

— Biogen (@biogen) September 17, 2020

Biogen Switzerland has been voted a national leader in representation of #WomenInLeadership roles, based on a new analysis of public data published by @DOITsmartCH. This result reflects Biogen’s #diversity, #equity and #inclusion philosophy and strategy. Learn more:

— Biogen (@biogen) September 17, 2020

We are proud to celebrate our colleague Antonella Santuccione Chadha who has been awarded the World Sustainability Award 2020 for outstanding contributions to sex and gender-oriented precision medicine through her work with the Women’s Brain Project.

— Biogen (@biogen) September 17, 2020

We applaud Google and every company working to rapidly and meaningfully address the climate crisis. Like Google, Biogen previously achieved carbon neutrality and we both now aim to run our operations entirely on carbon-free energy in the future. https://t.co/pZY46DkZus

— Biogen (@biogen) September 14, 2020

We are committed to supporting the elimination of racial inequality and promoting comprehensive #diversity, #equity and #inclusion initiatives. Learn more about @MassBio’s Open Letter 2.0 and the CEO commitment to addressing injustice in the #lifesciences industry.

— Biogen (@biogen) September 12, 2020

Highlights from #MSVirtual2020: CEO Michel Vounatsos on Biogen's longstanding commitment to the #MultipleSclerosis (MS) community and helping to improve care of MS.

— Biogen (@biogen) September 12, 2020

Last month, in support of #SMAAwarenessMonth, Biogen employees participated in a virtual race to raise donations for @CureSMA and show their passion for enhancing the lives of those in the #SMA community. pic.twitter.com/SfvZKRbXzg

— Biogen (@biogen) September 10, 2020

Our teams are researching the paths #medicines take in our bodies to provide a deeper understanding of how medications may impact the #brain. Learn more about this approach:

— Biogen (@biogen) September 10, 2020

Donna’s #connections help her understand that she is not alone. Watch her tell her #MS story in full here: #MSBeyondWords #ECTRIMS2020

— Biogen (@biogen) September 10, 2020

Cognitive difficulties may be closely linked to reduced work productivity in people living with #MultipleSclerosis (MS). CogEval® is a free iPad®-based app that allows #HCPs to routinely track and evaluate symptoms. https://t.co/1rvvnabcSm pic.twitter.com/orfxLuf9xq

— Biogen (@biogen) September 10, 2020

Spinal muscular atrophy (#SMA) is a rare genetic neuromuscular disease with debilitating effects. At Biogen, our patients help teach us how to best support them and our @EFPIA pledge is that #WeWontRest until we’ve improved the lives of those living with SMA. Read our pledges:

— Biogen (@biogen) September 10, 2020

We are proud to join @HRC and more than 30 other major U.S. companies to support the City of Philadelphia’s ability to enforce non-discrimination laws and ensure foster children have every option for a safe and loving home. https://t.co/KG2iqCWaGU

— Biogen (@biogen) September 8, 2020

Our ASO #research aims to change the current understanding of #neurological and #neuromuscular diseases. With several discoveries along the way and across disease states, our team hopes to establish a way past the blood-brain barrier. Learn more:

— Biogen (@biogen) September 8, 2020

#MSVirtual2020: Real-world data from a registry of >700 people with #MultipleSclerosis (MS) show racial disparities exist related to job, income, MS-related disability and therapy type. Understanding this gap is an important first step toward addressing these disparities.

— Biogen (@biogen) September 8, 2020

Our data at #MSVirtual2020 emphasize our dedication to progressing science that advances understanding of clinical and health disparities that exist for people living with #MultipleSclerosis.

— Biogen (@biogen) September 8, 2020

A massive milestone for Daniel was when he made #connections with a group of people his own age living with #multiplesclerosis. #MSBeyondWords pic.twitter.com/o1MSZqqIvo

— Biogen (@biogen) September 4, 2020

Biogen is committed to pursuing research for some of the most complex #neurological and #neurodegenerative diseases. Learn how our understanding of the brain has advanced over the past ten years:

— Biogen (@biogen) September 4, 2020

Muscle weakness due to spinal muscular atrophy (#SMA) results in an inability to perform basic life functions. Our EFPIA pledge is that we are committed to serving the SMA community and #WeWontRest until we’ve stopped this disease progression. Read our pledges via @EFPIA.

— Biogen (@biogen) September 3, 2020

Congratulations to Chris Leibman, Senior Vice President of Value and Access, for being selected for the @PhRMA 2020 We Work for Health Champion Award. This is a great honor and we are very proud! https://t.co/ZNecMJjr0V

— Biogen (@biogen) September 2, 2020

Through Coolidge Corner Theater, stream the documentary “From Controversy to Cure” by MIT Video Productions to learn how #science, #engineering, politics and #innovation came together during the 1976 Boston #biotech boom, featuring Biogen’s own co-founder Phillip Sharp. https://t.co/rfjjmiWucv

— Biogen (@biogen) September 2, 2020

Biogen is committed to advancing research aimed at discovering potential innovative therapies for people living with serious #neurological and #neurodegenerative diseases. Learn more about our dedication to the #neurology community:

— Biogen (@biogen) September 1, 2020

Spinal muscular atrophy (#SMA) affects the spinal motor nerve cells that impact nerves that control muscles, leading to debilitating and sometimes fatal muscle weakness. Biogen is dedicated to improving the lives of those living with this #raredisease.

— Biogen (@biogen) August 31, 2020

In celebration of #NHCW20, we recognize the importance of #communityhealth and are proud to support #telehealth initiatives through the Biogen Foundation that seek to provide communities with the healthcare services they need.

— Biogen (@biogen) August 14, 2020

Like many full-time #caregivers, when Heidi’s son, William, was diagnosed with spinal muscular atrophy (#SMA) at age 1, her life transitioned from HR executive to #advocate and fundraiser. Learn more about Heidi’s strength and commitment and how her son is managing today:

— Biogen (@biogen) August 10, 2020

We’re always looking for ways to pioneer science and bring hope to people living with #rarediseases. Our gene therapy research programs, focused on choroideremia and XLRP, aim to do just that. #Ophthalmology

— Biogen (@biogen) August 8, 2020

By high school, students often lose interest in #science. Our Biotech in Action: Virtual Summer Lab encourages students to pursue #biotech and science through labs, real-life application, conversations with Biogen and @LemelsonMIT scientists and more. Read more about the program:

— Biogen (@biogen) August 7, 2020

Tune in to the second day of @theNASEM virtual workshop to learn more about the lack of #diversity of older adults in #clinicaltrials and potential methods moving forward.

— Biogen (@biogen) August 6, 2020

We are excited to announce that Biogen and Denali Therapeutics have signed an agreement to co-develop and co-commercialize therapies for the treatment of #Parkinsons disease and certain TV-platform enabled programs for neurodegenerative diseases.

— Biogen (@biogen) August 6, 2020

Biogen applauds the #MAHouse for including #EnvironmentalJustice measures in the 2050 Roadmap to achieve the state’s net-zero emissions goal. We look forward to a final vote that codifies the framework and strengthens #sustainability provisions. #EJ4MA #mapoli

— Biogen (@biogen) August 5, 2020

This week, participants of the Biogen Neurohack program in Australia contributed to the creation of innovative concepts to address challenges faced by those with Spinal Muscular Atrophy (#SMA) and other neurological disabilities.

— Biogen (@biogen) July 24, 2020

We are proud to partner with @JoVEJournal on this venture and excited to have the opportunity to provide @SvilleSchools with STEM resources. https://t.co/CL0h5EDCdW

— Biogen (@biogen) July 24, 2020

Choroideremia is an inherited retinal disease (IRD) that can eventually cause blindness. Read James’ story to learn more about what it is like to live with choroideremia. #HealthyVisionMonth #EyeHealthIsMyHealth #MoreThan2020

— Biogen (@biogen) July 23, 2020

To help #neurologists stay up to date on the latest medical developments, we created Neurodiem, an independent, online platform that serves as a one-stop-shop for scientific neurological content. This #WorldBrainDay, learn more about the platform’s resources:

— Biogen (@biogen) July 22, 2020

This morning we reported our second quarter 2020 financial results, which demonstrate our dedication and commitment to #neuroscience. The webcast replay is now available: #Earnings $BIIB

— Biogen (@biogen) July 22, 2020

#SMA News from Biogen: we are planning to initiate a new global clinical study for the treatment of #SpinalMuscularAtrophy (SMA). Learn more:

— Biogen (@biogen) July 21, 2020

We are collaborating with @JoVEJournal to enhance online #STEM teaching and learning in @SvilleSchools. Teachers and students will have access to the full JoVE library with resources to support remote learning and science instruction.

— Biogen (@biogen) July 20, 2020

Biogen is proud to join @MilkenInstitute in establishing the Alliance to Improve Dementia Care. Together, we will aim to reduce disparities and ensure everyone affected by #dementia gets the right care at the right time.

— Biogen (@biogen) July 20, 2020

We’re committed to #givingback to our communities and supporting access to #STEM education. It’s an honor to be named one of @BosBizJournal's 2020 Top Corporate Charitable Contributors in Massachusetts. Learn more about our efforts:

— Biogen (@biogen) July 17, 2020

For long-term #nursing facility staff and residents, early detection of COVID-19 is critical. We worked with @MASeniorCare to launch a local pilot program leveraging surveillance testing for early identification of the virus to help keep staff and residents safe. Learn more:

— Biogen (@biogen) July 16, 2020

We’re honored to be named a 2020 “Best Place to Work for Disability Inclusion” receiving a 100% score on @DisabilityIN’s Disability Equality Index (DEI) for the third year in a row. We’re committed to employing people with #disabilities with the hopes of encouraging #equality.

— Biogen (@biogen) July 15, 2020

Closures, stay-at-home orders and fear of COVID-19 means family caregivers are at home 24/7, with little or no help. We were happy to support the recent discussion from @UsAgainstAlz on the pandemic’s ripple effect on care partners and communities. Listen here:

— Biogen (@biogen) July 9, 2020

Results from one of our genetic #ALS studies were published today in @NEJM. Learn more:

— Biogen (@biogen) July 8, 2020

Proud to announce that we are entering into an exclusive agreement with @MassEyeAndEar to focus on developing a potential treatment for inherited retinal degeneration due to mutations in the PRPF31 gene. https://t.co/nS8njn1CRn

— Biogen (@biogen) July 2, 2020

At Biogen, we value #inclusivity in our clinical studies, and this requires representation across demographics. We worked with @TuftsCSDD to better understand the challenges in reaching a diverse population when recruiting for clinical trials. Read more about our commitment:

— Biogen (@biogen) July 2, 2020

Many people continue to struggle to obtain basic needs such as childcare, food and healthcare. To help alleviate this strain, we’re supporting @UnitedWayMABay and @NCCHCAOnline to help provide support to our vulnerable communities.

— Biogen (@biogen) July 1, 2020

Biogen has joined more than 50 companies asking #EU policymakers to boost #RenewableEnergy use across the private sector to help support a green economic recovery from the COVID-19 pandemic in locations that are the most in need. Learn more about our climate strategy:

— Biogen (@biogen) June 26, 2020

Last week, @ManifestBoston hosted Alazar Ayele, Manager of Corporate Responsibility at Biogen, to discuss the importance of #STEM, including his passion for inspiring local youth to pursue careers in STEM through Biogen's #CommunityLab. Learn more:

— Biogen (@biogen) June 26, 2020

Today is #TheLongestDay of the year. While it is the day with the most sunlight, it’s also a time where people around the world shine a light on the fight to end #Alzheimers disease. Learn more from the @alzassociation on how you can get involved. #EndALZ

— Biogen (@biogen) June 20, 2020

We were delighted to host @CassSunstein for our virtual Expert Panel Series on “Planning for the Next Phase of #Alzheimers disease” to discuss the importance of recognizing early signs of cognitive impairment and how to take action. pic.twitter.com/nLcXsc3sFA

— Biogen (@biogen) June 18, 2020

We were proud to host author Meryl Comer at a virtual event with our employees in recognition of #TheLongestDay. Her book, "Slow Dancing with a Stranger," is a powerful account of her husband’s battle with AD. Hear more about her story:

— Biogen (@biogen) June 18, 2020

.@BioGen is helping accelerate the #RaceToZero: investing $250m to end fossil fuel in its operations by 2040. This means protecting citizens' health from pollution + delivering health solutions pic.twitter.com/XWS9n2snZG #ClimateWeekNYC #sciencebasedtargets #ouronlyfuture

— We Mean Business (@WMBtweets) September 22, 2020

Today's #HeroesinHealth event would not have been possible without the help of our sponsors! Thank you for your support. pic.twitter.com/BEAUPWKITl

— Alliance for Aging Research (@Aging_Research) September 15, 2020

Thank you again to @biogen for supporting the economic empowerment of our community through your contribution, helping our mission to close the racial wealth gap. #BankBlack #BuildBlack– https://t.co/9cbKpi2hqu

— OneUnited Bank (@oneunited) September 14, 2020

Great to see Ceres BICEP Network member @Biogen’s Healthy Climate, Healthy Lives goal to go fossil fuel free and advance the science on air pollution on human health. It’s a bold vision for scientific collaboration + action: https://t.co/ZULf2nq6iI https://t.co/GK5g6A4bBG

— Ceres (@CeresNews) September 14, 2020

Great hearing from @JohannaJobin about how @biogen has partnered with @EnviroLeagueMA to advocate for ambitious climate policy like the 2050 Roadmap Bill, environmental justice, and the Transportation & Climate Initiative. #ActOnClimate #MApoli #EJ4MA #TCI #NetZero pic.twitter.com/62BinS0uSG

— Miriam Posner (@MiriamKPosner) September 14, 2020

@Biogen takes significant step with Healthy Climate, Healthy Lives™ $250M, 20-year initiative, aimed at eliminating fossil fuels across its operations and collaborating with institutions to improve health. https://t.co/VnYHCa1oOl pic.twitter.com/X1JZYAoXKS

— NCBIO (@ncbio) September 14, 2020

https://twitter.com/CureSMA/status/1295139532833206273

The number of people living with dementia is projected to double by 2040.

With support from @AARP, @alzassociation, @biogen & @johnahartford, we’ve formed an Alliance to improve the healthcare systems that people affected by dementia must navigate. https://t.co/G4tmqBEoW2

— Milken Institute (@MilkenInstitute) July 31, 2020

Neurologists are pressed for time. A new knowledge platform named Neurodiem aims to keep them current. #AdFeature with @Biogen

— Nature Research Custom Media (@NatureCustom) July 16, 2020

.@Biogen has joined more than 50 companies asking #EU policymakers to boost #RenewableEnergy across the private sector to support a green economic recovery from the COVID-19 pandemic in locations most in need. Learn more about Biogen's climate strategy: https://t.co/NTLYC2tkqI pic.twitter.com/AFwnOLBbmw

— 3BL Media News (@3BLNews) July 13, 2020

.@biogen has pulled students from NC to participate in its virtual summer STEM program. Lab manager Alazar Ayele said: “Thinking about the next generation of STEM education and innovation, it’s so important to think about students.” @ncstem https://t.co/yDVxW2D739

— STEMx (@STEMx) June 18, 2020

Science and Technology Vol.41 (miscellaneous)

What does the operating room of the future look like? We asked surgeons and other experts about innovations that could be possible in the years ahead https://t.co/jaPs9zaodV pic.twitter.com/Fp8a51dlk0

— WSJ Health News (@WSJhealth) September 18, 2020

This speed bump measures how fast you're driving to prevent you from speeding. How neat! pic.twitter.com/D3viwoBnMa

— Digital Trends (@DigitalTrends) September 13, 2020

Manchester to co-host a new @EPSRC National Research Facility for lab-based X-ray computed tomography with @unisouthampton @warwickuni @ucl running cutting-edge 3D imaging experiments for industry and academia https://t.co/vhjlOPj5ms pic.twitter.com/F36TkGbV5I

— UoM News (@UoMNews) July 2, 2020

We are pleased to announce the launch of the Greater Manchester AI Foundry in partnership with @LancasterUni @SalfordUni @ManMetUni! Read more about the £6million project to develop AI in Greater Manchester here: https://t.co/bZ0loMptMd pic.twitter.com/GgsT9yyF5i

— UoM Institute for Data Science & AI (@idsai_uom) September 14, 2020

https://twitter.com/HealthInnovMcr/status/1284126159698112513

Funding Opportunity: Get funding for ideas that address COVID-19. Find out more from @UKRI_News here: https://t.co/nLxsK5aMLL pic.twitter.com/PdmlbaqYtb

— Digital Futures UoM (@DigitalUoM) June 25, 2020

Our Industrial-grade #PrivateWireless solution delivers the scalability, flexibility and coverage you need to create a smart digital manufacturing facility. Remake manufacturing today — and produce breakthroughs with #5G tomorrow. Learn more https://t.co/pRxp8qaOsE #Industry40 pic.twitter.com/CDFiojoIzy

— Nokia for industries (@nokiaindustries) September 11, 2020

What’s holding manufacturers back from making their shop floor (& their business) more efficient, productive & resilient? https://t.co/LeDIHqlWU0 via @forbes #Manufacturing #SupplyChainManagement #DigitalTransformation #Automation #Industry40 #Digital #Manufacturing #ERPsoftware

— COTHROM SYSTEMS (@cothromsystems) September 8, 2020

Xometry is excited to announce a $75MM round led by @TRowePrice, Durable Capital, and ArrowMark Partners to continue the expansion of our on-demand digital #manufacturing marketplace, providing #supplychain flexibility to companies around the world. https://t.co/QAPy6dyHwA pic.twitter.com/CiOc8WQGJ7

— Xometry (@Xometry) September 9, 2020

#COVID19 is emphasizing the potential of digital #manufacturing. https://t.co/pGRptw2QOr pic.twitter.com/B2MH4avvtA

— Manufacturing Business Technology (@mbt_mag) September 9, 2020

#3dprinting has put its tamp on the #Transportation industry. How @WabtecCorp will be working with @HP to open an #additivemanufacturing center of excellence to produce functional railway parts https://t.co/ds6bXSH4Mb #multijetfusion #hpmultijetfusion #digitalmanufacturing

— Avid Product Development (@AvidProduct) September 14, 2020

Have you heard? @Fictiv, a digital manufacturing ecosystem that delivers high quality parts at unprecedented speeds, announced a new radical transparency initiative that will introduce significant risk mitigation and cost-savings opportunities for customers. Details below. https://t.co/bviiNK2IFX

— Intel Capital (@intelcapital) September 10, 2020

We welcome you to view our virtual tour showcasing some of the facility and procedure updates MxD has implemented in response to the pandemic to keep our team and visitors safe. Watch: https://t.co/c41pcTQyDt #covid19 #safety #safeworkplace #returntowork #digital #manufacturing

— MxD (@MxDInnovates) September 10, 2020

Great news!@KWSPLtd to create 20,000+ sq ft #digitalmanufacturing centre in Silverstone Park's Enterprise Zone

This becomes the estate's 3rd specialist #Engineering facility (adding to those in #metrology & #aerodynamics)

Read more: https://t.co/tZycaWqrms pic.twitter.com/vmQEv46J1H

— silverstonepark (@SilverstonePark) September 8, 2020

KW Special Projects set to open new multi-million pound Digital Manufacturing Centre at Silverstone Park. Described as "one of the most technically advanced (facilities) of its kind in Europe", the production centre is due to open early next year https://t.co/0SLXGZ55Fx #UKmfg

— MTDMFG (@mtdmfg) September 15, 2020

https://twitter.com/cheddar/status/1159785393593602048

This robotic fish could be used to collect data under water pic.twitter.com/ixX8l9m8x3

— Mashable (@mashable) September 12, 2020

Scientists use an SNES controller to make this robofish spy on other real fish pic.twitter.com/5jDWY6I8Yh

— Gizmodo (@Gizmodo) March 23, 2018

This MIT robot fish is here to save the oceans: https://t.co/5MlNS5teu2 pic.twitter.com/6AQY2uCOgm

— WIRED (@WIRED) March 21, 2018

Scientists built a robot zebrafish to see if real fish would accept it as their own. pic.twitter.com/BWdHjcVQOV

— Quartz (@qz) November 28, 2017

https://twitter.com/adamsconsulting/status/1229612315441537024

A @WPI team builds an underwater #robot that takes aim at an invasive fish. https://t.co/K5OnkiuIHC pic.twitter.com/Nsya48FKvx

— WPI News (@WPINews) August 23, 2018

Inspired by the remora, scientists mimicked the hitchhiking fish's sucking fin to achieve #underwater adhesion with a robotic gripper. Presented by @studybuaa @wyssinstitute scientists in the September 2017 issue of @SciRobotics: https://t.co/mDEqGl1T0d ($) #robotics pic.twitter.com/UHyqtW7D9f

— Science Magazine (@ScienceMagazine) August 22, 2020

https://twitter.com/UberFacts/status/1300612586581438468
https://twitter.com/USASwimming/status/1307058460731887616

Wizardry is back on @CBS this weekend ✨@Debinha7 and @TheNCCourage host @ORLPride at 1 p.m. ET on Saturday. #NWSLFallSeries | #VerizonCommunityShield pic.twitter.com/IMxfVn9iSB

— NWSL (@NWSL) September 17, 2020

https://twitter.com/DigitalTrends/status/1305159299400790017

The record September cold could be linked to climate change https://t.co/v4Lryj05H5

— 9NEWS Denver (@9NEWS) September 12, 2020

Satellite-derived wind data indicate that Tropical Storm #Sally has formed and is centered just off the southwest coast of Florida. Maximum sustained winds are 40 mph. https://t.co/wVCrCIjDrB pic.twitter.com/KC7Bq1Vror

— National Hurricane Center (@NHC_Atlantic) September 12, 2020

Oregon homeowners, neighbors struggle to combat wildfires amid shortage of firefighters https://t.co/79DeFl7isW

— Los Angeles Times (@latimes) September 13, 2020

Perspective | From fury to serenity: Inside the eyewall and eye of Hurricane Sally in Alabama https://t.co/w2oFlHBPQJ

— The Washington Post (@washingtonpost) September 16, 2020

Scientists say there could be life on Venus—or at least in the clouds in its atmosphere https://t.co/PhBmhSV5iY

— The Wall Street Journal (@WSJ) September 15, 2020

JUST IN: Preliminary 4.6-magnitude earthquake strikes near El Monte, California, USGS reports. pic.twitter.com/tdjJR4ayzZ

— NBC News (@NBCNews) September 19, 2020

WATCH: April's supermoon, which is the largest one of 2020, shone down the deserted streets of Paris on Tuesday https://t.co/o1S0abeB7R pic.twitter.com/BrTnjYo6fr

— CBS News (@CBSNews) April 8, 2020

First intact planet the size of Jupiter is found orbiting the smouldering remains of a white dwarf star https://t.co/XpQSBCFXo5

— Daily Mail Online (@MailOnline) September 16, 2020

A second Earth? NASA scientists find planet similar to ours that may have liquid water https://t.co/2xv3Gy7a4s

— The Kansas City Star (@KCStar) April 17, 2020

.@businessinsider discusses how #IoT is changing the game. At @KETOS_H2O we're already leading the way w/ cutting edge #AI and IoT tech that's changing how industry and communities can monitor their #water more efficiently. https://t.co/uZmMv7wREP

— KETOS – Revolutionizing Water Analytics w/IoT & AI (@Ketos_H2O) August 26, 2020

This Dutch farm produces more food but uses no soil and 95% less water TY @wef via @enricomolinari #climatechange #IoT #renewables #fintech #data @enricomolinari @VivekGhosal @CioAmaro @iTrucker_ @angelicabedoy16 @PawlowskiMario @InsaneTech_ pic.twitter.com/SEqoWLYHfn

— Céline Gianni Darnet (@CelineDarnet_) February 15, 2020

This invention can turn seawater into drinking water@wef via @ingliguori mt @enricomolinari #sustainability #innotech #marketing #ehealth #AI @adamsconsulting @Julez_Norton @Fabriziobustama @HaroldSinnott @Hana_ElSayyed @jblefevre60 @FrRonconi @PawlowskiMario @mvollmer1 @vg_fco pic.twitter.com/xxhwmm8TFs

— Giuliano Liguori (@ingliguori) March 18, 2020

Water bubble control objective via @wef #tech #digital #data pic.twitter.com/nnZmw2Mmwm

— Kohei Kurihara -DataPrivacy for Fighting Covid-19- (@kuriharan) August 24, 2020

The U.S. gets a 'D' when it comes to drinking water infrastructure. Over 6 billion gallons of water is lost everyday to leaks. Wastewater only does a bit better with a 'D+." We need to spend more money on treatment facilities. #Rebuildbetter #DrinkingWaterInvestments pic.twitter.com/F2P9ZP3WgM

— South Coast Water District (@southcoastwater) September 17, 2020

Access to clean, safe, and continuous supply of water is essential especially during this time of pandemic when public health greatly depends on it.

Let us work together and do our part in protecting our scarce water resource to ensure its sustainability. pic.twitter.com/iaswk226Wk

— MWSS Regulatory Office (@mwssro) September 22, 2020

NEW – Guest post: Coronavirus food waste comes with huge carbon footprint | @b0jana https://t.co/pi4aCVfh4g pic.twitter.com/H4P0VjsKpv

— Carbon Brief (@CarbonBrief) September 17, 2020

Haley’s Health Inbox: Is it safe to drink from a water fountain during the pandemic?
> https://t.co/HoZR8xxjXF

— KPRC 2 Houston (@KPRC2) September 21, 2020

How Water Can Help Boost Immunity? Expert Revealshttps://t.co/eYipVMk7gl #water #immunity #expert #diet

— NDTV Food (@NDTVFood) September 23, 2020

Drink 8-10 cups of water every day!#COVID19 Nutrition Tips. pic.twitter.com/DPIcpwYgvW

— WHO Nigeria (@WHONigeria) September 22, 2020

Squeezing a bit of lemon into your H20 can boost immunity, detoxify and much more. https://t.co/yBkCPaIypd

— Shape Magazine (@Shape_Magazine) September 22, 2020

What's the best food for immune system that help to boost your immunity. Right here we'll talk about some good meals for A robust immune system. Due to A robust immune system helps lots in maintaining each individual healthy.#boostimmune #health https://t.co/Y6S8hIhS3Q pic.twitter.com/JXUj7WVC3W

— Real Healthline (@realhealthline) September 14, 2020

These 17 probiotic pairings will double your weight loss. https://t.co/WXgYQckHVH

— Eat This, Not That! (@EatThisNotThat) September 23, 2020

While no foods or dietary supplements can prevent or
cure #COVID19 infection, healthy diets are important for
supporting immune systems. Good nutrition can also reduce
the likelihood of developing other health problems.#POSHANMaah2020 @MoHFW_INDIA @MinistryWCD @POSHAN_Official pic.twitter.com/GfxkZkEtK6

— WeCollaborateforNutrition (@WeCan4Poshan) September 18, 2020

Joint @BACPR – @bdapublichealth summary infographic slides of statement on #nutrition and #cardiovascular health post –#COVID19 pandemic @drtom_butler @KEPatersonRD @StanfordDell @ EmiemmyRD @NusratkRD @BDA_Dietitians @uocClinSciNutr @NDLeedsBeckett @FoodSciLeeds pic.twitter.com/fx7ZFJaHHw

— BDA Public Health (@BDAPublicHealth) September 16, 2020

Dr. Shahnaz Sultan from the Division of Gastroenterology, Hepatology and Nutrition provided her insight for this unique article about #COVID19 and #data trends. https://t.co/Vnr1n2BKp8

— UMN Medical School (@umnmedschool) September 19, 2020

Link between VITAMIN D deficiency and #Covid19 confirms: get some sun and eat some fatty fish and eggs. This confirms that #publichealth should be promoting nutrition!! https://t.co/F80rm2xpi2

— Wayne Roberts (@wrobertsfood) September 22, 2020

https://twitter.com/LoveOneToday/status/1308448659281981440

“Along w/ social distancing measures & effective vaccines, a healthy immune system is our best defense against coronavirus infection. To keep it that way, proper nutrition is an absolute must.” ⁦@Nextgov⁩ #COVID19 #EatMoreVegetables #NutritionMatters https://t.co/MbQ0KIIWY7

— Christina Ayiotis (@christinayiotis) September 21, 2020

Don’t be ashamed. We’ve all backslid on our diets during the pandemic.

But remember, when it comes to the coronavirus, good nutrition is like a seatbelt for health; it doesn’t ensure you won’t get sick but it does improve your chances (via @USC @USCD… https://t.co/lmUDAz39Vk pic.twitter.com/7V5w4Y40oO

— The Conversation US (@ConversationUS) September 21, 2020

https://twitter.com/FAO/status/1305788442807336960

In this audio interview, the editors discuss guidelines for the deployment of potential SARS-CoV-2 vaccines from the CDC and the National Academies, as well as new information on two candidate vaccines. #COVID19 #SARSCoV2

— NEJM (@NEJM) September 9, 2020

Oxford, AstraZeneca resumes coronavirus vaccine trial https://t.co/wwcWfpwcsM

— FOX 8 New Orleans (@FOX8NOLA) September 12, 2020

….coronaviruses and flu viruses have very different structures, so even if their pieces did recombine, you'd probably be left with a non-functional mess that couldn't infect anything. https://t.co/OujKaZnB2N

— National Geographic (@NatGeo) September 18, 2020

Experts have been particularly concerned about AstraZeneca’s vaccine trials because of the company’s refusal to provide details about serious neurological illnesses in two participants. https://t.co/gw2Njo9Wrq

— NYT Science (@NYTScience) September 20, 2020

There is disagreement about how accurate the PCR tests for the coronavirus are, but estimates suggest that the false-negative rate could range as high as 30 per cent. https://t.co/dkqdx1EINL

— The New Yorker (@NewYorker) September 20, 2020

FDA is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the NIH has launched an investigation of the case. https://t.co/ExHwCow47Z

— Scientific American (@sciam) September 15, 2020

With major deals and a high-stakes fight against Covid-19 happening, investors are placing bets on pharmaceutical companies, explains @ahirtens #WSJWhatsNow pic.twitter.com/YFUTRiPfeW

— The Wall Street Journal (@WSJ) September 14, 2020

A global effort wants to make sure incoming scientists don't bring the coronavirus to Antarctica with them. https://t.co/Ih9lpcp6vq

— KARE 11 (@kare11) September 12, 2020

WATCH: Sometimes travel can be unavoidable. Here are some tips to stay safe and protected while staying at a hotel amid the pandemic. https://t.co/MBhqzLFl8L

— NBC 7 San Diego (@nbcsandiego) September 12, 2020

How can I get it? The evidence on coronavirus transmission https://t.co/wfoPSGkjf2

— Bloomberg (@business) September 19, 2020

Texas coronavirus cases and hospitalization continue to decline from July’s record highs, with COVID-19 patients currently occupying 5.5% of total hospital beds. https://t.co/KAtrm3XX7M

— Texas Tribune (@TexasTribune) September 18, 2020

12/ In fact, Texas has the highest uninsured rate in the U.S.

During the pandemic, an estimated 659,000 Texans lost their health care between February and May. https://t.co/nGvDViuM4Z

— Texas Tribune (@TexasTribune) September 19, 2020

Very telling account of how severe pandemics were handled in less hysterical times. People kept calm and carried on. https://t.co/6hNjSsEIoY

— Brit Hume (@brithume) September 18, 2020

This is the most comprehensive timeline of not just COVID but also the transition from Obama to Trump around pandemic preparedness from @rgoodlaw and colleagues consider this a MUST READ for anyone/it incorporates the Woodward tapes into the timeline: https://t.co/ev34iWfHCz

— Kavita Patel M.D. (@kavitapmd) September 10, 2020

Denmark Vol.2 (pharmaceutical corporations: Novo Nordisk)

People with diabetes and/or high blood pressure develop COVID-19 symptoms that are worse than average. Danish researchers will investigate whether the medicine taken for these conditions is the cause.#sciencenewsdk #COVID19 #covid19dk https://t.co/MHbEb46EnK

— Novo Nordisk Foundation (@novonordiskfond) September 22, 2020

Danish research shows that people with COVID-19 who are hospitalized rarely have bacterial infections. Antibiotics are therefore not needed at admission, says a researcher.#sciencenewsdk https://t.co/iBPkxpcAyT

— Novo Nordisk Foundation (@novonordiskfond) September 21, 2020

The Novo Nordisk Foundation is awarding DKK 14.4 million for 15 international initiatives that can mitigate the consequences of the COVID-19 pandemic in countries such as Sudan, Colombia and Myanmar.#COVID19 #COVID19dk #novonordiskfonden https://t.co/xZAUpBN8IU

— Novo Nordisk Foundation (@novonordiskfond) September 21, 2020

A new analysis of clinical trials testing low-dose corticosteroids against COVID-19 shows excellent effectiveness. Intensive care units in Denmark have started using corticosteroids, and mortality from COVID-19 is therefore expected to fall significantly.https://t.co/OJbqvgO1wi

— Novo Nordisk Foundation (@novonordiskfond) September 17, 2020

Researchers have collected vast quantities of data to determine how genetic variation between humans determines who develops depression, schizophrenia, Parkinson’s disease and many other brain disorders.#novonordiskfoundation #sciencenewsdk https://t.co/0QSrY9vJPU

— Novo Nordisk Foundation (@novonordiskfond) September 16, 2020

Researchers have many good reasons to insert genes from some organisms into others. An example is that they want bacteria to produce drugs or other biological molecules that may be useful in the health sciences.#sciencenewsdk https://t.co/VmBIgEiWLb

— Novo Nordisk Foundation (@novonordiskfond) September 16, 2020

New technological advances and advanced antiviral drugs are not what prevents most patients with COVID-19 from dying. Old-fashioned and well-established methods save their lives, but getting support for research in this field is difficult.#sciencenewsdk https://t.co/7g4h7xR6iq

— Novo Nordisk Foundation (@novonordiskfond) September 15, 2020

New Finnish research shows that adults who were born preterm at very low birthweight have an earlier circadian rhythm.#novonordiskfoundation #novonordiskfonden #sciencenewsdk https://t.co/wMvNak48nF

— Novo Nordisk Foundation (@novonordiskfond) September 10, 2020

The oxygen therapy given to acutely ill patients internationally is quite inconsistent, with few guidelines and little evidence about what works best. Danish researchers and doctors will now put an end to this.#sciencenewsdk #science https://t.co/4ngkFcJUdQ

— Novo Nordisk Foundation (@novonordiskfond) September 9, 2020

Four talented and promising young researchers are pulling up stakes and moving to Denmark having received a grant of DKK 25 million each from the Novo Nordisk Foundation.#novonordiskfonden #novonordiskfoundation https://t.co/irysyxn6Ll

— Novo Nordisk Foundation (@novonordiskfond) September 4, 2020

Researchers from Aarhus University and others are collaborating on a major research project to design new multifunctional drugs that can potentially be much more effective against cancer and other diseases and can be optimized for each individual.#science https://t.co/xcmH17591d

— Novo Nordisk Foundation (@novonordiskfond) September 3, 2020

The discovery of smallpox virus in skeletal and dental remains from the Viking Age shows that the world’s deadliest infectious disease ever was already widespread 1,000 years earlier than previously thought.#sciencenews #science https://t.co/eEyfWuzCf6

— Novo Nordisk Foundation (@novonordiskfond) September 2, 2020

Researchers have mapped the structure and function of a giant CRISPR-Cas complex. The mapping of these molecular scissors may advance researcher’s knowledge of how bacteria develop antimicrobial resistance and how this can be combatted.#science #research https://t.co/ZMb5l1CC4P

— Novo Nordisk Foundation (@novonordiskfond) September 1, 2020

Virologists throughout the world have had difficulty agreeing on the actual fatality rate from COVID-19. Antibody testing in Denmark’s blood banks shows that the fatality rate is very low among people younger than 70 years.#sciencenews https://t.co/DCqtO8FPLe

— Novo Nordisk Foundation (@novonordiskfond) August 31, 2020

Researchers have identified molecular principles that shape the development of the hypothalamus. The research provides new insight into the mechanisms that can go wrong and lead to the development of stress, anorexia and sleep disorders.#sciencenewsdk https://t.co/1rLkyKTIDd

— Novo Nordisk Foundation (@novonordiskfond) August 28, 2020

Proteins from plants, fungi and microorganisms must replace the demand for animal-based protein in our foods. The Novo Nordisk Foundation Challenge Programme will support research that will work towards achieving this goal.#novonordiskfoundation https://t.co/YmyNu4Ic9q

— Novo Nordisk Foundation (@novonordiskfond) August 27, 2020

Twenty years ago, researchers were shocked when they discovered that 30% of our proteins do not behave as proteins should. That realization has now spurred a major research project, which may turn out to be vital for enabling us to cure numerous diseases.https://t.co/C4qunLCmeW

— Novo Nordisk Foundation (@novonordiskfond) August 26, 2020

The new coronavirus (SARS-CoV-2) will be around for a while. A crucial question that needs to be answered to determine how to keep the virus at bay is whether previously infected people become immune – and whether they remain immune.#COVID19dk #COVID19 https://t.co/twAM6sj0To

— Novo Nordisk Foundation (@novonordiskfond) August 24, 2020

Obesity and diabetes appear to worsen the symptoms of COVID-19. The question is why? Researchers have found that adipocyte-like cells may be the potential culprit.#novonordiskfoundation #novonordiskfonden https://t.co/vAWy54TgSo

— Novo Nordisk Foundation (@novonordiskfond) August 22, 2020

The Novo Nordisk Foundation Challenge Programme seeks to support cross-disciplinary research with the aim of developing mathematical models that help to improve understanding of the mechanisms underlying health and disease.#novonordiskfonden https://t.co/VRd9MJtiXp

— Novo Nordisk Foundation (@novonordiskfond) August 20, 2020

A new study reveals that the naturally occurring sugar chains regulate peptide hormones and thus potentially how the body is balanced. By recreating these changes in the laboratory, researchers may be able to fine-tune the medicine of the future.#science https://t.co/jG9rtHBJCD

— Novo Nordisk Foundation (@novonordiskfond) August 20, 2020

According to new Danish research published in Gastroenterology, people who have inflammatory bowel disease (IBD) such as ulcerative colitis or Crohn’s disease in childhood have an increased risk of developing cancer later in life.#sciencenews #science https://t.co/1plZIYxadB

— Novo Nordisk Foundation (@novonordiskfond) August 19, 2020

An analysis of the genomes of 27,566 Icelanders now provides the most detailed information on the traces Neanderthals left in the human genome 50,000 years ago. https://t.co/FzTxwdtwpC

— Novo Nordisk Foundation (@novonordiskfond) August 19, 2020

Researchers in Denmark have discovered that people undergoing chemotherapy have a dramatically increased risk of developing leukaemia if they have specific gene mutations.#sciencenews #novonorfiskfoundation #novonordiskfonden https://t.co/poZCDtlvnQ

— Novo Nordisk Foundation (@novonordiskfond) August 17, 2020

Of the many types of bacteria in the oral cavity and throat, one species is worrying because it can colonize the lungs, ear and make us ill. Danish researchers are now closer to understanding why most oral bacteria are harmless and a few are not.https://t.co/zTMbtelFdm

— Novo Nordisk Foundation (@novonordiskfond) August 13, 2020

Danish researchers have developed a molecular biology tool to illuminate the immune cells when the immune system is active. The tool may provide completely new insight into the immune response to harmful pathogens such as SARS-CoV-2, the new coronavirus.https://t.co/OkVIGybMbv

— Novo Nordisk Foundation (@novonordiskfond) August 8, 2020

Health systems worldwide are battling multidrug-resistant bacteria, and a Danish-German research team has found a tiny, naturally occurring peptide with an extraordinary antibacterial effect.#novonordiskfonden https://t.co/pcwY4w567D

— Novo Nordisk Foundation (@novonordiskfond) August 6, 2020

People who have become seriously ill from the new coronavirus have experienced how their lungs struggle for survival. New research shows that damaged tissue is not repaired in the lungs, which is why many people succumb to COVID-19. #COVID19dk #COVID19 https://t.co/tpb91pykaG

— Novo Nordisk Foundation (@novonordiskfond) August 4, 2020

Bacteria have the potential to convert synthesis gas – a mixture of carbon monoxide (CO), hydrogen (H2) and often carbon dioxide (CO2) – into liquid fuel for passenger and commercial transport ranging from cars to aircraft.#sciencenews #science #research https://t.co/cJpHCDar8K

— Novo Nordisk Foundation (@novonordiskfond) August 4, 2020

Danish and Australian research shows how ubiquitin plays a key role in regulating protein degradation and adapting skeletal muscle following exercise. This process is important for maintaining a healthy body and healthy muscles, says a researcher.#science https://t.co/TiFIgn8ZNI

— Novo Nordisk Foundation (@novonordiskfond) August 3, 2020

Many of the world’s leading pharmaceutical companies and foundations have raised USD 1 billion (more than DKK 6 billion) to launch the @AMRActionFund to combat antimicrobial resistance.

Read more: https://t.co/475tKrUXC3 #AMR #AMRActionFund #Antimicrobialresistance pic.twitter.com/67PG5JLSgl

— Novo Nordisk Foundation (@novonordiskfond) July 9, 2020

https://twitter.com/NovoNordiskLive/status/1306612000752107521

Is obesity a disease? https://t.co/ixf81fVxTW

— Novo Nordisk Live (@NovoNordiskLive) September 4, 2020

Listen to Bjarne talk about living with #obesity in times of #COVID19 and social isolation. It's important to understand the science and potential impact of Covid-19 #ECOICO2020 pic.twitter.com/xMneQrtnfb

— Novo Nordisk Live (@NovoNordiskLive) September 2, 2020

#PRESS: Novo Nordisk launches new 100% renewable power target for suppliers

— Novo Nordisk (@novonordisk) September 21, 2020

https://twitter.com/novonordisk/status/1307595221367246849
https://twitter.com/novonordisk/status/1306927024141991937
https://twitter.com/novonordisk/status/1306519022847102978

Thank you to @wef for recognising our Hillerød, Denmark-based production facilities in its Global Lighthouse Network. Through digitalisation and advanced analytics in our factories, we serve the needs of 30 million people worldwide more efficiently and sustainably each year.

— Novo Nordisk (@novonordisk) September 14, 2020

https://twitter.com/novonordisk/status/1304022932847562752

This chair is just one way to recycle our insulin pens. We're working hard to make sure that all of our insulin pens will have a second life ♻️ #circularforzero

— Novo Nordisk (@novonordisk) August 31, 2020

There are many things you can do to lower the risk of cardiovascular disease when living with #type2diabetes ❤️ #ESCCongress

— Novo Nordisk (@novonordisk) August 30, 2020

https://twitter.com/novonordisk/status/1297857654069563392
https://twitter.com/novonordisk/status/1296422766346985475
https://twitter.com/novonordisk/status/1296011587036360707
https://twitter.com/novonordisk/status/1295616206075043840

#PRESS Novo Nordisk invests DKK 850 million in production facilities in Kalundborg

— Novo Nordisk (@novonordisk) August 14, 2020

https://twitter.com/novonordisk/status/1293857328165355520
https://twitter.com/novonordisk/status/1291788697625649152

#PRESS: Novo Nordisk's operating profit increased by 9% in Danish kroner and by 8% at constant exchange rates (CER) in the first six months of 2020

— Novo Nordisk (@novonordisk) August 6, 2020

We are now running all production worldwide on renewable power ♻️ – five years ago we didn’t know if this would ever be possible. https://t.co/X4jcVItCkh

— Novo Nordisk (@novonordisk) August 3, 2020

https://twitter.com/novonordisk/status/1288527207128641542
https://twitter.com/novonordisk/status/1282625708142014464
https://twitter.com/novonordisk/status/1281216847036272640

Might there come a day when all insulin pens can be re-purposed after use? ♻️ #circularforzero

— Novo Nordisk (@novonordisk) July 1, 2020

#PRESS Product approved in Japan for the treatment of type 2 diabetes

— Novo Nordisk (@novonordisk) June 29, 2020

#PRESS Novo Nordisk successfully completes phase 2 trial and phase 1 combination trial in obesity

— Novo Nordisk (@novonordisk) June 18, 2020

https://twitter.com/novonordisk/status/1273237973820076035
https://twitter.com/novonordisk/status/1265908729528168449

'I say diabetes is the best thing that's ever happened to me and it's so true.' Learn more about the Sustainable Development Impact Summit: https://t.co/z2FebkrRgi #sdi20 pic.twitter.com/UWJsgesbgK

— World Economic Forum (@wef) September 19, 2020

"Sharing our experience and making sure that could benefit other companies is a key priority for us." @DoretheN. Many congratulations to @novonordisk who are shortlisted for the Most Collaborative Leader category in the #RE100 Leadership Awards! https://t.co/ok7afS7G1W pic.twitter.com/eJWudZX8nO

— RE100 (@theRE100) September 10, 2020

After reaching its 100% renewable electricity target, through @theRE100 #CDPAList @novonordisk has committed to achieving a #NetZero target by 2030.

Learn more via @edie: https://t.co/nLm3ni6KxB

— CDP (@CDP) August 30, 2020

100s of leading companies including @novonordisk led by @larsfruergaard, are helping to build a healthy & resilient, zero-carbon future. A future that must be fair, inclusive & equal, & leave noone behind: #RacetoZero https://t.co/3Pg0MtJYDk pic.twitter.com/coE3GKhoy9

— We Mean Business (@WMBtweets) August 20, 2020

https://twitter.com/citiesdiabetes/status/1290905485797920768

Recognising the role pharma played on the frontline of #COVID19 https://t.co/xSLdzC4Qll via @Pharmafield

— Emma Morriss (@EmmaDMorriss) August 3, 2020

Sleep Apnea is a common breathing disorder that affects many people whilst they sleep & could be an early warning that diabetes development is underway.https://t.co/fmcPIYEXLi

— Diabetes.co.uk (@Diabetescouk) July 29, 2020

Mayors from around the world, supported by business leaders, youth climate activists & trade unions, have launched a detailed agenda to deliver a just & sustainable economic recovery from #COVID19. Read it here: https://t.co/trpIARnphc pic.twitter.com/fFsz4oUyNn

— C40 Cities (@c40cities) July 15, 2020

Caring for people with #diabetes in #humanitarian settings is challenging. #COVID19 has not made it easier. @ICRC we are grateful @novonordisk for providing free of charge #insulin & shipment. A testimony /#Pakistan #changingdiabetes #PartneringForChange https://t.co/kEfezhcUnX

— Rudina Turhani (@RudinaTurhani) July 3, 2020

Check out our poster @ADA_DiabetesPro conference investigating perceived attitudes and challenges in athletes with #T1D #ADAGoesVirtual #ADA2020 #changingdiabetes pic.twitter.com/l3dCeHiuuy

— Sam Scott (@SamNathanScott) June 15, 2020

https://twitter.com/Cities_Today/status/1271485669118849024

Thanks @PhilSoutherland for challenging me to join the @5K_ADA & to those who have walked & run over this weekend to promote physical activity to prevent #type2diabetes and its complications. Not being a runner, I took to the water and paddled 5K. It’s not too late to sign up. pic.twitter.com/hAvGzoAOrA

— Lars Fruergaard (@LarsFruergaard) June 14, 2020

Society, communities & industry must work together to #changingdiabetes. In 2020 we celebrate our 15 years of partnership w/ @AmDiabetesAssn in raising diabetes awareness. This year is special as everyone can take part by signing up for the @5K_ADA https://t.co/y4eRwABU9t pic.twitter.com/koYbN73GMt

— Lars Fruergaard (@LarsFruergaard) June 12, 2020

Research shows those living with #diabetes #heartdisease are at increased risk from severe coronavirus complications. Learn more and take control at https://t.co/hyttbb2GmY. #Type2Take2 Founding Sponsor @novonordiskus pic.twitter.com/xRNUkp8JRb

— American Heart Association (@American_Heart) July 29, 2020

Get the facts on #COVID19 and #obesity. Artists are using their voices to remind us that we’re all in this together, and help is out there.

Watch the PSA by @TheCreativeC and learn more: https://t.co/cXEkO5BSYj pic.twitter.com/9TvTqz81Kl

— Novo Nordisk US (@novonordiskus) September 21, 2020

Calling all #lifescience and #biotech innovators: Imagine what you could do at @LabCentral in Boston! Apply for the #NovoNordiskUS-sponsored #LCGoldenTicket for your chance to work in a shared lab space for a year: https://t.co/Lb9pbWXbqP pic.twitter.com/czAal1jpAV

— Novo Nordisk US (@novonordiskus) September 19, 2020

If you or someone you know are struggling to afford insulin, let us help. #NovoCare is here to support you with options that may be able to help you better afford your #diabetes medicine: https://t.co/TD5yLXnmQ6 pic.twitter.com/NVu5NXlFfL

— Novo Nordisk US (@novonordiskus) September 9, 2020

The story of #NovoNordiskUS intern, Nicole (21) and Connie (81) is a helpful reminder that age and distance don't matter when it comes to comforting each other during difficult times. Read their story: https://t.co/wKudzH0yHU @BigandMini pic.twitter.com/LrUg3d3oGl

— Novo Nordisk US (@novonordiskus) September 5, 2020

“How do I safeguard myself in public and/or at work during the #COVID19 pandemic?” Our CMO responds in today’s video. For more #NovoNordiskUS COVID-19 videos and resources: https://t.co/TVI74IcLXm pic.twitter.com/TgWbECUD1G

— Novo Nordisk US (@novonordiskus) September 4, 2020

Critical care #nurse and #NovoNordiskUS employee Mary and her fellow nurses have been affected by #COVID19 in ways they won’t soon forget. Mary’s story serves as a reminder to thank our healthcare workers for their dedication and sacrifices: https://t.co/fDFG3YPk9f pic.twitter.com/wXVditiabV

— Novo Nordisk US (@novonordiskus) August 26, 2020

1,500 boxes of food went to help #NewJersey families in need at the first of several food donation events we’re happy to host this summer. Thanks to everyone who volunteered their time! Check out highlights: https://t.co/TGQOG5aDMk pic.twitter.com/mWbq9Rz4S6

— Novo Nordisk US (@novonordiskus) August 24, 2020

Novo Nordisk Q2 2020 financial results were released this morning. Details here: https://t.co/1KsLk6lfXg pic.twitter.com/g6VSYThhA5

— Novo Nordisk US (@novonordiskus) August 7, 2020

One stop. Patient support. Now, more than ever, #NovoCare is here to help you understand your options, find costs and connect you to affordability support. Learn more and get help today: https://t.co/TD5yLXnmQ6 pic.twitter.com/TVvigsno47

— Novo Nordisk US (@novonordiskus) August 6, 2020

Thanks to our Clayton, NC colleagues for donating gowns, masks, and hand sanitizer to their local #COVID19 testing sites, and supporting community health professionals who are on the front lines. #ThanksHealthHeroes ❤️ pic.twitter.com/M6FB17XOu0

— Novo Nordisk US (@novonordiskus) August 3, 2020

California Vol.26 (corporations: Gilead Sciences)

The way we see it, the impossible is not impossible. It’s simply what hasn’t been achieved yet.

Come see what’s next: https://t.co/sFtNEwV5yr. pic.twitter.com/UtxuabvPhx

— Gilead Sciences (@GileadSciences) February 24, 2020

This National HIV/AIDS and Aging Awareness Day, read about our work with #AgePositively partners @HealthHIV, @GMHC and @sageusa to support and create positive health outcomes for people living and aging with #HIV. #CreatingPossible #NHAAD

— Gilead Sciences (@GileadSciences) September 18, 2020

This #WorldLymphomaAwarenessDay, watch a video and read more about Shon, who received #CARTcell therapy to treat his advanced blood cancer. https://t.co/LtgAlaehnr #CreatingPossible #WLAD2020 pic.twitter.com/vrJmPgAQ0f

— Gilead Sciences (@GileadSciences) September 16, 2020

Today, we announced our investigational treatment for myelodysplastic syndrome was granted Breakthrough Therapy designation by the @US_FDA. https://t.co/areCvOxOR0 #bloodcancer #MDS

— Gilead Sciences (@GileadSciences) September 15, 2020

Today we announced we will acquire @ImmunomedicsInc, providing Gilead with a foundational, first-in-class commercial oncology product. https://t.co/9oTitIanDW. pic.twitter.com/NwWtr3EIjO

— Gilead Sciences (@GileadSciences) September 13, 2020

We can learn from each other’s successes as @FastTrackCities works to address HIV/AIDS globally. See how HIV advocates in São Paulo are taking a united approach to ending the city’s #HIV epidemic: https://t.co/YLPLamcsKE #FTC2020

— Gilead Sciences (@GileadSciences) September 10, 2020

In partnership with @IAPAC, we visited six @FastTrackCities that are accelerating their urban #HIV responses. Learn how the HIV community in London worked to surpass the UNAIDS 90:90:90 targets: https://t.co/A80WrhyiBM #FTC2020

— Gilead Sciences (@GileadSciences) September 9, 2020

One year ago today, we partnered with @ejaf to launch RADIAN at the #FTC2019 conference. RADIAN aims to address new HIV infections and deaths from AIDS-related illnesses in EECA by elevating local initiatives. Learn more: https://t.co/0u782QGTKf pic.twitter.com/rwUBe1p4iR

— Gilead Sciences (@GileadSciences) September 9, 2020

Our Chairman & CEO Daniel O’Day joined @IFPMA in a virtual event to discuss industry efforts to fight against #COVID19: https://t.co/vVjblAsYLn. https://t.co/0cyuoY0Wsg

— Gilead Sciences (@GileadSciences) September 3, 2020

In recognition of #BloodCancerAwarenessMonth, read what motivates Jan Pineda, Cell Therapy Specialist at @KitePharma, as she works on the front lines of the CAR T manufacturing process. #CreatingPossible #FightBloodCancer #BCAM

— Gilead Sciences (@GileadSciences) September 1, 2020

Gilead announced the @US_FDA expanded the Emergency Use Authorization of our investigational antiviral to now also include hospitalized patients with COVID-19 not requiring oxygen supplementation: https://t.co/J4WzqE2wJu.

— Gilead Sciences (@GileadSciences) August 29, 2020

“If we can help 100 patients, that’s not a little thing. I know in my heart this is the right thing to do.” Today during #ILC2020, read how Silvana Lesidrenska and @HepActive are working to improve care and support for people living with viral hepatitis in Bulgaria. #HBV

— Gilead Sciences (@GileadSciences) August 28, 2020

As part of our commitment to people with #liverdisease, we’re pleased to announce the launch of our #HBV TREAT Program. It aims to identify barriers to care and support the development of novel treatment pathways. Find out more: https://t.co/WJNe4gyhhu pic.twitter.com/tGR8MvDMNU

— Gilead Sciences (@GileadSciences) August 28, 2020

As we kick off #ILC2020, we’re proud to continue our work with people such as George Kalamitsis, who leads an innovative program for hepatitis C virus screening and linkage to care among hard-to-reach people in Athens.

— Gilead Sciences (@GileadSciences) August 27, 2020

Tomorrow at #ILC2020, our #viralhepatitis symposium will help the community re-imagine #liverdisease care and explore how health systems and providers have adapted amid #COVID19. Find out more: https://t.co/03hzLIbBmN. pic.twitter.com/EEzHhuxZDq

— Gilead Sciences (@GileadSciences) August 27, 2020

Read about how Gilead grantees @OakUndivided and @SCodeAcademy are working to eliminate the educational and #tech disparity among students and families in the SF Bay Area during the COVID-19 pandemic and beyond. #OaklandUndivided #LevelUp

— Gilead Sciences (@GileadSciences) August 25, 2020

Gilead is presenting new research on our viral hepatitis portfolio, alongside pipeline updates on our #HBV functional cure research program and #NASH, at The Digital #ILC2020 hosted by @EASLnews: https://t.co/x4GIxks0Sa.

— Gilead Sciences (@GileadSciences) August 25, 2020

Gilead has received a complete response letter from the U.S. FDA for our investigational treatment in #rheumatoidarthritis https://t.co/3jarrBGBn2

— Gilead Sciences (@GileadSciences) August 18, 2020

Gilead and Tango Therapeutics today announced an expanded strategic collaboration focused on the discovery, development and commercialization of innovative targeted immune evasion therapies for patients with cancer: https://t.co/sxbiISLRKl.

— Gilead Sciences (@GileadSciences) August 17, 2020

Gilead submits New Drug Application (NDA) to the @US_FDA for our investigational antiviral for the treatment of COVID-19: https://t.co/gRtShrWYHp. pic.twitter.com/nvgmmmcWMn

— Gilead Sciences (@GileadSciences) August 10, 2020

Since January, we have taken multiple steps to ramp up production and build supply of our investigational antiviral for the treatment of COVID-19. Read more about our expanded manufacturing network that now includes more than 40 companies worldwide: https://t.co/fI25bKWZnS.

— Gilead Sciences (@GileadSciences) August 6, 2020

Stigma has a real impact on people living with and at risk of contracting HIV. Combating the misinformation that leads to stigma is an essential part of efforts to end the HIV epidemic. View the results of our new survey with @GLAAD.

— Gilead Sciences (@GileadSciences) July 31, 2020

“The need for more education couldn't be clearer…If people don’t feel comfortable talking about HIV, then they won’t feel comfortable getting tested or seeking treatment.”

View the State of HIV Stigma Study released this week by Gilead’s @BeOurCOMPASS and @GLAAD. #EndHIVStigma

— Gilead Sciences (@GileadSciences) July 29, 2020

“We believe that our flexibility in deal structuring is a key advantage that will help us grow our existing portfolio with new assets.” Learn more about Gilead’s recent string of oncology deals and what’s next for the company from Devang Bhuva, SVP of Corporate Development.

— Gilead Sciences (@GileadSciences) July 29, 2020

In recognition of #WorldHepatitisDay, read an interview with Tram Tran, VP of Medical Affairs, who discusses her career-long dedication to liver disease, how the pandemic is affecting those with viral hepatitis and what must happen to make global progress toward elimination.

— Gilead Sciences (@GileadSciences) July 28, 2020

A new report by @BCG reveals 10 countries are on track to achieve #HCV elimination by 2030, but more progress is needed. With 10 years to go until the @WHO elimination goals, find out what countries can do to make elimination possible. https://t.co/14KF09LJzV #WorldHepatitisDay pic.twitter.com/i7sJ9Ei4wt

— Gilead Sciences (@GileadSciences) July 28, 2020

Learn more about our new partnership with Satcher Health Leadership Institute at @MSMEDU to study racial health inequities associated with COVID-19: https://t.co/BngHroVNPF. pic.twitter.com/aprIE7EPEm

— Gilead Sciences (@GileadSciences) July 28, 2020

COVID-19 data demonstrate that racial and ethnic minority groups, particularly Black Americans, are disproportionately impacted. Learn more about our new partnership with @MSMEDU to address racial health inequities associated with COVID-19: https://t.co/WH7uFONBET. pic.twitter.com/6gUcd2JJFZ

— Gilead Sciences (@GileadSciences) July 28, 2020

Read about George Kalamitsis, who runs an innovative program for hepatitis C virus screening and linkage to care among hard-to-reach people in Athens. Find out more about how his team empowers community members to engage with health services.

— Gilead Sciences (@GileadSciences) July 27, 2020

Read about Silvana Lesidrenska and @hepactive, an advocacy group dedicated to improving care and support for people with viral hepatitis in Bulgaria. Find out how the organization has helped reduce barriers to care and even changed national laws. https://t.co/ZWln3zntHg pic.twitter.com/20mhV1HhEW

— Gilead Sciences (@GileadSciences) July 25, 2020

Julie Di Paolo, Executive Director of Inflammation Biology at Gilead, is #CreatingPossible for those with #rheumatoidarthritis and other inflammatory diseases. Learn about her team’s progress in unlocking pathways to potentially improve patient outcomes: https://t.co/4lKcwoyekF.

— Gilead Sciences (@GileadSciences) July 24, 2020

Today we received a positive opinion from the #CHMP for our investigational treatment for moderate to severe #rheumatoidarthritis: https://t.co/UZW1rF16o4.

— Gilead Sciences (@GileadSciences) July 24, 2020

Continued scientific discovery can help improve HIV prevention strategies worldwide. Today, @TheLancet published the first and largest active-controlled study of PrEP medications. Learn more here: https://t.co/snU37MvXly.

— Gilead Sciences (@GileadSciences) July 23, 2020

Gilead today announced it has secured an exclusive option to acquire Tizona Therapeutics, a developer of first-in-class cancer immunotherapies: https://t.co/UvRMkruNEO. pic.twitter.com/ii3bcyl6w2

— Gilead Sciences (@GileadSciences) July 21, 2020

Gilead presents additional data on our investigational antiviral for the treatment of COVID-19 at the Virtual COVID-19 Conference as part of #AIDS2020Virtual: https://t.co/ZO3qd9GKeQ. pic.twitter.com/SMtb5f4vDm

— Gilead Sciences (@GileadSciences) July 10, 2020

We are proud to partner with the Elton John AIDS Foundation on RADIAN. Sir Elton John and David Furnish recently announced the first grantees of the RADIAN Model Cities program and Unmet Need Fund at #AIDS2020Virtual. Learn more: https://t.co/0u782QYv8P. pic.twitter.com/lYR6kLydKm

— Gilead Sciences (@GileadSciences) July 9, 2020

Today Gilead announced the initiation of a Phase 1a clinical study to evaluate an investigational inhaled solution of our antiviral for the treatment of COVID-19: https://t.co/4fhRydQRbT. pic.twitter.com/VaDZbGVkbJ

— Gilead Sciences (@GileadSciences) July 8, 2020

Learn more about the data we presented at #AIDS2020Virtual highlighting the potential impact of #COVID19 on #HIV prevention strategies and access to care: https://t.co/m1PzHuoB6I.

— Gilead Sciences (@GileadSciences) July 8, 2020

We're proud to announce new data evaluating treatment in a broad range of people living with #HIV. Learn more: https://t.co/RTYPnCFVAY. #AIDS2020Virtual

— Gilead Sciences (@GileadSciences) July 4, 2020

European Commission grants conditional marketing authorization for Gilead’s investigational antiviral for the treatment of COVID-19: https://t.co/RC5jcRwPSV. pic.twitter.com/by2hczUnNY

— Gilead Sciences (@GileadSciences) July 3, 2020

We’re excited to be sharing new data from our #HIV research and development program at #AIDS2020Virtual: https://t.co/uCbEPZMAFE.

— Gilead Sciences (@GileadSciences) July 1, 2020

We announced the price today for our investigational antiviral for the treatment of COVID-19. We believe our unique approach will provide broad and equitable access. Read more from our Chairman & CEO: https://t.co/rrEbrDxrLk. pic.twitter.com/9ElSExqSU3

— Gilead Sciences (@GileadSciences) June 29, 2020

Today is National #HIVTestingDay. We’re committed to raising awareness about the importance of HIV testing and early diagnosis. Learn more about testing options, including self-tests that can be done at home. https://t.co/KrxtM8ayNE

— Gilead Sciences (@GileadSciences) June 27, 2020

Our virology research teams committed to the field of emerging viruses more than five years ago, which helped position us to advance our investigational COVID-19 treatment when the pandemic began. Learn more from Tomas Cihlar, our VP of Virology: https://t.co/GupeWxH9y6 pic.twitter.com/ok1OnmAgO8

— Gilead Sciences (@GileadSciences) June 22, 2020

We are continuing to explore the full potential of our investigational antiviral for the treatment of COVID-19. Read more from our Chairman and CEO Daniel O’Day about the next wave of studies and our efforts to increase supply and ensure access.

— Gilead Sciences (@GileadSciences) June 22, 2020

Gilead has designed and will soon begin enrollment of an open-label, single-arm Phase 2/3 clinical trial of our investigational antiviral for the treatment of COVID-19 in pediatric patients with moderate-to-severe COVID-19. Read more: https://t.co/WcgBg5xQ9e. pic.twitter.com/IrLBELPgpS

— Gilead Sciences (@GileadSciences) June 17, 2020

Gilead announced today that Javier Rodriguez, CEO of @DaVita, has been appointed to our Board of Directors. Read more: https://t.co/1N7Kn2xLPS. pic.twitter.com/L6OgpT3x7f

— Gilead Sciences (@GileadSciences) June 16, 2020

We are heartened by the #SCOTUS decision affirming the #LGBTQ community has full workplace protection under the law. We are hopeful this ruling is a step closer to the #EqualityAct and a future where everyone who identifies as LGBTQ can live without fear of discrimination. https://t.co/v0qwpM3M5T

— Gilead Sciences (@GileadSciences) June 15, 2020

Gilead adds four additional generic manufacturers in Egypt and India to our non-exclusive voluntary licensing agreements to further expand supply of our investigational antiviral for COVID-19 in 127 countries. Learn more here: https://t.co/CiRPnx5O1N.

— Gilead Sciences (@GileadSciences) June 12, 2020

We recently introduced a program that enables our employees with medical backgrounds to take paid leave to volunteer in health settings in response to the COVID-19 pandemic. Read about Gilead employee Shayon Salehi’s experience volunteering in the UK: https://t.co/wivCfvhI91 pic.twitter.com/hYP2aSB17B

— Gilead Sciences (@GileadSciences) June 9, 2020

Data from our Phase 2 EQUATOR clinical program in #psoriaticarthritis will be presented today at #EULAR2020: https://t.co/Ez9Hj3ty7M. #PsA #biomarkers #inflammation

— Gilead Sciences (@GileadSciences) June 5, 2020

Today we shared results from our Phase 3 FINCH clinical program in #rheumatoidarthritis #RA: https://t.co/PRRzXraCcF

— Gilead Sciences (@GileadSciences) June 4, 2020

Gilead has been focused on rapidly studying the potential for our investigational antiviral to treat patients with COVID-19. Read more about the totality of clinical data to date: https://t.co/KnDN3DsScI.

— Gilead Sciences (@GileadSciences) June 1, 2020

Gilead announces results from Phase 3 trial of our investigational antiviral drug in patients with moderate COVID-19: https://t.co/Fmj5M0eUMt. pic.twitter.com/3b0JW7vgiT

— Gilead Sciences (@GileadSciences) June 1, 2020

At this weekend’s #ASCO20 meeting, we’re sharing updates across our immuno-oncology pipeline. Learn more in an interview with Pankaj Bhargava, our VP of Clinical Research who has been the ad-interim Therapeutic Area Head for Oncology at Gilead: https://t.co/85X1pLmLnB pic.twitter.com/U6COQaAy4o

— Gilead Sciences (@GileadSciences) May 30, 2020

The human gut contains tens of trillions of micro-organisms, and disruption in the gut #microbiome can be linked to conditions such as ulcerative colitis. For World Digestive Health Day, learn more about the microbiome from @WorldGastroOrg: https://t.co/UkWkVKMYRk. #WDHD2020 pic.twitter.com/XKXfXF67fS

— Gilead Sciences (@GileadSciences) May 29, 2020

Today we are presenting data for an investigational anti-CD47 antibody in myelodysplastic syndrome and acute myeloid leukemia at #ASCO20: https://t.co/uy6euWtEeE. pic.twitter.com/YugerLaeKN

— Gilead Sciences (@GileadSciences) May 29, 2020

Gilead and Arcus Biosciences establish 10-year partnership to co-develop and co-commercialize next-generation cancer immunotherapies: https://t.co/RLxO2KWKU5. pic.twitter.com/vBQtg66XqU

— Gilead Sciences (@GileadSciences) May 27, 2020

Gilead statement on the @NEJM publication of data from the NIAID study of our investigational antiviral drug to treat COVID-19: https://t.co/b7cN7hTlyX. pic.twitter.com/e0UcdM8OKR

— Gilead Sciences (@GileadSciences) May 23, 2020

More than 300 million people worldwide live with at least one type of autoimmune arthritis. On #AiArthritisDay we recognize the resilience of individuals as they manage living with autoimmune conditions during the COVID-19 pandemic: https://t.co/PvEiJt9Tuy #ArthritisAwareness #RA

— Gilead Sciences (@GileadSciences) May 20, 2020

Today we announced topline results from the Phase 2B/3 SELECTION study in ulcerative colitis #IBD #Colitis: https://t.co/UUVMzy4dBJ.

— Gilead Sciences (@GileadSciences) May 20, 2020

Many years before COVID-19, our teams were working to help develop treatments for life-threatening viruses. Read about Gilead’s legacy in helping to address viral pandemics from the perspective of John Sayre, our SVP of Development Operations: https://t.co/eLFVVFU2WQ. pic.twitter.com/JfxVX6A8Pb

— Gilead Sciences (@GileadSciences) May 19, 2020

Inflammatory bowel disease can impact every part of a person’s life, from relationships to employment opportunities. This #WorldIBDDay2020 and every day, we’re committed to advancing care for those affected by IBD: https://t.co/hpI7cxbOPY. #MakeIBDWork pic.twitter.com/AVfGdxsYo9

— Gilead Sciences (@GileadSciences) May 19, 2020

Defeating #lymphoma will require a global collaboration. We are grateful to everyone involved in this fight and are proud to support @knowyournodes on World Lymphoma Awareness Day. #WLAD2020 pic.twitter.com/T8LgsKpfr8

— Kite, a Gilead Company (@KitePharma) September 15, 2020

#NEWS: Today, we submitted a supplemental biologics license application to @US_FDA for our #CARTcell therapy in relapsed or refractory indolent non-Hodgkin lymphomas

— Kite, a Gilead Company (@KitePharma) September 4, 2020

Kite CEO Christi Shaw reflects on her first year, lessons learned and the advancements made to support people living with #cancer

— Kite, a Gilead Company (@KitePharma) August 10, 2020

#BREAKING: Today, the @US_FDA granted accelerated approval of our second #CARTcell therapy.

— Kite, a Gilead Company (@KitePharma) July 24, 2020

#ICYMI: Our new European manufacturing facility brings #celltherapy production closer to patients in Europe and the surrounding regions, reducing the time it takes #CARTcells to reach patients by almost a week.

— Kite, a Gilead Company (@KitePharma) July 22, 2020

Our singular focus is #celltherapy, which we believe has the potential to change the way #cancer is treated

— Kite, a Gilead Company (@KitePharma) July 20, 2020

Kite’s new European manufacturing facility will help streamline the #CARTcell manufacturing process, reducing the time it takes to return cells to patients in Europe and the surrounding regions by almost a week

— Kite, a Gilead Company (@KitePharma) June 12, 2020

At Kite, our goal is to fundamentally change the way people think about cancer treatment by pushing the boundaries of what is possible with cell therapy

— Kite, a Gilead Company (@KitePharma) May 28, 2020

Moderate-COVID remdesivir trial from @GileadSciences out in @JAMA_current today. https://t.co/mrMUjYv9tV

— Steve Joffe (@SteveJoffe) September 16, 2020

This isn't the fun content I know you all crave, but this is more important to share. @GileadSciences is charging between $2k and $3k for their COVID-19 drug, which cost $1 per vial to make. Treasurer Torsella is gathering treasurers to fight back.https://t.co/lyJSsx7jZP

— Pennsylvania Treasury (@PATreasury) September 17, 2020

.@GileadSciences Adds “Cornerstone” Cancer Drug in $21B Immunomedics Buyout
– by @frankvinluan https://t.co/kxZsYFCzQ6 $GILD $IMMU

— Xconomy (@Xconomy) September 14, 2020

World Vol.47 (mainly on U.S. incl 2019)

From the FRED Blog: Between February and April, miles traveled by rail declined 92%, miles by air declined 96%, and miles by automobile declined 41%. Car travel has since rebounded, perhaps due to socially distanced road trips https://t.co/2WxQV2XDmu pic.twitter.com/LFIzRTdLp7

— St. Louis Fed (@stlouisfed) September 18, 2020

From 2012 to 2015, the median GDP growth rate for U.S. urban counties was 1.70%, while it was only 1.18% for rural counties https://t.co/J7AgRbIDRD pic.twitter.com/2kLh3AqeHv

— St. Louis Fed (@stlouisfed) July 31, 2019

On October 28, the #GDPNow model nowcast of real GDP growth in Q32019 is 1.7%. View GDPNow for more details. https://t.co/MU1lsZuy5l pic.twitter.com/4xh0p545fB

— Atlanta Fed (@AtlantaFed) October 28, 2019

5 facts about presidential and vice presidential debates https://t.co/rTMCFmVf7O pic.twitter.com/Uu11BHqYVu

— Pew Research Center (@pewresearch) September 17, 2020

Has the U.S. flattened the curve enough to reopen? How important is widespread testing to safely reopening the country? @ashishkjha answers our questions. pic.twitter.com/lZm75AZU2X

— TODAY (@TODAYshow) April 19, 2020

Is our new reliance on virtual connections creating a “new normal” or is the novelty of Zoom quickly wearing thin? https://t.co/oWtmnrQbKX

— The Wall Street Journal (@WSJ) April 18, 2020

https://twitter.com/UUtah/status/1228091909542793216

Good update on corona numbers, including important deaths by population and cases by population comparinf Mn. to neighboring states. https://t.co/traxjxVVXe

— Joe Spear (@jfspear) April 7, 2020

#HAPPENINGNOW : @RIStatePolice and @MassStatePolice are escorting 300,000 N95 masks to NY for frontline healthcare workers.
Using a trailer truck w the #Patriots logo, it dropped off about 900,000 masks in Massachusetts and 100,000 in Rhode Island. @NBC10 pic.twitter.com/Fc9YOJmttT

— Connor Cyrus (@NBC10_Connor) April 3, 2020

Infographic | EU-UK deadlock on Brexit

No progress has been made in negotiations between the #EU and the #UK to shape trade relations after #Brexit. The UK’s violations of the Brexit bill have strained relationshttps://t.co/z1yPFB7IpR pic.twitter.com/EBNO5QaZho

— ANADOLU AGENCY (ENG) (@anadoluagency) September 16, 2020

Guy’s security camera catches kid tearing it up on his driveway almost every day, so he decides to do something about it. pic.twitter.com/ZDVb7zLgZo

— Mike Sington (@MikeSington) August 27, 2020

45 years later and I still haven't hung up the picture. Fawlty Towers premiered on this day in 1975. What was your favourite line? pic.twitter.com/LobwR6LXjo

— John Cleese (@JohnCleese) September 19, 2020

FBI Uncovers Plot Where JFK Was Buried https://t.co/1gPmkdDo88 pic.twitter.com/0shwv51OA7

— The Onion (@TheOnion) September 20, 2020

Barack Obama Storms Out Of Michelle Obama Podcast Interview After Questions About Administration’s Drone Use https://t.co/8VmA1rdyPu pic.twitter.com/zxUHq436Rl

— The Onion (@TheOnion) September 19, 2020

From The Archives | Report: China To Overtake U.S. As World's Biggest Asshole By 2020 https://t.co/sPSG8yDyWI pic.twitter.com/OeVPZ1aAUn

— The Onion (@TheOnion) September 19, 2020

Scientists Study Brains Of Baseball Fans To Find Out How They Stay Interested During First 7 Innings https://t.co/mdOswSoCoM pic.twitter.com/Gxs3YoazDn

— The Onion (@TheOnion) September 18, 2020

On this day in 1973, more than 30,000 people piled into the Houston Astrodome to see Billie Jean King take on Bobby Riggs—at the time the largest crowd ever to watch a tennis match.https://t.co/rxZXGKvihO

— The New Yorker (@NewYorker) September 20, 2020

Earlier this year, Ginsburg spoke with Slate about her time at Harvard Law and the other women in her class. "It's amazing to me how distinctly I remember each of these women," she said, before telling us several stories about those early days. https://t.co/Wb7VrVE27q

— Slate (@Slate) September 20, 2020

https://twitter.com/NPR/status/1306988942256988162

Former President Barack Obama is calling on Republicans to delay replacing Justice Ruth Bader Ginsburg until after the election. https://t.co/HZ8cbvzd9t

— NPR (@NPR) September 19, 2020

A new NPR poll shows households of color have been hardest hit financially by COVID-19.

Percentages of households that report facing "serious financial problems" during the pandemic:
-Latino: 72%
-Black: 60%
-Native American: 55%
-Asian: 37%
-White: 36%https://t.co/2KUr3Q9ZcU

— NPR (@NPR) September 18, 2020

As you can see here they are blocking the entrance to the voting site. #EarlyVoting #VA #FairFax pic.twitter.com/KJ6fbLdP3G

— Anthony Tilghman (@AnthonyTilghman) September 19, 2020

“Many of the deaths and much of the economic hardship could have been avoided had President Trump acted on the intelligence and public health information he received before the coronavirus crisis began.” Here’s clear evidence of that claim:
https://t.co/xyEp5rkhO2

— Laurence Tribe (@tribelaw) September 15, 2020

Barron’s on MarketWatch: Paul Volcker hailed as the man who tamed U.S. inflation https://t.co/IIwR8Qaizc

— MarketWatch (@MarketWatch) December 9, 2019

BREAKING: Paul Volcker, the Carter-Reagan Fed chairman who beat inflation, dies at age 92 – reports
https://t.co/MP5eROFMVu

— CNBC Now (@CNBCnow) December 9, 2019

Worth remembering, Paul Volcker's battle on inflation was what the body politic wanted at that time. https://t.co/fm5VFZ2cjC

— David Beckworth (@DavidBeckworth) December 9, 2019

Happy birthday, #Illinois! The "Prairie State" joined the US #OTD in 1818. This newspaper reported that besides being the 21st state, Illinois would be "the second in territorial extent" and "the first in richness of soil."

Read the clipping on our site! https://t.co/Ks38E2i6IY

— Newspapers.com (@_newspapers) December 3, 2019

https://twitter.com/JFKonThisDay/status/1109549130773397505
https://twitter.com/JFKonThisDay/status/1185609060793704448

This historically Black school is partnering with the University of the Bahamas to offer a free semester to students displaced by Hurricane Dorian pic.twitter.com/fnD04iWria

— NowThis (@nowthisnews) September 6, 2019

Hurricane Dorian has washed up bricks of cocaine on Florida’s coast pic.twitter.com/HldhSzClI4

— NowThis (@nowthisnews) September 6, 2019

https://twitter.com/nowthisnews/status/1169078377187291136

RESCUED! PETA's Emergency Rescue team wasted NO time leaping into action after receiving a report of a pelican who was unable to fly & stranded on a bridge in the middle of #HurricaneDorian.

Four more wind-battered birds were found and all were brought to safety. pic.twitter.com/mYjybdHVVq

— PETA (@peta) September 6, 2019

The Trump administration is sitting on tens of billions of dollars in unspent recovery money meant to help Americans recover from disasters, leaving people less able to rebound from the effects of Hurricane Dorian and other stormshttps://t.co/ECGxYUYczu

— The New York Times (@nytimes) September 7, 2019

What do #Boeing737Max jets & nuclear plants have in common? Regulators that want to abandon oversight & turn it over to the industry. That approach already has crashed & burned for the #FAA. Why would we wait for same outcome from a hands-off @NRCgov? https://t.co/tXFHKSBCuK

— Scott Stapf (@stapf) July 30, 2019

The NYPD just attacked us at the Times Square abolish ICE protest for stepping off the sidewalk. Several organizers arrested for no reason. Police violence at protests is escalating in nyc, please pay attention pic.twitter.com/HcyAosYEtu

— Isabelle Leyva (@isabelle_leyva) September 19, 2020

Obama in 2016:

"I have fulfilled my Constitutional duty. Now it's time for the Senate to do theirs. Presidents do not stop working in the final year of their term. Neither should a Senator." pic.twitter.com/Je4OAL7BDo

— Kelb Hull (@CalebJHull) September 19, 2020

Who selected Jerome Powell? https://t.co/kLFAsq6T1j

— Bill Kristol (@BillKristol) August 23, 2019

"He got hit on the knee with a canister of tear gas," President Trump says, of @AliVelshi, who was actually hit by a rubber bullet. "Wasn't it really a beautiful sight? It's called law and order." pic.twitter.com/sVvnZUft5B

— David Gura (@davidgura) September 19, 2020

https://twitter.com/ColumbiaBugle/status/1307482691923714048

“I want you to use my words against me. If there’s a Republican president in 2016 and a vacancy occurs in the last year of the first term, you can say Lindsey Graham said let’s let the next president, whoever it might be, make that nomination." pic.twitter.com/quD1K5j9pz

— Vanita Gupta (@vanitaguptaCR) September 19, 2020

These 5 charts show how milk sales changed and made it tough for Dean Foods to avert bankruptcy. https://t.co/q9OfGLPTAZ pic.twitter.com/1a14henvrg

— CNBC (@CNBC) November 14, 2019

BREAKING: Fed chair Powell in Jackson Hole speech: No 'rulebook' on trade, pledges the Fed will 'act as appropriate' to sustain the economyhttps://t.co/9PJGTCBWdQ

— CNBC Now (@CNBCnow) August 23, 2019

All eyes are on Jerome Powell ahead of the annual gathering of central bankers in Jackson Hole, Wyoming https://t.co/IboMIdUfqJ

— The Economist (@TheEconomist) August 22, 2019

At the Jackson Hole monetary-policy conference, Fed chief Jay Powell indicated that he hopes to control what he can and rise above what he can’t. His speech implied that running the Fed is an unenviable job under an unpredictable president. @GinaChon https://t.co/8XzB7icbqn pic.twitter.com/RWlZIvNmFg

— ReutersBreakingviews (@Breakingviews) August 23, 2019

Powell speaks this week in Jackson Hole and he’s in a tough spot, caught between a president proactively blaming him for the downturn markets are getting nervous about https://t.co/dlwzd0ocOj

— Nick Timiraos (@NickTimiraos) August 18, 2019

Fed's Powell must signal a more aggressive stance on rates at Jackson Hole or stocks will tumble, James Bianco warns https://t.co/HasvMw6E3S (via @StephLandsman)

— Trading Nation (@TradingNation) August 18, 2019

Our faculty co-director on @Nasdaq's podcast – episode is called "Panic but Don't Paralyze" – check it out! https://t.co/rGEaRz70om

— Business&Enviro@Yale (@YaleCBEY) June 14, 2019

WATCH: President Obama on online cancel culture: "This idea of purity and you're never compromised and you're always politically woke, and all that stuff — you should get over that quickly." pic.twitter.com/3VZSuk8RLG

— NBC News (@NBCNews) October 30, 2019

In Northern California, the monster #KincadeFire has been burning since Wednesday night in the heart of wine country.

The massive blaze has consumed over 76,000 acres and has destroyed at least 189 structures, including 86 single-family homes. https://t.co/pham56aFHh pic.twitter.com/W9qJfwzcXv

— ABC News (@ABC) October 30, 2019

As states cut vaccine exemptions, skeptical parents may switch tactics. https://t.co/CVpuBLFStG pic.twitter.com/fBxGeZ0ewZ

— ABC News (@ABC) November 4, 2019

Venice residents and tourists waded through the floodwaters that have taken over much of the lagoon city.

People were warned of the rising water with sirens and nursery schools were closed as a precaution. https://t.co/FjtSj8UQAB pic.twitter.com/7IIdjW6XtF

— ABC News (@ABC) November 13, 2019

Iceland's leader announces that she will skip Vice Pres. Mike Pence's visit to her Nordic nation. https://t.co/II33CNR29i

— ABC News (@ABC) August 24, 2019

TERRIFYING: A resident in Poland, New York captured the tragic moment a house floated down a river after a severe storm on Friday https://t.co/wL3ykdpiFf pic.twitter.com/lRfinycP92

— CBS News (@CBSNews) November 2, 2019

"Usually I'm measured, but that's just ridiculous." Democratic Rep. Ro Khanna reacts to President Trump attacking Federal Reserve Chairman Jerome Powell on Twitter, suggesting the central bank is as big of a threat to the US economy as Beijing. https://t.co/Tjs5VNGlW0 pic.twitter.com/weMv4JguJ8

— CNN (@CNN) August 23, 2019

The best 1-star reviews of the Seven Wonders of the World https://t.co/qliBv1ujmu

— The Washington Post (@washingtonpost) August 26, 2019

Heard on the Street: Recent good news from Biogen and Bristol-Myers Squibb bolsters hope that years of weak performance may be ending https://t.co/9ptZBP9paN

— The Wall Street Journal (@WSJ) November 3, 2019

Mark Carney on global trade conflicts: ‘Certainly, the U.S. is involved in the theaters—all of the theaters—in this war’ https://t.co/R0anHYDFAe

— The Wall Street Journal (@WSJ) August 25, 2019

Stocks climbed at the end of a week dominated by central-bank policy, with a closely watched speech expected from Fed Chairman Jerome Powell later in the day https://t.co/8Dk23Mhny9

— The Wall Street Journal (@WSJ) August 23, 2019

Good summary of Jay Powell's speech here by @NickTimiraos.

Monetary policy can only do so much amid the uncertainty surrounding the WH's trade policy, Powell says, in his highly anticipated speech. https://t.co/kkVE8nUDcN

— Nancy Cook (@nancook) August 23, 2019

U.S. stocks pared losses and Treasuries climbed after Jerome Powell said the central bank will act as appropriate to sustain the expansion. https://t.co/iKBXB0b4Js pic.twitter.com/MvQwKQetwO

— Bloomberg (@business) August 23, 2019

Keith and Mick during recordings at Longview Farm, Worcester, Massachusetts. Sept. 1981 (photo by Ken Regan) pic.twitter.com/JkVQSwxelZ

— Rolling Stones Data (@StonesData) May 24, 2020

When technique and heart outweigh a size advantage. pic.twitter.com/V37x9Xsnle

— Ohio State Wrestling (@wrestlingbucks) April 26, 2020

https://twitter.com/Chiefs/status/1253542123376345089

Walmart has been hiring 5,000 people a day and wants 50,000 more. Here’s how to apply https://t.co/hwyJU7h2PV

— The Kansas City Star (@KCStar) April 18, 2020

During this year’s State of the Union, President Trump is expected to contrast his record of productivity with the Democrats’ crowning achievement—a wasteful, partisan impeachment. https://t.co/sSelZIdOh5

— Heritage Foundation (@Heritage) February 4, 2020

Before tonight’s State of the Union address, here’s a look back at the national security highlights of last year’s speech, organized by topic, in the order in which they were mentioned:https://t.co/VNN66eKR85

— Lawfare (@lawfareblog) February 5, 2020

What should we expect from Trump's #SOTU? Before the speech gets underway, watch Brookings experts offer insights, analysis, and predictions: https://t.co/y2KSn9s8TO

— Brookings Governance (@BrookingsGov) February 5, 2020

“Jobs are soaring,” President Trump starts his #SOTU speech. But are the jobs actually paying and are Americans actually doing better? https://t.co/HXsiCDLIjS

— BrookingsInst (@BrookingsInst) February 5, 2020

What is the USMCA and why might it fall short? @davidrdollar discusses with @SenToomey (R-PA): https://t.co/gFZyBeK0fZ #SOTU

— BrookingsInst (@BrookingsInst) February 5, 2020

America's 2016 presidential #election was the target of voter manipulation via #socialmedia, particularly on #Facebook. Is history is about to repeat itself? More from @HBSWK : https://t.co/4AVR1vf2My pic.twitter.com/68GNS42VCh

— Harvard Business (@HarvardHBS) July 31, 2019

To make #customer experiences stick, Professor Stefan Thomke finds it's not extra features or value for money—it's emotion. Learn more via @mitsmr: https://t.co/T6MZ4rxIVS pic.twitter.com/FnpFpMiG6r

— Harvard Business (@HarvardHBS) August 7, 2019

Beto O'Rourke: "I live in and I'm raising my kids on a beautiful part of the U.S.-Mexico border … I think I can tell a very powerful, compelling, positive message about the role that immigration and immigrants play" https://t.co/g7HX8Iddm1 pic.twitter.com/3EPZpx0dfa

— ABC News Politics (@ABCPolitics) June 9, 2019

Mexico's president hails 'important deal' with U.S. on trade and migrants https://t.co/I8K9u8MwZ0

— Bloomberg (@business) June 9, 2019

Yet another great deal reached by @realDonaldTrump!

As CNN notes, “the U.S. got almost everything it wanted from Mexico”pic.twitter.com/epOriYXIYW

— Ronna McDaniel (@GOPChairwoman) June 9, 2019

Great conversation about the need for #rail expansion and importance of infrastructure with @amyklobuchar & @MayorJoyceCraig today at @UNHManchester. Strong support for the economic and quality of life benefits. Cc @PeterJMacone @WH_Bagshaw @CampoEnoteca #fitn #NHPolitics pic.twitter.com/uZHgkfBC6h

— NH Business for Rail Expansion (@NHBiz4Rail) April 19, 2019

Dr. Krista Wiegand was featured in the popular Monkey Cage blog produced by the @washingtonpost. Check it out below!https://t.co/mJIUXzJPOV

— Baker Center for Public Policy (@UTBakerCenter) April 17, 2018

Massachusetts Vol.19 (corporations: Moderna)

As of Friday, September 18, 2020, 25,976 participants have been enrolled in the Phase 3 COVE study and approximately 28.5% of participants enrolled cumulatively are from diverse communities. 11,879 participants have received their second vaccination. https://t.co/swJNxTd1zg

— Moderna (@moderna_tx) September 19, 2020

Moderna's strategic priorities presented at our 2020 R&D Day event pic.twitter.com/Ik0lMVErcL

— Moderna (@moderna_tx) September 17, 2020

A look at Moderna in September, 2020. #mRNA pic.twitter.com/eElbcvqpIW

— Moderna (@moderna_tx) September 17, 2020

ICYMI: Our collaborations with @VertexPharma to address #cysticfibrosis. Read more: https://t.co/2JTZE4UOwK pic.twitter.com/Mq1UmKW7te

— Moderna (@moderna_tx) September 17, 2020

An independent Data and Safety Monitoring Board (DSMB) ensures continuous data monitoring and enhances participant safety. pic.twitter.com/Z2NRQnCrwp

— Moderna (@moderna_tx) September 17, 2020

Enrollment update for the Phase 3 COVE study of mRNA-1273, our vaccine candidate against COVID-19. #mRNA pic.twitter.com/LwxXqfO5so

— Moderna (@moderna_tx) September 17, 2020

Dr. Jacqueline Miller, Moderna's SVP, Infectious Diseases Development, is now presenting on the clinical development update of our COVID-19 vaccine candidate, mRNA-1273. https://t.co/WiMSqtIn7o pic.twitter.com/JtPc88kp0R

— Moderna (@moderna_tx) September 17, 2020

We remain committed to raising awareness of cytomegalovirus. Learn more here: https://t.co/26gQ72syGa #CMVvoices #StopCMV #CMVawareness #CMVspeaks pic.twitter.com/iwzmWOjYeA

— Moderna (@moderna_tx) September 17, 2020

At R&D Day, Dr. Panther also shared an update on the late stage development plan for our #CMV vaccine candidate, mRNA-1647. Read more here: https://t.co/YqPyTBYId1 pic.twitter.com/qzSBHVsQ6C

— Moderna (@moderna_tx) September 17, 2020

Dr. Lori Panther, Moderna's Senior Director of Clinical Development, Infectious Diseases, is now presenting on the clinical development of our #CMV vaccine candidate, mRNA-1647. #StopCMV #mRNA pic.twitter.com/shdKRlbYf6

— Moderna (@moderna_tx) September 17, 2020

From our R&D Day: An update on our methylmalonic acidemia program, mRNA-3705 https://t.co/p50rA1mpqe #mRNA pic.twitter.com/rJEU08jc79

— Moderna (@moderna_tx) September 17, 2020

To provide additional transparency in context of pandemic, the protocol for the Phase 3 COVE study of mRNA-1273 being conducted in collaboration with the NIH and BARDA is now available: https://t.co/ToJWTwNyYa #mRNA pic.twitter.com/hYaGi1iohK

— Moderna (@moderna_tx) September 17, 2020

We just announced a collaboration with Chiesi Group to discover and develop #mRNA therapeutics for Pulmonary Arterial Hypertension (PAH) read more: https://t.co/R18kmdfqrK pic.twitter.com/x3mIy2a72U

— Moderna (@moderna_tx) September 16, 2020

We are pleased to share that as of today, Friday, September 11th, 23,497
participants have been enrolled in the COVE Phase 3 study of mRNA-1273. Find out more about the trial here: https://t.co/swJNxTd1zg Check back next Friday evening for an updated enrollment number. pic.twitter.com/cQhj3WtRoG

— Moderna (@moderna_tx) September 11, 2020

We just announced that we have expanded our footprint in North America with a new Canadian subsidiary and have named Michael Mullette as Managing Director, Canada. Read more: https://t.co/IPhl0dYNDw pic.twitter.com/ivY7v6uWwH

— Moderna (@moderna_tx) September 10, 2020

We are proud to participate in this pledge to uphold the integrity of the scientific process in the research and development of a #COVID19 vaccine. #WeStandWithScience, and @BioNTech_Group, we invite you to stand with us. https://t.co/O1wDca3KoU pic.twitter.com/34Y2VMRTrS

— Moderna (@moderna_tx) September 8, 2020

Just announced: Biopharma leaders unite to stand with science https://t.co/OFK5jgLyAa #westandwithscience pic.twitter.com/r9O1ahEZ10

— Moderna (@moderna_tx) September 8, 2020

Moderna Confirms Discussions with the Ministry of Health, Labour and Welfare to Supply Japan with 40 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273): https://t.co/jpsGTOv9BQ pic.twitter.com/fo0XC7pCXo

— Moderna (@moderna_tx) August 28, 2020

Dr. Jacqueline Miller, our Sr. Vice President of Infectious Disease Development is now presenting at the ACIP meeting. View slides here: https://t.co/MWMns8FCdW and watch the presentation here: https://t.co/u8xGxAWtlE pic.twitter.com/IopB2kVAN7

— Moderna (@moderna_tx) August 26, 2020

Moderna is presenting at the @CDCgov Advisory Committee on Immunization Practices (ACIP) August Meeting today. Read more here: https://t.co/uUJ7W3sNLU pic.twitter.com/qS9MMt4vSY

— Moderna (@moderna_tx) August 26, 2020

We just announced that we have concluded advanced exploratory talks with the European Commission to supply 80 million doses of mRNA-1273. Read more here: https://t.co/mRNWi2ffPh pic.twitter.com/Q83RYHphmH

— Moderna (@moderna_tx) August 24, 2020

Our commitment to #diversity and #inclusion pic.twitter.com/zWURhsLD6i

— Moderna (@moderna_tx) August 21, 2020

We just announced a supply agreement with the U.S. government for an initial 100 million doses of mRNA-1273, our vaccine candidate against COVID-19. Read more here: https://t.co/skd7iLdEW2 pic.twitter.com/JwZ7OD7EjO

— Moderna (@moderna_tx) August 11, 2020

Tune in to this new podcast to hear Dr. Tal Zaks, our Chief Medical Officer discuss the importance of #diversity and #inclusion in #clinicaltrials with @IAmBiotech CEO @DrMichelleBIO . Stream on your favorite podcast platform or click here: https://t.co/Qe11EERCGB pic.twitter.com/0zYSIg6hnw

— Moderna (@moderna_tx) August 7, 2020

A snapshot of Moderna in August, 2020 pic.twitter.com/HMWdg8DNcW

— Moderna (@moderna_tx) August 5, 2020

“As we pivot to a commercial stage company, we recognize the need for responsible pricing in the face of the pandemic.” – Stéphane Bancel, Moderna’s CEO pic.twitter.com/mOQHF2QNYc

— Moderna (@moderna_tx) August 5, 2020

Data generated to date for mRNA-1273, our vaccine candidate against COVID-19 include: pic.twitter.com/9MwtwZon2H

— Moderna (@moderna_tx) August 5, 2020

Our Chief Medical Officer Dr. Tal Zaks details the late stage development for our #CMV #vaccine candidate (mRNA-1647). #StopCMV pic.twitter.com/OE5x6FRUm0

— Moderna (@moderna_tx) August 5, 2020

Our CEO, Stéphane Bancel highlights accomplishments from the second quarter 2020. Read more: https://t.co/gn25wTczlp $MRNA pic.twitter.com/xP0NFSpWLE

— Moderna (@moderna_tx) August 5, 2020

Just published in @nature : SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Read the manuscript here: https://t.co/v07pB2RzXH pic.twitter.com/MKq0Stux14

— Moderna (@moderna_tx) August 5, 2020

We just announced the publication of a nonhuman primate preclinical viral challenge study of mRNA-1273 in @NEJM. Read more: https://t.co/5xE2gjC05P pic.twitter.com/1rjK7gELnO

— Moderna (@moderna_tx) July 28, 2020

Just published in @NEJM : Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates. Read the manuscript here: https://t.co/wCfuu7z1WI

— Moderna (@moderna_tx) July 28, 2020

We just announced that the Phase 3 study of mRNA-1273, our vaccine candidate against COVID-19 has begun. The Phase 3 study being conducted in collaboration with @NIH and @BARDA. Read more here: https://t.co/Xi9SV6fk4z pic.twitter.com/oESeuKjF08

— Moderna (@moderna_tx) July 27, 2020

We just announced an expansion of our agreement with @BARDA for up to an additional $472 million to support our late stage clinical development of mRNA-1273, including the execution of a 30,000 participant Phase 3 study in the U.S. Read more: https://t.co/g9r7aXtguI pic.twitter.com/5bhmfEkQ5t

— Moderna (@moderna_tx) July 26, 2020

We just announced interim results from the NIH-led Phase 1 Study of our #mRNA #vaccine against COVID-19 (mRNA-1273) in @NEJM. Read more: https://t.co/YqPyTCgjBB pic.twitter.com/e2AStO92ES

— Moderna (@moderna_tx) July 14, 2020

Moderna to join the #NASDAQ100 Index beginning July 20, 2020: https://t.co/21Co0CYOhr $MRNA @Nasdaq pic.twitter.com/wZnKin0GDx

— Moderna (@moderna_tx) July 14, 2020

The https://t.co/XvCSRI7uD8 listing for Moderna’s Phase 3 study of mRNA-1273, our #vaccine candidate against COVID-19 is now live. Find more information on the study including site locations here: https://t.co/9uIYZ069JU pic.twitter.com/QkPEoAXw7b

— Moderna (@moderna_tx) July 14, 2020

We just announced a collaboration with @Rovi_IR for OUS fill-finish manufacturing of our COVID-19 #vaccine candidate. Read more here: https://t.co/3EdEYj80xZ #mRNA pic.twitter.com/iJMZxJTi2B

— Moderna (@moderna_tx) July 9, 2020

We have completed enrollment of our Phase 2 study of mRNA-1273, our vaccine candidate against COVID-19. Read this morning's press release here: https://t.co/RZWlyCgUUd pic.twitter.com/FBMsaH20Pg

— Moderna (@moderna_tx) July 8, 2020

We just announced that Elizabeth Tallett has joined our Board of Directors. Read more: https://t.co/TSSrenSziD pic.twitter.com/2yfK1aUKnC

— Moderna (@moderna_tx) July 1, 2020

CMV Parent, Farah sits down with Moderna's Drew Nathenshon to honor & remember her daughter Maddie who passed away due to complications associated with CMV 12 days after her birth. Watch our new #CMVvoices video here: https://t.co/lWMBCe7VGe #StopCMV pic.twitter.com/NvxVeUwRs1

— Moderna (@moderna_tx) June 29, 2020

We just announced a collaboration with @CatalentPharma for fill-finish manufacturing of mRNA-1273, our COVID-19 #vaccine candidate. Read more https://t.co/8Uldz2BwuI pic.twitter.com/81Px3RW69Q

— Moderna (@moderna_tx) June 25, 2020

We are delighted to share that Ray Jordan has joined Moderna as Chief Corporate Affairs Officer, effective today. Read more: https://t.co/HnrdAcFQfa pic.twitter.com/HXovsuN7RF

— Moderna (@moderna_tx) June 15, 2020

We are pleased to share a preprint of the preclinical manuscript for our #vaccine against #SARS-CoV-2 to potentially prevent #COVID19 disease. We thank the NIAID team for their collaboration with our infectious disease research team. https://t.co/weLnGLvfv3 @NIAIDNews

— Moderna (@moderna_tx) June 12, 2020

We just announced an update on late-stage development of our vaccine (mRNA-1273) against COVID-19. Read more: https://t.co/eVwiVzaz5L pic.twitter.com/EyoOYGRFky

— Moderna (@moderna_tx) June 11, 2020

We are delighted to announce that David Meline has joined Moderna as Chief Financial Officer, effective Monday, June 8, 2020. Read more: https://t.co/U77O8Iikij $MRNA pic.twitter.com/FHRCeErUif

— Moderna (@moderna_tx) June 4, 2020

Today, at our third annual Science Day, we are highlighting our #mRNA platform science and innovative vaccine research. Read more & join the webcast beginning at 8am ET: https://t.co/gtlL0F0A4D pic.twitter.com/tnlmmHSvbp

— Moderna (@moderna_tx) June 2, 2020

We just announced that the first participants in each age cohort have been dosed in the Phase 2 study of our mRNA vaccine (mRNA-1273) against novel coronavirus. Read more: https://t.co/woPlKz1bZC #mRNA pic.twitter.com/9VGUoJu5cS

— Moderna (@moderna_tx) May 29, 2020

During a @CNN interview yesterday, Dr. Anthony Fauci explained why he is encouraged by early findings in the NIH-led Phase 1 study of mRNA-1273. https://t.co/eIMGBSnhsQ pic.twitter.com/j3gczwYL24

— Moderna (@moderna_tx) May 22, 2020

In our call with Governors today, Dr. Fauci shared exciting news from biotech company, Moderna! The first potential Coronavirus vaccine has shown promising results in a clinical trial. 45 participants received 2 doses of the vaccine & all 45 produced antibodies.

— Mike Pence (@Mike_Pence) May 19, 2020

Summary of our SARS-CoV-2 #vaccine (mRNA-1273) interim Phase 1 data. Read more: https://t.co/aIq34ullAh #mRNA pic.twitter.com/BVbYuWTkOy

— Moderna (@moderna_tx) May 18, 2020

Our #CMV Phase 2 dose confirmation study is fully enrolled & the first Phase 2 interim analysis is expected in the third quarter of 2020. #mRNA #StopCMV https://t.co/5XdkPGIpUw pic.twitter.com/4EHG6atobG

— Moderna (@moderna_tx) May 7, 2020

Moderna and @LonzaPB announce worldwide strategic collaboration to manufacture Moderna's #vaccine (mRNA-1273) against novel coronavirus. Read more: https://t.co/sz7RYbLFmH #mRNA pic.twitter.com/2C3NIBM9oV

— Moderna (@moderna_tx) May 1, 2020

We just announced that we have submitted an IND application to the U.S. FDA for a Phase 2 study of our mRNA Vaccine (mRNA-1273) against novel coronavirus. Read more: https://t.co/5w6UcdHc2Y pic.twitter.com/eKnA1DDYZ9

— Moderna (@moderna_tx) April 27, 2020

At Moderna, we strive to pursue innovative ways to grow our business while minimizing our environmental footprint. Read about our efforts to manage our environmental impact in our corporate social responsibility framework: https://t.co/u1858CDFzc #EarthDay pic.twitter.com/aBtl84mLJJ

— Moderna (@moderna_tx) April 22, 2020

We just announced an award from U.S. government agency @BARDA for up to $483 million to accelerate development of our mRNA vaccine (mRNA-1273) against novel coronavirus https://t.co/Sn20aJVr8Z pic.twitter.com/DbvywrTPcB

— Moderna (@moderna_tx) April 16, 2020

Moderna's #mRNA vaccine candidate against the novel coronavirus: from concept to Phase 1 in 42 days pic.twitter.com/rGyfyRzSlv

— Moderna (@moderna_tx) April 14, 2020

The NIH-led Phase 1 study of mRNA-1273, Moderna’s vaccine candidate against the novel coronavirus, continues on track with enrollment of participants at the highest dose pic.twitter.com/RhvsmBlvt3

— Moderna (@moderna_tx) April 14, 2020

#CMV is the most common infectious cause of birth defects in the U.S.; there is no approved #vaccine to prevent CMV. mRNA-1647 is Moderna's #mRNA vaccine candidate against CMV. #stopCMV pic.twitter.com/52vE1XImVG

— Moderna (@moderna_tx) April 14, 2020

1st interim analysis of Phase 1 Zika vaccine candidate (mRNA-1893) study shows that 10 µg & 30 µg dose levels seroconverted 94% & 100% of seronegative participants, respectively, and effectively boosted seropositive participants. Both dose levels were generally well-tolerated. pic.twitter.com/3hJrNjhaee

— Moderna (@moderna_tx) April 14, 2020

An analysis by @AndrewWLo compared #infectiousdisease vaccines to other therapeutic areas & found that #vaccines have an overall 33% probability of success that increases to 42% once a Phase 2 study is launched, the highest of all therapeutic areas. https://t.co/4T9DzZKzBS pic.twitter.com/5CCbc1LDwE

— Moderna (@moderna_tx) April 14, 2020

Accelerated research and development timelines are a potential advantage of #mRNA vaccines pic.twitter.com/s51Ex9k6dJ

— Moderna (@moderna_tx) April 14, 2020

Vaccines create significant value for healthcare systems by preventing infectious disease; despite this, the vast majority of viruses do not have commercial vaccines available, representing a large opportunity pic.twitter.com/lflRFYu73z

— Moderna (@moderna_tx) April 14, 2020

We just announced that we will highlight the potential opportunities of mRNA vaccines at our first Vaccines Day. Read more: https://t.co/ttEhFhlY2h pic.twitter.com/LJ4nw7onYk

— Moderna (@moderna_tx) April 14, 2020

Congratulations to Said Francis, SVP, head of business development & corporate strategy at Moderna, for being named one of @Endpoints #20under40 ! https://t.co/hRBQaiSrf8

— Moderna (@moderna_tx) April 6, 2020

Our CEO Stéphane Bancel participated in a webinar with @AndrewWLo to discuss Moderna’s work on our vaccine candidate against the novel coronavirus. Tune in here: https://t.co/QZqmPqhyCO

— Moderna (@moderna_tx) April 3, 2020

Today, we took steps to speed the development and secure domestic manufacturing of two vaccines – one by @Moderna_tx & another by @JanssenUS – to prevent the spread of #COVID19 and protect people at home and abroad. https://t.co/2X5aBSkbKY pic.twitter.com/tr4oSv6Qm7

— BARDA (@BARDA) March 30, 2020

Tune in to hear Moderna CEO Stéphane Bancel & @JimGreenwood of @IAmBiotech discuss our vaccine candidate (mRNA-1273) against COVID-19. Moderna delivered the vaccine candidate to the @NIH for their Phase 1 study in 42 days from sequence selection. https://t.co/MoLpWJ7sbj #mRNA pic.twitter.com/vxCMPRMLzM

— Moderna (@moderna_tx) March 30, 2020

.@EmoryUniversity in Atlanta will begin enrolling participants in the NIH-led Phase 1 clinical trial of mRNA-1273, Moderna’s vaccine against COVID-19 #mrna https://t.co/y0z1xCHBsR

— Moderna (@moderna_tx) March 27, 2020

We just announced that the first participant has been dosed in the NIH-led Phase 1 study of our #mRNA vaccine (mRNA-1273) against novel coronavirus https://t.co/14SDfdI1Az pic.twitter.com/LnJWYhAbkx

— Moderna (@moderna_tx) March 16, 2020

California Vol.25 (corporations: Amgen)

In our 40th anniversary year, we are proud to be joining the Dow Jones Industrial Average, an internationally recognized index for evaluating the performance of the U.S. stock market. #WeAreBiotech $AMGN

— Amgen (@Amgen) August 25, 2020

Eli Lilly @Lillypad and Amgen announce a manufacturing collaboration for #COVID19 antibody therapies. $AMGN

— Amgen (@Amgen) September 17, 2020

AI is used in speech recognition, electric cars, and now… for #osteoporosis. Crystal Bone, Amgen’s novel digital health algorithm under development, may one day advance a doctor’s ability to identify a patient’s risk of #osteoporosis bone fractures.

— Amgen (@Amgen) September 12, 2020

New data show that in the U.S., diagnosis and treatment of #osteoporosis varies from state to state in women who had an osteoporosis-related fracture. To learn more about the geographic variation of osteoporosis, visit the link below. #ASBMR2020

— Amgen (@Amgen) September 12, 2020

Supporting communities is a huge part of our mission, especially during #COVID19. Amgen South San Francisco recently donated 500 cloth masks to @ALASdreams, which will distribute them to their food pantry clients.

Check out other ways we've helped via the link below.

— Amgen (@Amgen) September 9, 2020

#ICYMI @AmgenOncology’s Christophe Bourdon connected with @PatrickDempsey to talk about our @DempseyCenter partnership, the upcoming Dempsey Challenge (going virtual this year!) and their personal connections to cancer through their moms.

— Amgen (@Amgen) September 5, 2020

We’re joining the @CDCFound, @MillionHeartsUS and health organizations in spotlighting the importance of heart health during #COVID19. Watch the @CDC-approved PSA below to learn more.

— Amgen (@Amgen) September 5, 2020

Learn more about this study at https://t.co/mKpkeM0Jb0. #COVID19 https://t.co/1WgpR7u5bC

— Amgen (@Amgen) September 2, 2020

Today, biotech pioneer @Amgen ($AMGN) joined the DJIA. Congrats on your addition as the 6th #NasdaqListed company on the 30-stock benchmark!

Learn more: https://t.co/E4fXHFjHk6 pic.twitter.com/hval73ehq1

— Nasdaq (@Nasdaq) August 31, 2020

During #COVID19, maintaining your heart health is more important than ever. That’s why we’ve joined @MillionHeartsUS on this important @CDC-approved PSA. Focus on your health, take your heart medication & don’t be afraid to keep your regular appointments.

Watch to learn more.

— Amgen (@Amgen) August 15, 2020

From working as nurses in the ICU to caring for the elderly to helping administer #COVID19 testing, Amgen's employees stepped up to help out over the last few months.

Click the link below to learn how each of them made a difference. #wearebiotech

— Amgen (@Amgen) August 29, 2020

Question: How can healthcare be better, faster, easier and more affordable?

Answer: Technology!

Amgen’s Patrick Dey offers his point of view on the rapidly emerging role of healthcare technology. Link to Patrick’s @Wired article below. #wearebiotech

— Amgen (@Amgen) August 15, 2020

'Seed and soil.’ @drsidmukherjee recently spoke at a virtual lecture hosted by Amgen about the term coined by Stephen Paget that continues to inform Mukherjee's thinking about cancer research.

Click below to hear more from the Pulitzer Prize winning author.

— Amgen (@Amgen) August 14, 2020

.@amgenfoundation partner @salkhanacademy shares his point of view on how to make virtual learning work during the time of #COVID19. Read his opinion piece in the link below. https://t.co/nmkXy2DJIU

— Amgen (@Amgen) August 13, 2020

Getting ready to return to college or go to college for the first time? Take 90 seconds to read some great career and life advice from our CEO Bob Bradway. Link below.

— Amgen (@Amgen) August 13, 2020

It’s “all hands on deck” in the fight against #COVID19. Click the link below to learn about the I-SPY COVID Trial and how it might be helpful in COVID-19 patients who need respiratory support.

— Amgen (@Amgen) August 10, 2020

We are proud to be a member of the COVID R&D Alliance and to work with our peers to identify potential treatment options that may address the urgent needs of patients living with #COVID19. Click below to learn about the work underway. #wearebiotech

— Amgen (@Amgen) August 4, 2020

While vaccines offer promise in the future, patients with #COVID19 need treatment options urgently. Amgen, @AbbVie and @TakedaPharma, members of the COVID R&D Alliance, are participating in the I-SPY COVID trial to investigate potential therapy candidates for COVID-19.

— Amgen (@Amgen) August 3, 2020

#BlackChemistsWeek pic.twitter.com/lF8v9yxDu8

— MC HAMMER (@MCHammer) August 6, 2020

People with serious heart conditions are at a higher risk for severe illness from #COVID19. Don’t neglect your heart health. Take your heart medication. Keep your regular appointments, and call your medical team with concerns.

Watch this @CDC-approved PSA to learn more.

— Amgen (@Amgen) September 19, 2020

For people with lung cancer, expanded biomarker testing is key to advancing science. Read more about @Amgenoncology's work with emerging biomarkers KRAS G12C and DLL3. Link below.#ESMO20 $AMGN

— Amgen (@Amgen) September 18, 2020

Part of recovering from a heart attack is managing your cholesterol levels and making changes to your lifestyle.

Make sure you and your family #DontMissABeat. pic.twitter.com/W3OwGMZZC5

— Amgen (@Amgen) September 18, 2020

It’s not too late to sign up for the Dempsey Challenge. Just pick your activity, your distance and fundraising goal. Join us and the @Dempsey_Center for this virtual event to support patients.

Remember, no one beats cancer alone. It takes a team!#Reimaginethechallenge

— Amgen (@Amgen) September 18, 2020

We're proud to share that the @MELLODDY_IMI project has successfully trained a unique predictive model across 10 #biopharma and pharma companies.

Its potential: advancing #drugdiscovery by addressing data-sharing challenges within pharma research. https://t.co/WZQLafz4kn

— Amgen (@Amgen) September 17, 2020

Amgen to showcase data from #oncology pipeline in solid tumors during the European Society for Medical Oncology’s Virtual Congress, kicking off this weekend. #ESMO2020 $AMGN

— Amgen (@Amgen) September 16, 2020

Three quick facts about Nancy:
She's a lawyer.
She's originally from Argentina.
She aspires to build the next generation of compliance officers.

Read the Q&A with her via the link below. #wearebiotech

— Amgen (@Amgen) September 16, 2020

Thanks to Edda for her work in insuring everyone at Amgen feels embraced and respected. We’re highlighting her leadership to kick off #HispanicHeritageMonth today.

Learn more about our commitment and actions to DI&B via the link below.#wearebiotech

— Amgen (@Amgen) September 15, 2020

Amgen and @MBiolabs announce 2020 Amgen Golden Ticket winners: BigHat Biosciences and Trilo Therapeutics.

“Funding these companies and providing them the necessary lab space to move their science forward is so important,” said Amgen’s Flavius Martin. (thread)#wearebiotech

— Amgen (@Amgen) September 15, 2020

Amgen's Dr. David Reese talked to @ResearchAmerica about what inspired him to pursue a career in medicine and science. Hint: It was a book written by Charles Darwin that you may have heard of. Looks like David has added to his book collection since then. #RAForum

— Amgen (@Amgen) September 15, 2020

Amgen’s Susan Sweeney tackles everything – from personal stories to her work at Amgen to the five changes she would implement to improve our healthcare system – in a recent interview with @AuthorityMgzine. #wearebiotech

— Amgen (@Amgen) September 14, 2020

Congrats to David Baker on receiving this year’s Breakthrough Prize in Life Sciences award. Learn how Amgen is working with David and the @UWproteindesign team in the search for new medicines: https://t.co/sUCZMfFzao https://t.co/XN8JDjJW7x

— Amgen (@Amgen) September 14, 2020

Crystal Bone, Amgen’s novel digital health algorithm under development, may one day advance a doctor’s ability to identify a patient’s risk of #osteoporosis bone fractures. #digitalhealth #AI

— Amgen (@Amgen) September 13, 2020

Supporting communities is a huge part of our mission, especially during #COVID19. Amgen South San Francisco recently donated 500 cloth masks to @ALASdreams, which will distribute them to their food pantry clients.

Check out other ways we've helped via the link below.

— Amgen (@Amgen) September 9, 2020

#ICYMI @salkhanacademy & @AmgenFoundation's @EduardoCetlin recently connected to talk about supporting the next generation of #STEM leaders and innovators by building scientific literacy and sparking curiosity.

Watch their conversation via link below.

— Amgen (@Amgen) September 9, 2020

There have been some recent conversations in the news about #migraine, a debilitating and misunderstood disease. Hear more from Amanda, who experienced the stigma and shares hope for others.

— Amgen (@Amgen) September 8, 2020

Lowering your cholesterol is one of the most important ways to prevent another heart attack.

Amgen is proud to support AHA’s Check. Change. Control. Cholesterol initiative. Thank you @American_Heart for spreading this important message. https://t.co/uZNz7DallU

— Amgen (@Amgen) September 4, 2020

Congrats to @STATNews on this impressive milestone!

We’re happy Amgen has been able to contribute, including this one by @AmgenFoundation’s @EduardoCetlin: https://t.co/BlyV0NB95W and this recent one about #COVID19 co-authored by Amgen’s Dr. David Reese: https://t.co/KaBbB35szH https://t.co/UTJkgxvgpq

— Amgen (@Amgen) September 3, 2020

This year’s winners are making significant contributions in the fields of biology, chemical biology and chemistry. #wearebiotech #STEM

— Amgen (@Amgen) September 3, 2020

It’s #ChildhoodCancerAwarenessMonth and we’re sharing one of our top posts on social media from last year. Click the link below to learn the story behind this emotional moment.

In honor of #CCAM, we hope you will consider becoming a bone marrow donor.

— Amgen (@Amgen) September 2, 2020

In our latest video for the #ESCCongress, watch as Dr. Darryl Sleep, Chief Medical Officer, shares why continuity of care is so important for cardiovascular patients during #COVID19.$AMGN pic.twitter.com/WF9DHmzTWJ

— Amgen (@Amgen) August 31, 2020

"The COVID-19 pandemic has illustrated the necessity to continue to raise awareness on the need to diagnose and promptly treat cardiovascular disease, one of society’s most prevalent serious illnesses."

Read Amgen’s Dr. Isma Benattia article via link below.#ESCCongress

— Amgen (@Amgen) August 30, 2020

Watch Amgen Executive Medical Director Dr. Bart Molemans talk about how many patients aren’t achieving the recommended LDL-C targets, and why more intensive lipid-lowering is needed. #ESCCongress $AMGN pic.twitter.com/s8Mr9D2fMA

— Amgen (@Amgen) August 30, 2020

Together with @Servier and @Cytokinetics, we continue our commitment to improving awareness of #heartfailure with reduced ejection fraction during this year’s #ESCCongress.

— Amgen (@Amgen) August 29, 2020

New data from a Phase 3 trial brings us one step closer to another treatment option for children living with heterozygous familial hypercholesterolemia (HeFH).

Our team will be presenting this data virtually at #ESCCongress. $AMGN

— Amgen (@Amgen) August 29, 2020

On this day − in a year so many once again march for justice − take a moment to read and reflect on Dr. King’s historic speech 57 years ago. The current climate is a reminder that we all have work to do to insure that systemic racism is addressed. #MarchOnWashington

— Amgen (@Amgen) August 28, 2020

Today marks the 100th anniversary of the ratification of the 19th amendment, which gave women in the United States the right to vote. We’re inspired by the suffragettes, but recognize more work remained to ensure women of color also received this right.#WomensEqualityDay

— Amgen (@Amgen) August 26, 2020

Therapies for #multiplemyeloma have come a long way since the turn of the century. Learn how a chance meeting between two academics years ago laid the groundwork to launch an innovative medicine for these patients.

— Amgen (@Amgen) August 21, 2020

Following the tragic explosion in #Beirut, Lebanon earlier this month, two Amgen employees share their recollections of what had been a typical day. One was at the supermarket; the other home drinking a cup of coffee.

Click the link below to find out what happened next.

— Amgen (@Amgen) August 20, 2020

Today, we announce the @US_FDA approved a new combination with one of our treatments for #multiplemyeloma. Press release in the link below. $AMGN

— Amgen (@Amgen) August 20, 2020

Amgen is proud to support this CDC-approved PSA to help spread the word about the importance of managing heart disease during #COVID19. https://t.co/Z3ZYxThiI3

— Amgen (@Amgen) August 13, 2020

There have been some important discussions this week about managing #mentalhealth during #COVID19. Click the link below for advice that may help if you are struggling during this stressful time.

— Amgen (@Amgen) August 6, 2020

Supporting communities is a big part of our mission. We're proud that Amgen South San Francisco was once again listed in the @SFBusinessTimes Top 100 Corporate Philanthropy Awards. https://t.co/ODxa0ix5uC

— Amgen (@Amgen) July 31, 2020

#TBT: Thirty years ago this week, the Americans with Disabilities Act (ADA) was signed into U.S. law, a landmark piece of civil rights legislation that banned discrimination based on mental & physical disabilities.

Learn more via link below. #ADA30LeadOn

— Amgen (@Amgen) July 30, 2020

Leveraging @SomaLogic’s proteomic technology will provide new approaches to help advance Amgen’s drug discovery and development efforts. $AMGN https://t.co/5sUMt6pakq

— Amgen (@Amgen) July 30, 2020

By harnessing @SomaLogic’s comprehensive proteomics
technology, Amgen can gain a deeper understanding of human health and discovery of drug development targets.

Read more in the link below. $AMGN

— Amgen (@Amgen) July 30, 2020

Read more from @Amgen’s Chad Pettit in @OnBiosimilars. Article link below https://t.co/VEv1yH2Jd6

— Amgen (@Amgen) July 28, 2020

Amgen reports Q2 earnings. Join our senior leadership team for a call at 2pm PT/5pm ET to discuss business developments, including #COVID19 updates. Details in the link below. $AMGN

Safe Harbor: https://t.co/hxhdRHOpTa

— Amgen (@Amgen) July 28, 2020

Our industry is making progress towards advancing science literacy for all. @AmgenFoundation President, Eduardo Cetlin, discusses increasing STEM opportunities and advancing equity in STEM education during #COVID19. Read his guest blog at https://t.co/4XGRozj1fz

— PhRMA (@PhRMA) August 24, 2020

It may be necessary for those with higher risk factors to monitor their #cholesterol more often and take medication to manage cholesterol levels. @Amgen sponsors the American Heart Association’s #CheckChangeControl Cholesterol initiative. https://t.co/IJhXL3KSC1 pic.twitter.com/z5Exxxhe8Z

— American Heart News (@HeartNews) September 10, 2020

https://twitter.com/Nasdaq/status/1298379467837014016

Learn about our oncology pipeline during the virtual #ESMO20. Get up close and personal with 10 of our investigational anticancer modalities in our new immersive #360PipelinePath video: https://t.co/8qxYpPZu2e

— Amgen Oncology (@AmgenOncology) September 18, 2020

If you have cancer, you are at higher risk of serious problems from some vaccine-preventable diseases, like the flu. Talk with your doctor to make sure you’re getting the right vaccinations at the right time. #NationalImmunizationAwarenessMonth pic.twitter.com/sibgL7DYHg

— Amgen Oncology (@AmgenOncology) August 7, 2020

Today is #WorldLungCancerDay and Christophe Bourdon, along with the @Amgen team reaffirms our commitment to those affected by the disease. For more information on our research in lung cancer visit https://t.co/nS2DiHLOzH. #WLCD pic.twitter.com/TTUKAbHNMN

— Amgen Oncology (@AmgenOncology) August 1, 2020

.@Amgen is dedicated to developing biologics, including biosimilars, across six therapeutic areas. Discover more about our commitment.

— Amgen Biosimilars (@AmgenBiosim) August 28, 2020

In a recent Q&A with @PharmaBoardroom, @Amgen’s Alper Ureten shares the strategy behind Amgen’s success with #biosimilars and emphasizes the need for competition in order to foster a robust marketplace with biosimilars. Read it here.

— Amgen Biosimilars (@AmgenBiosim) August 14, 2020

Competition supported by biosimilars has the potential to help alleviate some of the COVID-19-driven financial pressure for governments, hospitals, and patients, while delivering the clinical benefits of originator biologics. Read more from @Amgen’s Chad Pettit in @OnBiosimilars.

— Amgen Biosimilars (@AmgenBiosim) July 31, 2020

"Because free resources should be awesome resources." Through the vision of @RobertLue4edu and the support of @AmgenFoundation, LabXchange is and will stay free for learners and educators. And not just free: top quality. #ScienceMadePossible.#SciEd #EdTech pic.twitter.com/dmrI7Eo3JR

— LabXchange (@LabXchange) September 1, 2020

I had the opportunity to speak with the Association of Corporate Citizenship Professionals (@accprof) about @khanacademy, equity, and the @AmgenFoundation. #stem #equity #philanthropy https://t.co/KU9gghI1hb pic.twitter.com/3ReHIk6jL3

— Scott Heimlich (@ScottHeimlich) August 10, 2020

https://twitter.com/cheddar/status/1286320719765307393

To bring quality science #education to all, we must reimagine science learning. This summer, our @ASP_GPO #SummerScienceSeries did just that with a virtual program focused on inspiring a wide range of undergraduate scientists. #ScienceMadePossible https://t.co/jK62mfxyGb pic.twitter.com/JmHU4bskzO

— Amgen Foundation (@AmgenFoundation) August 31, 2020

Take a moment to read the @USATODAY interview with Amgen Foundation partner @salkhanacademy in which he discusses how Khan Academy has seen a big uptick in use during #COVID19 and the organization’s plans to support virtual learning this fall. https://t.co/a9ZI4fydJc

— Amgen Foundation (@AmgenFoundation) July 30, 2020

We couldn't ask for a better partner. #ScienceMadePossible https://t.co/8gPA1HO7GV

— Amgen Foundation (@AmgenFoundation) July 23, 2020

World Vol.46

14 September 2020 is very special for #OPEC, the day it celebrates its 60th anniversary. Few could have foreseen six decades ago that the Organization would rise to become a respected and leading force in the global energy arena. Happy #OPEC Day! pic.twitter.com/3HTnrNhiAC

— OPEC (@OPECSecretariat) September 14, 2020

Depressed business demand for inputs is obviously helping ensure demand for fuels remains relatively low—and is part of the story in the newly-rebuilding oil glut. https://t.co/4fPcjCO1pV

— OPEC News (@OPECnews) September 16, 2020

Phillips 66 is bringing forward planned maintenance activities at its Alliance refinery on the Mississippi River in Belle Chasse, Plaquemines Parish, La., following the refinery’s shutdown ahead of #HurricaneSally #oilandgas https://t.co/qz2M3flv5c pic.twitter.com/dIgm03cyLM

— Oil & Gas Journal (@OGJOnline) September 16, 2020

"When we reach peak demand it will look a lot like what we saw this year in the #Covid_19 response. Price setting will become a very different game—it will be very unpredictable" says @Shell's Maarten Wetselaar #peakoil #oil #gas https://t.co/AIT7YMwJYI

— Petroleum Economist (@PetroleumEcon) September 14, 2020

Abu Dhabi takes $615 million stake in Cheniere Energy. https://t.co/c4a73jxcCE #AbuDhabi #CheniereEnergy #US #SabinePass #LNG #oilandgas #oilandgasnews #LNGnews

— World Oil Online (@WorldOil) September 16, 2020

Kuwait aims to finish the Middle East's biggest LNG terminal by March https://t.co/XTkHs9Fayq

— Bloomberg Energy (@BloombergNRG) September 16, 2020

“Gas prices in Europe are higher than the cost of exporting U.S. LNG” explains Julien Hoarau in @WSJ #ONGT #NaturalGas #LNG https://t.co/aW0Sx3s7jd

— ENGIE EnergyScan (@Energyscan_egm) September 16, 2020

Mery Mogollon / Platts -Venezuela inches up oil production in
the oil belt https://t.co/VINawMWdTs pic.twitter.com/mlXBgqDK9o

— Elio Ohep – Editor Petroleumworld1 (@petroleumworld1) September 16, 2020

88 Energy confirms large oil discovery – upgrades Net Pay from Charlie-1 Well [Promoted] – https://t.co/X5icdmDuFQ – NGW News & Insight

— Natural Gas World (@NatGasWorld) September 16, 2020

Economic activity is stabilizing across most advanced economies, though still far below pre-Covid levels, according to Bloomberg Economics gauges https://t.co/0W2s4WLAD2

— Bloomberg Asia (@BloombergAsia) September 17, 2020

"We decided that at least part of the shattered glass… our local industries should benefit from as a raw material." – Ziad Abichaker, Cedar Environmental

How Lebanese volunteers are recycling broken glass from the Beirut blast. pic.twitter.com/kFB0q4G34V

— Al Jazeera English (@AJEnglish) September 15, 2020

“It emboldens Israel to continue making its moves that are anti-peace.”

As the UAE and Bahrain signed a deal to normalise relations with Israel at the White House, protesters outside called it ‘shameful’ and said it was counterproductive to peace. pic.twitter.com/enYrrdT0Zl

— Al Jazeera English (@AJEnglish) September 16, 2020

The United Arab Emirates and Bahrain are signing historic agreements normalizing relations with Israel at the White House.

Watch the ceremony live here:https://t.co/w6FlvyFl6U https://t.co/Dagmue2FfE

— Al Arabiya English (@AlArabiya_Eng) September 15, 2020

TV #series fuels #Pakistanis’ love for #Turkey

*Globally popular Turkish #drama Dirilis (#Resurrection) Ertugrul helps nurture Pakistani-Turkish relationshttps://t.co/mz6AOWtl22 pic.twitter.com/WIjpq2bDHP

— ANADOLU AGENCY (ENG) (@anadoluagency) September 16, 2020

Israeli jets bomb Gaza after rocket firehttps://t.co/RWQitky4XD pic.twitter.com/1x0crEFHXu

— AFP news agency (@AFP) September 16, 2020

Key Brexit dates ahead https://t.co/XPUQDoaf7u

— ForexLive (@ForexLive) September 16, 2020

Why I'm buying gold now, before the FOMC https://t.co/DU9gKuQP5q

— ForexLive (@ForexLive) September 16, 2020

Federal Reserve Chair Jerome Powell speaks after leaving rates unchanged https://t.co/IZR1bTZHof

— Reuters (@Reuters) September 16, 2020

The @Yale Labor Survey data on employment and unemployment were little changed in the week ending August 29. The results remain consistent with a general improvement in household labor market conditions since mid-July.

Read more: https://t.co/LCJfXFK2BW pic.twitter.com/0tC6vZDe8g

— BostonFed (@BostonFed) September 8, 2020

Actions have consequences. So regardless what the FOMC announces tomorrow, one consequence of its unprecedented #dollar money printing will be more $ debasement from higher inflation. Own physical #gold and #silver to protect the purchasing power of your hard earned savings. pic.twitter.com/XW6CEq3cCm

— James Turk (@FGMR) September 15, 2020

#Gold Price Clobbered In Front of FOMC Meeting https://t.co/xSKriK2vK5 via @YouTube

— ArcadiaEconomic (@ArcadiaEconomic) September 16, 2020

Mourners join in a rendition of "Imagine" by John Lennon as they honor the legacy of Supreme Court Justice Ruth Bader Ginsburg, the standard bearer for the court's liberal wing and a progressive icon. https://t.co/QcBKdeDxe2 pic.twitter.com/62Sh502TdS

— ABC News (@ABC) September 19, 2020

WATCH: Trump hears from a reporter that Justice Ginsburg has died.

"She just died? Wow. I didn't know that, you're telling me now for the first time."

"She led an amazing life. What else can you say? She was an amazing woman…I'm sad to hear that." pic.twitter.com/5Na3vHzP7f

— Yahoo News (@YahooNews) September 19, 2020

How do I vote in my state in the 2020 election? https://t.co/NAFJF0ubuQ

— CBS News (@CBSNews) September 19, 2020

"We're 32 million voters. That's a huge bloc. We're going to decide this," says actor @JohnLeguizamo of Latinx voters on #AmanpourPBS. Watch: https://t.co/CQgY0Hei2q @AmanpourCoPBS @AnaCabrera pic.twitter.com/xxt9NTPwjy

— PBS (@PBS) September 16, 2020

It's not just you. The pandemic has made all kinds of products, from paper towels to living-room furniture, difficult to track down right now, writes @amandamull: https://t.co/FhrMkPPQHa

— The Atlantic (@TheAtlantic) September 15, 2020

TikTok will be banned on Sunday https://t.co/2ZbL8f7ySs

— Newsweek (@Newsweek) September 18, 2020

Millions of Americans are "house rich" but don't have enough money to make their mortgage payments. Wall Street landlords are ready. https://t.co/V7S6gbnCMe

— The Wall Street Journal (@WSJ) September 18, 2020

Billionaire investor Warren Buffett was an active campaigner for the past two Democratic presidential nominees. In 2020, he’s yet to become publicly involved with Joe Biden’s bid to reclaim the White House. https://t.co/H6N9ia9EPe

— The Wall Street Journal (@WSJ) September 13, 2020

People are taking out lots of mortgages. The Fed is gobbling them up. @davidhodari explains the link between the central bank and tens of millions of American homes. #WSJWhatsNow pic.twitter.com/1EM4sVgsdu

— The Wall Street Journal (@WSJ) September 16, 2020

The U.S. charged five Chinese citizens with computer-hacking crimes in alleged attacks on over 100 companies in the U.S. and overseas https://t.co/HPibdHZTiW

— The Wall Street Journal (@WSJ) September 16, 2020

Wildfires continue to rage in parts of California, Oregon and Washington as fire crews brace for weather conditions that could fan the flames #WSJWhatsNow pic.twitter.com/AIJ44NktjY

— The Wall Street Journal (@WSJ) September 14, 2020

President Trump doubts the impact of climate change on wildfires, while Joe Biden says reelecting a “climate denier” could lead to worse natural disasters #WSJWhatsNow pic.twitter.com/dqnY3FB5Mp

— The Wall Street Journal (@WSJ) September 15, 2020

Extreme poverty ($1.90 a day) declined from 42% in 1981 to 9% in 2018. There is more net forest on the planet than 40 years ago. Deaths from natural disasters have dropped by 99% since the '30s. Progress is everywhere but the media. Watch: https://t.co/2r7L00qOPm

— Nick Gillespie (@nickgillespie) September 15, 2020

After the Chicago Marathon was canceled, a Catholic nun ran a solo treadmill marathon to raise funds for food.

Full story: https://t.co/4Ae5zscN0l pic.twitter.com/nZvHTOY7VS

— AP Sports (@AP_Sports) September 19, 2020

President Trump and California Gov. Gavin Newsom strongly disagree on the role that climate change plays in the devastating wildfires. But on Monday, they were exceedingly polite about it. https://t.co/zThEsy5ePb pic.twitter.com/khLAfxC6O4

— The New York Times (@nytimes) September 14, 2020

Maps: We're tracking fires and air quality in California, Oregon and Washington https://t.co/l7NHS1xeuQ

— The New York Times (@nytimes) September 16, 2020

The number of new U.S. coronavirus cases has dropped from its peak in late July. But hidden in that trend is a rise in daily cases in the Midwest — which has recently seen its highest level so far.https://t.co/4aSFaqDXMz

— The New York Times (@nytimes) September 14, 2020

The U.S. Postal Service was slower to deliver the mail in July and August, a slowdown that started after the arrival of Louis DeJoy, the postmaster general, and the start of policies to trim transportation costs.https://t.co/WrGrvr3gA9

— The New York Times (@nytimes) September 14, 2020

More cities and states are opening bars and restaurants despite mounting evidence of potential danger https://t.co/D56IsNcB8h

— The Washington Post (@washingtonpost) September 14, 2020

Analysis: The Senate seats most likely to flip in November https://t.co/siIYpD4KAS

— The Washington Post (@washingtonpost) September 16, 2020

Opinion: Deep-red Montana could be Democrats’ biggest catch in 2020. Can they land it? https://t.co/wREHSmxgqr

— The Washington Post (@washingtonpost) September 15, 2020

How former Trump adviser Steve Bannon joined forces with a Chinese billionaire who has divided the president’s allies https://t.co/6pDETKgvwV

— The Washington Post (@washingtonpost) September 13, 2020

Hurricane Sally is already lashing areas along the Gulf Coast ahead of its expected landfall Wednesday morning near Dauphin Island, Ala., where protective dunes have already begun to give way. https://t.co/RFWkwsxjAm pic.twitter.com/urSUYDCISq

— CBS Evening News (@CBSEveningNews) September 16, 2020

A 42 mile stretch of Nioghalvfjerdsfjorden, the Arctic's largest remaining ice shelf, has broken off and shattered near Greenland. https://t.co/rBt6HUnR2P

— CBS This Morning (@CBSThisMorning) September 15, 2020

Wildlife experts in New Mexico say birds in the region are dropping dead in alarming numbers, potentially in the "hundreds of thousands." https://t.co/dV8RajUsBW

— NBC News (@NBCNews) September 15, 2020

"Everybody thinks that veterans get health care for life, but they don't. They only get health care if their injury or illness can be tied to their service," Jon Stewart says about legislation that would help veterans affected by toxic burn pits. https://t.co/L3q7TQ9bkt

— MSNBC (@MSNBC) September 15, 2020

MSNBC analyst blames Bernie Sanders for Biden underperforming with Latino voters in Florida pic.twitter.com/7iY16vjioC

— Ibrahim (@Ibrahimpols) September 15, 2020

Scientific American is backing Joe Biden for president, the first endorsement in the magazine's 175-year history. https://t.co/mR1lZwjCnV

— CBS This Morning (@CBSThisMorning) September 16, 2020

"Let's understand what this is: Donald Trump has confessed, on tape, to the greatest and most deadly lie in all the long history of the United States bar none."@SteveSchmidtSES on Trump downplaying the threat of the coronavirus. #TheReidOut pic.twitter.com/QeZScMGjLM

— The ReidOut (@thereidout) September 15, 2020

Hurricane Sally brought wild winds and rain to the Alabama and the Gulf Coast of Florida as it moved to make landfall early Wednesday. https://t.co/xUIpwjX4Yb pic.twitter.com/4BOjYnY1Cm

— ABC News (@ABC) September 16, 2020

JUST IN: By a 2-to-1 margin, most Americans think Joe Biden has more respect for those who serve in uniform than Pres. Trump does. https://t.co/ahE3Y53vvt

— ABC News (@ABC) September 13, 2020

Colorado secretary of state sues Postal Service over voting information https://t.co/7YiMHU59Rm

— 9NEWS Denver (@9NEWS) September 12, 2020

https://twitter.com/DanScavino/status/1305039891936325633

Air quality in parts of #Washington deemed "hazardous" due to #wildfire smoke. They could use some rain! pic.twitter.com/HUzW4xlBR6

— Ben Dery (@BenDeryKARE11) September 12, 2020

10,000 North Carolinians vote absentee in first weekhttps://t.co/cE51oJJKuL

— Joe Bruno (@JoeBrunoWSOC9) September 11, 2020

61% of Americans looking for jobs right now want to switch careers https://t.co/ZubLs5laf8

— KMBC (@kmbc) September 11, 2020

To be elected mayor of Philadelphia, you have to convince the city’s voting poor that you have a plan to solve their problems. Yet administration after administration, those plans have solved nothing, writes Lynette Tolbert Hazelton. https://t.co/2eZpbRspfL

— Philly Mag (@phillymag) September 6, 2020

Overfishing has led to a loss of 90% of the ocean's larger fish pic.twitter.com/bEdf6s57mE

— Business Insider (@businessinsider) September 11, 2020

A government agency just warned this week's West Coast wildfires could spark a financial crisis. A top economist thinks the effects could linger for years. https://t.co/Y5NqtCGbll

— Business Insider (@businessinsider) September 12, 2020

Nearly two decades after the 9/11 attacks, we're now learning more about one of the best-kept secrets from the fateful mission to hunt down Osama Bin Laden.@CBS_Herridge spoke with the model maker who built a replica of his hideout to help Navy SEALs prepare for the raid. pic.twitter.com/m5NXq5STph

— CBS This Morning (@CBSThisMorning) September 11, 2020

https://twitter.com/NBCNews/status/1304432893733801985

WATCH LIVE: Kamala Harris offers remarks at a 9/11 remembrance in Fairfax, Virginia https://t.co/RSza752psg

— PBS NewsHour (@NewsHour) September 11, 2020

President Donald Trump told a rally crowd he misled Americans about the coronavirus pandemic to avoid panic and compared his leadership to Winston Churchill during World War II. pic.twitter.com/rJL7k1z6Xm

— HuffPost (@HuffPost) September 11, 2020

NEVER FORGET: U.S. Navy in Japan flies flag at half-staff to mark 9/11 anniversary. https://t.co/cH9kjQ8J57 pic.twitter.com/XCFJE2rRzk

— ABC News (@ABC) September 11, 2020

"It’s hard to call Abe a transformational leader,” writes @ianbremmer. “But just because Abe failed to be a transformative politician hasn’t made him a failed one.” https://t.co/s9LSpBa3c6

— TIME (@TIME) September 11, 2020

John Adams set a precedent that U.S. presidents accept the result when they lose re-election. For more than 200 years, his successors have followed his lead https://t.co/zqWm79C4xA

— TIME (@TIME) September 11, 2020

https://twitter.com/njdotcom/status/1304887510926004224

Check out my VIRTUAL "Laugh Your Face Off" Comedy Fundraiser. Text "LYFO2020" to 243-725 to donate, and bid in our Silent Auction! https://t.co/Ofe6x4l5eh

— Pat Tomasulo (@pattomasulo) September 12, 2020

In 1942, the WAVES program allowed #women to serve in the @USNavy. This week we highlight their contributions in #WWII. #WAVESweek2020 #militaryhistory https://t.co/JtpMoEGKhA

— OkStateLibrary (@OkStateLibrary) June 8, 2020

The deadline to register ahead of time to vote in D.C., Maryland, Virginia and West Virginia is coming up. How are you voting in November? Get up to speed with your options and important dates here: https://t.co/J71Sype1iz pic.twitter.com/cx6q3yz5ae

— NBCWashington (@nbcwashington) September 13, 2020

Indiana Vol.8 (corporations: Eli Lilly)

#News: We are pleased to share data from our Phase 2 trial of a neutralizing antibody in the #COVID19 outpatient setting. Read more: https://t.co/DmeWSci6W6 pic.twitter.com/HFg72XUzH4

— Eli Lilly and Company (@LillyPad) September 16, 2020

Just in: Lilly is pleased to share initial positive data from the Adaptive COVID-19 Treatment Trial (ACTT-2), conducted by @NIAIDNews. One of our medicines has potential as a treatment for hospitalized #COVID19 patients. Read more: https://t.co/fesGkDn7Qo pic.twitter.com/rkp4eg3JAm

— Eli Lilly and Company (@LillyPad) September 14, 2020

Transforming RVs into “clinical research units on wheels” to reach elderly patients for a #COVID19 clinical trial was truly a #Hoosier effort. Learn how two Indiana-based companies helped us bring our vision to life: https://t.co/oueHbn2HX2 #WeAreLilly @GovHolcomb pic.twitter.com/vKylrIZtfR

— Eli Lilly and Company (@LillyPad) August 6, 2020

The speed of our #COVID19 innovation isn’t just happening in labs. In just 30 days, Lilly employees – with help from two Indiana-based companies – transformed an RV into a “clinical research unit on wheels” to reach elderly patients: https://t.co/oueHbn2HX2 #WeAreLilly pic.twitter.com/ke1jNe8dgi

— Eli Lilly and Company (@LillyPad) August 3, 2020

Just announced: Lilly, in partnership with @NIAIDNews & others, will initiate a Phase 3 trial of one of our potential antibody treatments for the prevention of #COVID19 in long-term care facilities. Learn more: Read more: https://t.co/OQTzjG8AMQ pic.twitter.com/0O19vP9U3t

— Eli Lilly and Company (@LillyPad) August 3, 2020

Just announced: Lilly will initiate a Phase 3 clinical trial to evaluate one of our medicines as a potential treatment for hospitalized #COVID19 patients. Read more: https://t.co/crwsmvSHx5 pic.twitter.com/F3aetQyMP4

— Eli Lilly and Company (@LillyPad) June 15, 2020

New today: We've announced, with partner Junshi Biosciences, the start of a Phase 1 study for our second potential antibody treatment designed to fight #COVID19. Here's the full story: https://t.co/Rk6eNa7egX pic.twitter.com/MEqQYKxMBk

— Eli Lilly and Company (@LillyPad) June 8, 2020

Lilly scientists delivered the first doses of our potential #COVID19 antibody treatment, flown to hospitals in several U.S. cities to start the world’s first human study of this kind of therapy to fight COVID infections. #WeAreLilly pic.twitter.com/aCRrjtu4V6

— Eli Lilly and Company (@LillyPad) June 1, 2020

We continue to focus on making medicines that people count on, as our scientists and medical experts search for #COVID19 treatments. #INThisTogether #WeAreLilly pic.twitter.com/Uq5dJUXjRU

— Eli Lilly and Company (@LillyPad) May 20, 2020

New: The Central Indiana #COVID19 Community Economic Relief Fund has granted $4M to 56 organizations in Marion County. Learn more: https://t.co/spgq0I5VmN #WeAreLilly #INthistogether pic.twitter.com/OQcsyLPmlT

— Eli Lilly and Company (@LillyPad) May 14, 2020

Our ongoing work in the fight against #COVID19 includes putting our scientific R&D expertise front and center. Learn how we're battling the virus while keeping our employees safe in this new @WSJ video: https://t.co/K3A8bMD1mQ #WeAreLilly pic.twitter.com/boBIw3HClh

— Eli Lilly and Company (@LillyPad) September 15, 2020

We're sharing our Q2 2020 results today, including R&D pipeline progress to bring medicines to people to make life better. Here's the full story: https://t.co/mX6YneXh5W $LLY pic.twitter.com/BEYeNGwHSU

— Eli Lilly and Company (@LillyPad) July 30, 2020

Congratulations, @AbCelleraBio! https://t.co/ziLNUEy9h0

— Eli Lilly and Company (@LillyPad) July 29, 2020

How can the next generation of value-based arrangements put patients front and center? We explored this in our new white paper with @Prime_PBM: https://t.co/PAF9tDyPsN #WeAreLilly pic.twitter.com/sTUrG2y6Qw

— Eli Lilly and Company (@LillyPad) July 28, 2020

We’re pleased to share that today the European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion for a Lilly medicine for the treatment of adult patients with moderate to severe #atopicdermatitis. https://t.co/QnqVKdRtDG pic.twitter.com/hFfxQz1H0p

— Eli Lilly and Company (@LillyPad) September 18, 2020

#DYK there will be an estimated 52,890 new cases of thyroid cancer diagnosed in 2020? To learn more about a targeted therapy approved for people living with advanced RET-driven #thyroid cancers, see here: https://t.co/6PINwWi09V pic.twitter.com/2IoAq6hlPP

— Eli Lilly and Company (@LillyPad) September 17, 2020

Watch Dr. Christopher Gharibo of @NYULangone speak with Grace Whiting, president and CEO of @NA4Caregiving, about how chronic pain due to #osteoarthritis can be a source of frustration for those who suffer from it. Watch to learn more. #PainAwarenessMonth #WeAreLilly pic.twitter.com/SXcFGmfu0T

— Eli Lilly and Company (@LillyPad) September 16, 2020

Lilly is committed to providing people with effective acute treatments for #migraine that can offer pain freedom from attacks. Read about exciting new Phase 3 data presented at #PAINWeek: https://t.co/9mRgOphU3N pic.twitter.com/WqjQ9drShi

— Eli Lilly and Company (@LillyPad) September 11, 2020

Announcement: Lilly is presenting data from 20 studies across its oncology portfolio at the @myESMO Virtual Congress. Learn more about the powerful science that we’re bringing to the conference: https://t.co/p2VJbTnHry #ESMO20 pic.twitter.com/DbCmhwRk2J

— Eli Lilly and Company (@LillyPad) September 10, 2020

This #PainAwarenessMonth, Lilly is dedicated to highlighting the growing burden of chronic pain and to supporting patients with chronic pain stemming from conditions such as #osteoarthritis. #PAINWeek #WeAreLilly pic.twitter.com/Gcsz9PESP7

— Eli Lilly and Company (@LillyPad) September 9, 2020

#DYK @NEJM published two manuscripts with data from our recent trial in RET-driven cancers? We’re proud to share the results as we bring the newly approved treatment to people with certain RET-driven lung and thyroid cancer. Learn more: https://t.co/JSUuWVjdoG pic.twitter.com/wc9HyZgsDp

— Eli Lilly and Company (@LillyPad) August 27, 2020

As a founding funder of the Indianapolis eLearning Fund, the Lilly Foundation applauds @GovHolcomb for awarding $11.5 million to provide devices and internet connectivity to students in Marion County schools to support #eLearning. https://t.co/7iSnvbbGZ1

— Eli Lilly and Company (@LillyPad) August 20, 2020

We certainly miss working alongside each other, but we’re incredibly proud of the innovative work our Lilly scientists are doing to discover a potential #COVID19 treatment. #WeAreLilly https://t.co/diU4OT7mR2

— Eli Lilly and Company (@LillyPad) August 18, 2020

Breaking News: @NIAIDNews announces the start of ACTIV-3, a Phase 3 clinical trial of one of Lilly’s potential #COVID19 antibody treatments for hospitalized patients. Read more: https://t.co/HDR431b4ZK pic.twitter.com/UjhbqRT23H

— Eli Lilly and Company (@LillyPad) August 4, 2020

ICYMI: Lilly announces positive top-line results from Phase 3 OASIS-2 study for patients with moderate to severe plaque #psoriasis. https://t.co/5QqJPLVu4r pic.twitter.com/atomEgb2Fi

— Eli Lilly and Company (@LillyPad) July 23, 2020

Lilly is proud to be one of more than 20 pharmaceutical companies that has collectively invested nearly $1 billion to create the AMR Action Fund, which aims to bring 2-4 new antibiotics to patients in the next decade. #WeAreLilly https://t.co/ShaphH78Wa

— Eli Lilly and Company (@LillyPad) July 9, 2020

After a drought of treatment innovation that lasted 20+ years, advancements in our understanding of migraine have resulted in new treatments and more meaningful care approaches. While we are in the midst of a golden era for #migraine care, we can’t rest. https://t.co/jQ0tkFzMqg pic.twitter.com/LkI3Dz8UJX

— Eli Lilly and Company (@LillyPad) June 18, 2020

To provide a more comprehensive understanding of #migraine pain, Lilly explored total pain burden. Solving for migraine means more than reducing the frequency of attacks. Learn more about the data Lilly presented at #AHS2020: https://t.co/tIsTx1Hc9c pic.twitter.com/1X7F2aK8hm

— Eli Lilly and Company (@LillyPad) June 17, 2020

Lilly announces positive top-line results from Phase 3 monarchE study in high risk early #breastcancer for its CDK4 & 6 inhibitor: https://t.co/immGOKBHpl pic.twitter.com/Y1b5zzFxtz

— Eli Lilly and Company (@LillyPad) June 16, 2020

Lilly highlights the evolution of its Dermatology portfolio at the American Academy of Dermatology (AAD) Virtual Meeting Experience. Learn more: https://t.co/M8euBBoKGO #AADVMX2020 pic.twitter.com/IrIetQrAeL

— Eli Lilly and Company (@LillyPad) June 15, 2020

Thanks to everyone who joined us for the Indy Day of Solidarity – We Stand Together virtual event. If you missed it, you can watch it here: https://t.co/T6W4HMob8E #WeAreLilly pic.twitter.com/rcdwNgYB5Z

— Eli Lilly and Company (@LillyPad) June 13, 2020

As we prepare for #AADVMX2020, get to know our very own Dr. Lotus Mallbris, Lilly’s vice president of immunology development, and how her decade of experience as a physician and researcher all began. https://t.co/UxN90fzupw #WeAreLilly pic.twitter.com/HvvfxkQhvO

— Eli Lilly and Company (@LillyPad) June 12, 2020

SVP Patrik Jonsson shares his insights on what Lilly’s recent @US_FDA approval of a medicine for nr-axSpA means for patients living with this chronic condition. https://t.co/dyz6aZAXF5 pic.twitter.com/FXzrRJ8W8i

— Eli Lilly and Company (@LillyPad) June 9, 2020

A Lilly medicine has recently been approved by the @US_FDA for treating nr-axSpA. This is an important milestone for the hundreds of thousands that live with this condition. https://t.co/dyz6aZAXF5 pic.twitter.com/3IN8Vmtzpk

— Eli Lilly and Company (@LillyPad) June 8, 2020

Lilly is proud to announce that we’ve received @US_FDA approval for a medicine that treats Non-Radiographic Axial Spondyloarthritis (nr-axSpA). https://t.co/dyz6aZAXF5 pic.twitter.com/8WI6U8Ldyn

— Eli Lilly and Company (@LillyPad) June 1, 2020

We’re pleased to have presented positive data at #ASCO20 from the LIBRETTO-001 trial evaluating an approved treatment for people living with RET-driven lung and thyroid cancers. Learn more: https://t.co/eiUPUbY3Vt pic.twitter.com/au3Rc6GiSN

— Eli Lilly and Company (@LillyPad) May 30, 2020

Breaking: @US_FDA approved one of our oncology medicines for the first-line treatment of people with metastatic EGFR-mutated non-small cell #lungcancer. We’re proud to provide a new option for people living with this type of cancer. Learn more: https://t.co/APLBsCAYEw #NSCLC #FDA pic.twitter.com/WqFjppH9yu

— Eli Lilly and Company (@LillyPad) May 30, 2020

Breaking: @US_FDA approved one of our oncology medicines for the first-line treatment of people with metastatic EGFR-mutated non-small cell #lungcancer. #NSCLC #FDA pic.twitter.com/3UGurvdLTO

— Eli Lilly and Company (@LillyPad) May 29, 2020

We are thrilled to make history with the approval of a new diagnostic agent for the evaluation of patients suspected of having #Alzheimers disease: https://t.co/UsiWxZ7SFP #FDAapproval pic.twitter.com/ysYTJzYQwe

— Eli Lilly and Company (@LillyPad) May 29, 2020

#EAN2020 data highlights how preventive #migraine treatment can improve day-to-day functioning and work productivity for those living with this debilitating disease. Learn more: https://t.co/hScOF6UZgc pic.twitter.com/cJSlXESJmj

— Eli Lilly and Company (@LillyPad) May 27, 2020

We’re pleased to participate in this important model that will make insulin more affordable for U.S. seniors. Collaborations like this prove that when business and government work together, we can make a meaningful difference for patients. #InsulinSavings https://t.co/nnK4haoFyi

— Eli Lilly and Company (@LillyPad) May 26, 2020

Data from 23 studies from Lilly #Oncology will be presented at the world’s largest cancer conference, @ASCO. Learn more: https://t.co/5OtFbrPyp1 #ASCO20 pic.twitter.com/vXTuZbOxb5

— Eli Lilly and Company (@LillyPad) May 13, 2020

#DYK: The most common endocrine #cancer continues to be #thyroidcancer. And the @US_FDA recently approved a new therapy for patients living with RET-driven lung and thyroid cancers. Here’s the latest: https://t.co/6PINwWi09V pic.twitter.com/NNe2IWvCBx

— Eli Lilly and Company (@LillyPad) May 12, 2020

#LungCancer is the leading cause of cancer deaths worldwide – and the good news is a new treatment option was just approved by the @US_FDA for people living with metastatic RET-driven lung #cancer. Learn more: https://t.co/6PINwWi09V pic.twitter.com/QU7olCdRNP

— Eli Lilly and Company (@LillyPad) May 11, 2020

Keep track of our updates as we make progress against #COVID19 via our global response page. https://t.co/oOXMOFEHjJ pic.twitter.com/6IXPoZhGm0

— Lilly Trials (@LillyTrials) September 16, 2020

Speaking of different settings, more and more clinical trials are being brought directly to the participant! Read our story about how Team Lilly brought research to elderly patients. https://t.co/bj1mHYC1AL #WeAreLilly

— Lilly Trials (@LillyTrials) September 15, 2020

Clinical trials take place in different settings. Whether it be hospitals, universities, doctors' offices, community clinics, or somewhere closer to home, trials may be more accessible than you think. https://t.co/wRPRbODJ6m pic.twitter.com/eKIMfMQVYa

— Lilly Trials (@LillyTrials) September 15, 2020

#WeekendRead: Only ~13% of English speakers in the US have proficient levels of #healthliteracy, and this isn't a patient issue; it's a provider one. Read @PEHealthIT to understand how #HCPs and clinical researchers can better clarify health information: https://t.co/vmrSVS7Jkh

— Lilly Trials (@LillyTrials) September 12, 2020

Each brick in the #HerosJourneyArt project represents a unique voice, reflecting the thoughts and feelings of patients, their family and friends, caregivers, physicians, scientists and researchers. Learn more: https://t.co/6pdIDSMA0N pic.twitter.com/sMKyc5ajhu

— Lilly Trials (@LillyTrials) September 11, 2020

#FlashbackFriday: In 2016, we shared a recap from the BIO International Convention that shared insight into the "#digitalhealth revolution". A lot has changed since then, but many of those takeaways remain true. Check it out: https://t.co/wW4uhCYvQq

— Lilly Trials (@LillyTrials) September 11, 2020

Research physicians have a big impact not just on their patients, but also on their patients' loved ones. Abby Jeske, a Lilly employee, shares how her late grandfather's research physician reignited her passion in #clinicalresearch: https://t.co/nv5HDlI2Ja #TrialsTruth

— Lilly Trials (@LillyTrials) September 10, 2020

Pros of a #platformtrial:
1️⃣ You can feel like you're part of something bigger
2️⃣ The process is similar to traditional #clinicaltrials
3️⃣ If you want to try different options, it offers a consistent journey

Want to learn the cons too? Read more here: https://t.co/ybwnktod3N

— Lilly Trials (@LillyTrials) September 10, 2020

Get the latest information on our progress against #COVID19: https://t.co/mMMnpmd6yY pic.twitter.com/hOOH33K8BD

— Lilly Trials (@LillyTrials) September 8, 2020

#SundayRead: It's estimated that about 50-70% of all appointments could be replaced with teleconsultations. How might we expand some of these innovations to the clinical trial setting? Read @NewYorker to explore the pros and cons of #telehealth: https://t.co/kJohCaYdu2

— Lilly Trials (@LillyTrials) September 6, 2020

#WeekendRead: @ClinicalLeader1 tackles the issue of systemic racism, and how it impacts #clinicaltrials. As communities of color are being disproportionately impacted by #COVID19, this article and its suggested solutions are incredibly important. Read on: https://t.co/r8aTy7C1Z8

— Lilly Trials (@LillyTrials) September 5, 2020

#FridayFact: For clinical trials of #CrohnsDisease and #UlcerativeColitis, you will probably need to visit the research doctor more often than you do for your normal care. Learn more about what to expect and find resources here: https://t.co/5r6JQJdqaQ

— Lilly Trials (@LillyTrials) September 4, 2020

Want to learn more about #clinicaltrials in general? 10 more facts you should know are here: https://t.co/Cs2zv7SphH

— Lilly Trials (@LillyTrials) September 3, 2020

5 facts about #Alzheimers clinical trials:
1️⃣ Study volunteers are vital for developing treatment options
2️⃣ You don't need to have #Alz to participate
3️⃣ Most studies require a study partner
4️⃣ Ask questions
5️⃣ All studies have drawbacks

Learn more: https://t.co/XMapkKT8SW

— Lilly Trials (@LillyTrials) September 3, 2020

To kick things off on our researcher #TrialsTruth series, read more about two people making in-home visits a reality with mobile nursing. https://t.co/H6snoxIUlZ

— Lilly Trials (@LillyTrials) September 2, 2020

#WeekendRead: Lack of #diversity in clinical trials is a moral, scientific, and medical issue. Read @mnt's article for a better understanding of the problem at hand, as well as what #HCPs, researchers, and the FDA should be doing to solve it: https://t.co/8E1QjUgDPy

— Lilly Trials (@LillyTrials) August 29, 2020

#FridayFact: There are 4 phases of clinical trials, and altogether, the process can take as long as 8 years. Want to learn more about what #clinicaltrials are like? Watch @CISCRP's Finding Treatments Together video for a helpful overview: https://t.co/oHS2hYpiXO

— Lilly Trials (@LillyTrials) August 28, 2020

#DYK: Lilly helped pioneer the modern age of antibiotics, beginning by manufacturing penicillin-G during World War II. Our work didn't stop there, and we are committed to bringing new medicines to the next decade: https://t.co/WG3fm6cI1v

— Lilly Trials (@LillyTrials) August 27, 2020

Greater diversity in clinical trials ensures #COVID19 treatments help diverse populations most at risk. It's crucial to reduce barriers to entry & include more minorities in research. New @politico from our chief medical and diversity officers: https://t.co/tVEaZp2PYN #WeAreLilly

— Lilly Trials (@LillyTrials) July 21, 2020

NEW BLOG: Lilly is testing the safety and efficacy of three different antibodies that may provide future options for medical care of #COVID19 patients. Learn more in our blog by Lilly's Chief Scientific Officer Dan Skovronsky: https://t.co/v2x7whj86F

— Lilly Trials (@LillyTrials) June 23, 2020

DYK 1.5 million people experience a heart attack annually in the U.S. The @US_FDA Fast Track designation for the investigation of our medicine with @boehringerus highlights the unmet needs in adults who have had a heart attack.

More information: https://t.co/XcpAwR4IJW pic.twitter.com/biKyXpc5P9

— Lilly Diabetes (@LillyDiabetes) September 15, 2020

#News: @US_FDA approved two additional doses of our #T2D medicine, providing a new option for those with evolving treatment needs. Learn more: https://t.co/gvXYsgHdYE pic.twitter.com/WUhCHGhrsA

— Lilly Diabetes (@LillyDiabetes) September 3, 2020

We’re pleased to share full results from our phase III study in adults with #HFrEF at #ESCcongress 2020 with @boehringerus. We're committed to advancing knowledge for those with #heartfailure, the leading cause of hospitalization in the U.S. Learn more: https://t.co/XiATX9R3pF pic.twitter.com/Mv4IdGS4U2

— Lilly Diabetes (@LillyDiabetes) August 29, 2020

In partnership with @boehringerus, we’re pleased to announce that our phase III study in adults with #heartfailure met its primary endpoint. With the 6.5 million adults in the U.S. affected by heart failure, we are thrilled by these positive results. https://t.co/qvWgNHomc0 pic.twitter.com/R9M008r25e

— Lilly Diabetes (@LillyDiabetes) July 30, 2020

Today, we announced the launch of Know Before the Low. The campaign aims to raise awareness about #lowbloodsugar and very low blood sugar emergencies, and encourage people with #diabetes to be prepared. Check out our Know Before the Low resources. https://t.co/vcTm6OaRMi

— Lilly Diabetes (@LillyDiabetes) June 24, 2020

We are advancing our commitment to #diabetes care with the @US_FDA approval of our new rapid-acting mealtime insulin for adults with #type1diabetes and #type2diabetes. Learn more: https://t.co/PpwQa8yac9 pic.twitter.com/Umm4aNXNH5

— Lilly Diabetes (@LillyDiabetes) June 16, 2020

This morning Project HOPE delivered 18,520 respirator masks & 20,000 surgical masks to @PGCountyOEM and @PGCCommunity! Thank you @LillyPad for donating these lifesaving supplies so we could help frontline health workers in Maryland. #COVID19 pic.twitter.com/dAzEYxZISp

— Project HOPE (@projecthopeorg) June 11, 2020

Congratulations to Christopher Otto & Dr. Janelle Sabo from @LillyPad. They helped develop Indiana’s largest COVID-19 reference lab and the state’s largest drive-through testing facility: https://t.co/ktvXugDpC8 pic.twitter.com/t7ghajXMg0

— We Work For Health (@weworkforhealth) September 8, 2020

New York Vol.36 (corporations: Bristol Myers Squibb)

How might brain volume loss impact #MultipleSclerosis patients? During #MSVirtual2020, learn more about the relationship between MS and the brain.

— Bristol Myers Squibb (@bmsnews) September 11, 2020

#MEDIA: Learn how we’re accelerating progress across cancers with high unmet needs through our upcoming presentations at this year’s #ESMO20 congress. https://t.co/FMk23QXxgz pic.twitter.com/Gur4aqi9hz

— Bristol Myers Squibb (@bmsnews) September 8, 2020

Genetic abnormalities can silence genes that usually suppress tumors in the body, which can lead to the development of different cancers. Research around gene modifying therapies may play a role in identifying new potential #cancer treatments.

— Bristol Myers Squibb (@bmsnews) September 3, 2020

In acute myeloid #leukemia, if patients achieve remission, their odds of long-term survival are typically low, fueling our research for new options that may extend patients' overall survival.

— Bristol Myers Squibb (@bmsnews) September 2, 2020

Every 3 minutes, someone in the U.S. is diagnosed with a #bloodcancer. During #BloodCancerAwarenessMonth, we’ll be shining a spotlight each week on our advocacy partners who support people with a form of the disease. #BMSBloodCancerRelay

— Bristol Myers Squibb (@bmsnews) September 1, 2020

Answer: Low blood pressure is not a risk factor for #NASH. Learn more about NASH during #ILC2020: https://t.co/6llwmBCAMk pic.twitter.com/OBpJubhSSJ

— Bristol Myers Squibb (@bmsnews) August 28, 2020

Our Chief Medical Officer, Global Drug Development, Samit Hirawat shares how BMS helped patients overcome barriers to clinical trial participation and advanced its pipeline amid the global pandemic.

— Bristol Myers Squibb (@bmsnews) August 27, 2020

CEO Giovanni Caforio, PhRMA chair, recognizes We Work for Health Champions and all members of the industry’s workforce for their round-the-clock work during #COVID19. https://t.co/Ok7iTteA9w

— Bristol Myers Squibb (@bmsnews) August 27, 2020

With Bristol Myers Squibb Foundation support, 200+ volunteers with @montclairstateu Shield Our Heroes produced over 30k face shields for health facilities in New Jersey during #COVID19.

— Bristol Myers Squibb (@bmsnews) August 18, 2020

#DYK a #mesothelioma prognosis varies based on what type of cell is involved? See how research aims to uncover new possibilities for all patients with malignant pleural #mesothelioma.

— Bristol Myers Squibb (@bmsnews) August 8, 2020

Announcing our Q2 2020 results, including revenues of $10.1 billion, GAAP loss per share of $0.04 and non-GAAP earnings per share of $1.63. Read our press release here: https://t.co/HfCyqsbpuP pic.twitter.com/KxquLld1Bv

— Bristol Myers Squibb (@bmsnews) August 6, 2020

#MEDIA: #EMA validates application for our #celltherapy for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma, primary mediastinal B-cell lymphoma and follicular lymphoma grade 3B https://t.co/6YuWdKEk0r pic.twitter.com/9sbjRJg53Q

— Bristol Myers Squibb (@bmsnews) July 17, 2020

CEO Giovanni Caforio, PhRMA chair, sees great progress for cancer patients and important medical advances while viewing inevitable setbacks as an opportunity to learn more in the fight against cancer. https://t.co/dfQwQeWuCv

— Bristol Myers Squibb (@bmsnews) July 16, 2020

Our Occupational Health Lead David Shepperly oversees the well-being of 30k colleagues worldwide, part of a team coordinating our #COVID19 efforts to protect our workforce to ensure we can continue to deliver medicines to our patients. https://t.co/hjteUuHLkb via @BW

— Bristol Myers Squibb (@bmsnews) July 15, 2020

Will the pharmaceutical industry keep collaborating after COVID-19? Novartis and Bristol Myers Squibb CEOs say it has to https://t.co/2d4dBMRjv5

— Bristol Myers Squibb (@bmsnews) July 8, 2020

Curious about how the #biopharma industry is adapting in the face of COVID-19? Read this article from @business on the rise of digital engagements. https://t.co/h7zE9XNW5U

— Bristol Myers Squibb (@bmsnews) June 15, 2020

Did you know that non-alcoholic steatohepatitis (#NASH) can lead to scarring of the liver called cirrhosis? On International #NASHDay, learn about this #liverdisease and see why investigating potential new treatment options is so important.

— Bristol Myers Squibb (@bmsnews) June 12, 2020

Strategic alliances are key to achieving our goal to discover, develop and deliver transformational medicines to patients. Learn more about why we partner. #BIODigital

— Bristol Myers Squibb (@bmsnews) June 10, 2020

Our CEO, Giovanni Caforio, discusses the value of collaboration and shares why he is optimistic about the future of medical research. https://t.co/RXnNMLNRBC

— Bristol Myers Squibb (@bmsnews) June 10, 2020

#DYK that #renalcellcarcinoma, the most common type of kidney cancer, is twice as common in men as it is in women?

— Bristol Myers Squibb (@bmsnews) September 17, 2020

#MEDIA: Announcing positive four-year survival data from our Phase 3 dual immunotherapy trial in previously untreated or metastatic #renalcellcarcinoma #ESMO20 https://t.co/IQkEwsJk9R pic.twitter.com/RWnyni0FX5

— Bristol Myers Squibb (@bmsnews) September 17, 2020

#AFibAwarenessMonth is the perfect opportunity to take a moment to hear what leaders from @HeartNurses want people to know about #AFib and stroke risk #AMatterofMoments

— Bristol Myers Squibb (@bmsnews) September 16, 2020

During #BloodCancerAwarenessMonth, we recognize World Lymphoma Awareness Day with a world of thanks to @LLSUsa, @knowyournodes, & @lymphoma for the important role they play in supporting people with #lymphoma #BMSBloodCancerRelay #WLAD2020

— Bristol Myers Squibb (@bmsnews) September 15, 2020

#Mesothelioma is a challenging disease with limited treatment options. By driving research advancements, we’re working to introduce potential innovations for patients.

— Bristol Myers Squibb (@bmsnews) September 15, 2020

Learn more about how #MultipleSclerosis affects patients to better understand our focus on the MS community. #MSVirtual2020

— Bristol Myers Squibb (@bmsnews) September 13, 2020

On the one-year anniversary of Business Roundtable’s Statement of Purpose of a Corporation, CEO Giovanni Caforio reflects on how to build a better, healthier world.#WorkingTogetherForPatients https://t.co/zDjPCKmIfM

— Bristol Myers Squibb (@bmsnews) September 11, 2020

We must work together to fight #healthdisparities. Read our CEO Giovanni Caforio’s message: https://t.co/HryPhTqds6 pic.twitter.com/9vA445WmeS

— Bristol Myers Squibb (@bmsnews) September 10, 2020

AFib is a type of irregular heartbeat that increases risk of stroke by up to 5x. Susan Bush from @HeartNurses highlights the importance of #AFib awareness. #AFibAwarenessMonth

— Bristol Myers Squibb (@bmsnews) September 4, 2020

#MEDIA: Announcing #FDA approval of a new therapy for people with acute myeloid #leukemia

— Bristol Myers Squibb (@bmsnews) September 1, 2020

#MEDIA: At #MSVirtual2020, interim results from our long-term Phase 3 study in patients with relapsing forms of #MultipleSclerosis will be featured, as well as data from 14 other company-sponsored and collaborative studies https://t.co/CCze5fRJjm pic.twitter.com/acIv5xSQB6

— Bristol Myers Squibb (@bmsnews) September 1, 2020

We’re glad to be part of the thriving #lifesciencesecosystem in Washington State. Hear our own Al Terry and Nathan Martin describe what it’s like to work for BMS in the Seattle area. https://t.co/cv8fvkRsVg #Biotechnology #FindYourBestLifeinWA pic.twitter.com/VO9QASPBN7

— Bristol Myers Squibb (@bmsnews) August 31, 2020

We’re looking forward to what our team will accomplish at our new combined @CXCambridge site. https://t.co/zpWAi7vD0L

— Bristol Myers Squibb (@bmsnews) August 26, 2020

Our acquisition of @Forbius_ will aid in our important work of developing new solutions for immunotherapy resistance in #cancer patients and addressing unmet medical needs. https://t.co/XahcaWRCR2 pic.twitter.com/CEpPmxCabS

— Bristol Myers Squibb (@bmsnews) August 24, 2020

Last week, we announced a $300 million commitment to accelerate #healthequity and #diversity & inclusion efforts. Join us this week as we share more on the 5 focus areas. (1/6) pic.twitter.com/BBtxpO5IAX

— Bristol Myers Squibb (@bmsnews) August 17, 2020

#MEDIA: Announcing exclusive global license with @dragonflytx for investigational #immunotherapy program. https://t.co/te2i96CRth pic.twitter.com/99okjVgzLC

— Bristol Myers Squibb (@bmsnews) August 17, 2020

“Now more than ever, we recognize our role in creating the change needed to address health disparities and racial inequality.” Our CEO Giovanni Caforio shares with the BMS community on today's announcement.

— Bristol Myers Squibb (@bmsnews) August 12, 2020

#MEDIA: Announcing positive results from our Phase 3 trial in first-line gastric and esophageal #cancers https://t.co/zec80j0dN1 pic.twitter.com/81QBAhTkFx

— Bristol Myers Squibb (@bmsnews) August 11, 2020

Hear from our Robert Plenge about the #biopharma industry’s response to #COVID19, in conversation with @ldtimmerman at @AtlanticLIVE #AtlanticPULSE.

— Bristol Myers Squibb (@bmsnews) July 31, 2020

Announcing that our Board has elected two new independent directors. Paula A. Price (l) and Derica W. Rice (r) will join the Board, effective September 1, 2020. Read our press release here: https://t.co/6tP5TMeQsg pic.twitter.com/Fkjx9SFtAk

— Bristol Myers Squibb (@bmsnews) July 30, 2020

“I give COVID as much respect as cancer.” – Donna speaks with @SterlingKBrown about what it’s like to live with #multiplemyeloma during COVID-19.

— Bristol Myers Squibb (@bmsnews) July 28, 2020

Our Chief Human Resources Officer Ann Powell takes part in a virtual panel today at the @DisabilityIN Annual Conference to discuss how we foster a culture that promotes the value of differently-abled individuals. https://t.co/PyjaXslJvv #DisabilityAdvantage pic.twitter.com/vEKSZuYgoB

— Bristol Myers Squibb (@bmsnews) July 16, 2020

Furthering our longstanding support of @SU2C, our recent grant commitment will better help identify diagnostic & treatment methods for #lungcancer patients in need.

— Bristol Myers Squibb (@bmsnews) July 16, 2020

We’re proud to partner with @LupusResearch on the first LRA-BMS Accelerator Award, supporting cutting-edge research to help advance scientific understanding and potential new treatment approaches for this complex disease.

— Bristol Myers Squibb (@bmsnews) July 15, 2020

We are pleased to help @CISCRP bridge communication and expand education in the importance of diversity in #clinicaltrials. https://t.co/hRWeHtK9pH

— Bristol Myers Squibb (@bmsnews) July 14, 2020

We are committed to reducing cancer risk for our colleagues and their families as well as patients so we’re honored to receive Global CEO Cancer Gold Standard™ accreditation in recognition of our efforts. https://t.co/LQYHakvJOH pic.twitter.com/pPJZDeqFvz

— Bristol Myers Squibb (@bmsnews) July 13, 2020

Thank you @CEOCancerfight for recognizing our commitment to the health and safety of our colleagues. https://t.co/z1kVgPLMv2

— Bristol Myers Squibb (@bmsnews) July 13, 2020

We are excited to be part of industry-wide efforts to defeat #COVID19. Learn more about the unprecedented ways biopharmaceutical companies are working together in this latest video from @PhRMA: https://t.co/ZpDG6iCdf2

— Bristol Myers Squibb (@bmsnews) June 29, 2020

#MEDIA: European Commission approves our treatment for patients with #MDS or #betathalassemia https://t.co/PtFXKoUaoJ pic.twitter.com/FMkX8394TH

— Bristol Myers Squibb (@bmsnews) June 26, 2020

Sharon Cload, our vice president of Discovery and Biotherapeutics, East Coast, looks forward to serving on the @MassBio Board of Directors to help advance Massachusetts’ leadership in the #lifesciences. https://t.co/BdZlY3vefR

— Bristol Myers Squibb (@bmsnews) June 26, 2020

Working with @GRYTHealth we’ve launched a virtual meeting place for patient advocacy organizations. Our head of Corporate Affairs, Kathryn Metcalfe, shares more. #AdvocacyExchange https://t.co/she8Jq2sY0

— Bristol Myers Squibb (@bmsnews) June 25, 2020

Ensuring all #cancer patients have access to quality care is our priority. To help improve cancer care in disadvantaged communities & direct funding to black & minority cancer researchers, we’re providing a $1m grant to @TheVFoundation Stuart Scott Memorial Cancer Research Fund. pic.twitter.com/oYaOLi9jl6

— Bristol Myers Squibb (@bmsnews) June 22, 2020

Even after #WorldBloodDonorDay, we thank blood donors for their life-saving contributions. https://t.co/3pBWlvXine

— Bristol Myers Squibb (@bmsnews) June 16, 2020

Blood cancer patients need our help now more than ever. This Blood Cancer Awareness Month, let's unite to #CancelBloodCancer. Learn more >> https://t.co/66WeCWbDaD pic.twitter.com/piYf02bKUe

— The Leukemia & Lymphoma Society (@LLSusa) September 1, 2020

https://twitter.com/CALifeSciences/status/1293939487957975042

In a huge step towards improving ED&I in the #LifeSciences, @bmsnews announced that it will commit $300 million over the next 5 years to tackle racial health disparities & accelerate its D&I efforts. Learn more: https://t.co/fhFMY2Ks6G

— MassBio (@MassBio) August 12, 2020

Diversity is long overdue in the drug industry—and it’s going to take more than just hiring Black candidates https://t.co/0ao0YWE3yJ

— FORTUNE (@FortuneMagazine) August 12, 2020

Bristol Myers Squibb commits to $300 million to combating racial inequity https://t.co/7pLrOPtgwK

— Endpoints News (@endpts) August 12, 2020

This year’s Virtual #WalkToCureArthritis was a huge success, thanks in part to our amazing, supportive #sponsors! Read more about the partners who helped us succeed during this #pandemic: https://t.co/KwH1awxXWh. #arthritis #COVID19 #coronavirus #WeLiveYes pic.twitter.com/s5ynf71MjH

— Arthritis Foundation (@ArthritisFdn) July 11, 2020

https://twitter.com/HHPHorg/status/1278386387968983046

Proud to join my @phrma colleagues in this video series that covers how the biopharmaceutical industry is working to develop safe and effective #COVID19 vaccines https://t.co/h5SpbUAzbf

— Stephen J. Ubl (@steveubl) June 29, 2020

Bristol Myers CEO Caforio on coronavirus R&D: Let's make it a 'new standard for collaboration' https://t.co/8e5kKArNSo

— FiercePharma (@FiercePharma) June 10, 2020

Lymphomas are categorized into 2 main types: Hodgkin #lymphoma or non-Hodgkin lymphoma (NHL). #DYK NHL is more common than Hodgkin lymphoma, with 7 times more case expected by 2040 #WLAD2020

— Science At BMS (@ScienceAtBMS) September 17, 2020

Myelofibrosis is a rare bone marrow cancer in which bone marrow cells that produce the blood cells develop and function abnormally. The JAK2 gene is present in more than half of these patients. #BloodCancerAwarenessMonth

— Science At BMS (@ScienceAtBMS) September 9, 2020

Learn about how deepening our understanding of the relationship between HSP47 and #fibrosis guides our research for patients with fibrotic diseases during #ILC2020.

— Science At BMS (@ScienceAtBMS) August 29, 2020

As a potential biomarker of #liverfibrosis disease activity, PRO-C3 may help us better identify and address unmet needs in #NASH. #ILC2020

— Science At BMS (@ScienceAtBMS) August 27, 2020

Gastroesophageal junction (GEJ) #cancer is an aggressive tumor that forms in the area of the digestive tract where the esophagus and stomach connect.

— Science At BMS (@ScienceAtBMS) August 12, 2020

During #ISTH2020, learn about the potential complications cancer patients can experience, including venous thromboembolism (VTE)

— Science At BMS (@ScienceAtBMS) July 10, 2020

#DYK red blood cells don’t mature properly in #MDS and targeting different stages of their maturation may lead to much-needed new treatment options for patients?

— Science At BMS (@ScienceAtBMS) June 29, 2020

Red blood cell transfusions are a cornerstone of treatment for #anemia caused by a variety of blood disorders. Frequent transfusions can burden patients, hospitals and healthcare systems.

— Science At BMS (@ScienceAtBMS) June 28, 2020

#DYK #betathalassemia can lead to the production of fewer healthy red blood cells and the development of varying degrees of #anemia?

— Science At BMS (@ScienceAtBMS) June 27, 2020

Frequent blood transfusions used to treat #MDS #anemia can be associated with an increased risk of iron overload, transfusion reactions and infections.

— Science At BMS (@ScienceAtBMS) June 26, 2020

How are researchers thinking about the next generation of CTLA-4 inhibition? Learn from our Lee James about how we’re building on today’s science to research tomorrow’s medicines. #AACR20

— Science At BMS (@ScienceAtBMS) June 21, 2020

Illinois Vol.11 (corporations: AbbVie)

To our patients, health care providers, partners, shareholders and communities – read AbbVie CEO Rick Gonzalez’s letter to employees about our commitment to racial equality and justice. https://t.co/u9EOnqPokR @eji_org @NAACP_LDF #EnoughIsEnough pic.twitter.com/S6GOqkVq0k

— AbbVie (@abbvie) June 16, 2020

Working parents are heroes and this year proves it. Read why @_workingmother_ said we’re one of its 100 Best Companies: https://t.co/KEIJEcujhV #WM100Best

— AbbVie (@abbvie) September 15, 2020

How do we #CareForAtopicEczema? We push the boundaries of science every day in #dermatology: https://t.co/8NIfcmWtzs #AtopicEczemaDay pic.twitter.com/tF1jXULwTc

— AbbVie (@abbvie) September 15, 2020

The #MDSCongress is underway, and we’re sharing our commitment to patients with movement disorders like #Parkinsons and post-stroke #spasticity. Learn more about our efforts: https://t.co/S2aCkEcG7U pic.twitter.com/8uoNVDM81s

— AbbVie (@abbvie) September 14, 2020

In honor of #BloodCancerAwarenessMonth read about our collaborations and advancements in oncology: https://t.co/a4P6L4vtub pic.twitter.com/14wBWvQJI5

— AbbVie (@abbvie) September 14, 2020

#AtopicDermatitis goes beyond physical symptoms like itchy skin. Learn about the psychological and emotional impact of this condition: https://t.co/sChDgaBFFB #AtopicEczemaDay pic.twitter.com/AILnQGtsN1

— AbbVie (@abbvie) September 14, 2020

#MigraineAwarenessWeek ends today, but our commitment to #chronicmigraine patients continues. Read how #COVID19 has disrupted care for some patients but not our dedication to them: https://t.co/MUH17Xou6v pic.twitter.com/f8iK8wwxbb

— AbbVie (@abbvie) September 12, 2020

As this year’s #MDSCongress begins, we’re shining a light on our partner @euparkinsons for its efforts to help people with #Parkinsons. Learn more: https://t.co/pJNm76Z1ne #EPDA @movedisorder pic.twitter.com/PilDZu6w43

— AbbVie (@abbvie) September 12, 2020

#AtopicDermatitis is a disease that impacts all ages around the world. This #AtopicEczemaDay, we’re joining @IADPO and @EFA_Patients in raising awareness about this complex condition. pic.twitter.com/o76RcLiFhu

— AbbVie (@abbvie) September 11, 2020

Globally, more than 1.85 million cases of blood cancer are expected to be diagnosed in 2040. That’s why our pursuit to discover advances in patient care never stops. Learn more: https://t.co/Ujqy5cug3b #BloodCancerAwarenessMonth pic.twitter.com/c8zzUuyx5m

— AbbVie (@abbvie) September 8, 2020

This #MigraineAwarenessWeek, learn how we’re advancing research to help those affected by the realities of neurologic disorders like #migraine: https://t.co/CGDr0gdRIu pic.twitter.com/X9zQQvENsl

— AbbVie (@abbvie) September 6, 2020

What happens when you mix good news with a little bit of fun? Some very excited employees learning their children won an AbbVie Possibilities Scholarship. Watch: #AbbVieLife #FridayFeeling pic.twitter.com/O50b3nuGqj

— AbbVie (@abbvie) September 4, 2020

How is #COVID19 affecting #biopharmaceutical collaboration? Mike Severino, Vice Chairman and President, joined @BioCentury to discuss our short and long-term partnership strategy. Watch the full panel: https://t.co/8swsvzaHoU pic.twitter.com/iIq1d8O76Z

— AbbVie (@abbvie) September 3, 2020

From remote working to our #COVID19 Resilience Fund to volunteering on the frontlines, we’re focused on the health of our employees, communities & patients. Thanks for including us @people & @GPTW_US. #50CompaniesCare https://t.co/cTa7lsJHNy

— AbbVie (@abbvie) September 2, 2020

Men are three times as likely to be affected by #AnkylosingSpondylitis. Get to know the signs and symptoms. https://t.co/7gLq8nJP3e pic.twitter.com/izeGpgoTx8

— AbbVie (@abbvie) September 2, 2020

This #WorldAlzMonth, we’re supporting #Alzheimers patients and caregivers like Jim and Lisa, who experience new challenges every day from this #neurodegenerative disease. Learn more: https://t.co/JQNTXeFr1P pic.twitter.com/mVKChzDWsW

— AbbVie (@abbvie) September 1, 2020

While there is more progress to be made towards #HCV elimination, we can work together to achieve @WHO’s 2030 goal. https://t.co/FkCbGZY0IM

— AbbVie (@abbvie) August 31, 2020

Digital #ILC2020 may be over but our work to eliminate #HCV doesn’t stop here. Read about our commitment to the HCV community: https://t.co/3QgoT9b9bA pic.twitter.com/hvAN09pSJU

— AbbVie (@abbvie) August 30, 2020

Are most countries on track to eliminate #HCV by 2030? Today during Digital #ILC2020, we’re presenting data on the timing of HCV elimination in 45 high-income countries. Learn more: https://t.co/O4BTfTvWdC pic.twitter.com/jvtfXJ7Hlw

— AbbVie (@abbvie) August 29, 2020

RT @AbbVieUS: If you need help with lost or damaged AbbVie medicines following #HurricaneLaura or due to the #CaliforniaWildfires, please call 800-633-9110 so we can help. See full list of AbbVie medicines: https://t.co/WtRj0JcSvy pic.twitter.com/bPAGXwXzTr

— AbbVie (@abbvie) August 28, 2020

Our work to eliminate #HCV is now more important than ever as we continue to navigate #COVID19. https://t.co/lK8240NZDw

— AbbVie (@abbvie) August 27, 2020

What disease causes chronic, progressive, inflammatory musculoskeletal symptoms that can impact daily life? #AnkylosingSpondylitis. https://t.co/t8px0UMbjK pic.twitter.com/5giCw6smfN

— AbbVie (@abbvie) August 27, 2020

He once sailed around the world in a tall ship. Today, our VP of #discovery Jose-Carlos Gutiérrez-Ramos has his sights on advancing our pipeline of medicines. Learn more: https://t.co/DubP2LqS4D pic.twitter.com/RCMfCxjwio

— AbbVie (@abbvie) August 26, 2020

BREAKING: We announced our @US_FDA submission in #ankylosingspondylitis. Get the latest: https://t.co/JkwZGpEAns pic.twitter.com/VpQFYbvu4c

— AbbVie (@abbvie) August 25, 2020

Chemical reactions are an essential part of developing treatments, and the process is getting greener. Hear from Wilfried Braje, senior principal scientist, about how we’re harnessing micellar #chemistry in our research: https://t.co/lPns1I6WBS @cenmag #greenchemistry

— AbbVie (@abbvie) August 14, 2020

In four short years, the #HCV community has made strides in the fight against hepatitis C. We may still have a lot to accomplish, but learn more about what has been achieved so far: https://t.co/u6E43zF7W7 pic.twitter.com/vzstQtahZv

— AbbVie (@abbvie) August 14, 2020

Hear Chairman & CEO Richard Gonzalez discuss driving #innovation in the #aesthetics field and the impact of our acquisition of Allergan with @DrGrantStevens : https://t.co/eLW7vEuXaU pic.twitter.com/XItiaNLqhM

— AbbVie (@abbvie) August 13, 2020

Results of a Phase 3 study in acute myeloid leukemia (AML) have been published in @NEJM. Read more: https://t.co/fQeM43m8fN pic.twitter.com/3L9NLNccL0

— AbbVie (@abbvie) August 12, 2020

Congratulations to #genetics researcher Howard Jacob for being recognized as a ‘Change Agent’ on this year’s #PharmaVOICE100. Take a look: https://t.co/tWdiHq2fuF @PharmaVOICE pic.twitter.com/UAmITAsoWM

— AbbVie (@abbvie) August 12, 2020

What makes #remotework teams successful? Christo Kruger, who heads up our business intelligence, explains via @Forbes: https://t.co/oI81gFTE5R #WFH

— AbbVie (@abbvie) August 7, 2020

https://twitter.com/abbvie/status/1291750228941516800

To truly achieve #HCV elimination, we need to think small. Each country around the world can make an impact, which is why we’re working closely with our local partners. Hear from Professor Juozas Kupcinskas on what elimination means to him: pic.twitter.com/Qsbw0h3XUB

— AbbVie (@abbvie) August 5, 2020

Black and Latinx communities have been hit especially hard by #COVID19. @IMC_Worldwide built 20 new emergency medical field units to increase capacity where it was needed most. Learn how our partnership made this possible: https://t.co/bqu7Qi9vBU #AbbVieGivesBack pic.twitter.com/bp0Vqo1jPH

— AbbVie (@abbvie) August 4, 2020

In partnership with @Amgen and @TakedaPharma, and as members of the COVID R&D Alliance, we’re announcing the first patients enrolled in the I-SPY COVID clinical trial in search of therapy candidates for #COVID19. Learn more: https://t.co/pntELOdU4I pic.twitter.com/g0Ju0I3RvQ

— AbbVie (@abbvie) August 3, 2020

A lifelong love of reptiles turned into a career researching #Alzheimers and #Parkinsons. Learn more about our neuroscientist Samantha Brecht (& her blue-tongued skink named Scaleycat): https://t.co/b138gx4O0S #ScientistsRock pic.twitter.com/vCjW0qNKgL

— AbbVie (@abbvie) August 1, 2020

A healthy and #sustainable world for our patients, families, communities and future generations – that's our priority. Read about our impact in our 2019 Responsible Action Report. https://t.co/e4JknGUW4H #AbbVieGivesBack pic.twitter.com/7eMLGDPoIg

— AbbVie (@abbvie) July 31, 2020

#WorldHepatitisDay may be over, but partnership in the fight to eliminate #HCV remains essential. Hear Professor Ieva Tolmane explain why HCV elimination isn’t possible without collaboration: pic.twitter.com/GcukuQd9Q5

— AbbVie (@abbvie) July 30, 2020

Once a professional rower, our scientist Samantha Brecht is now intent on achieving strokes of genius in the uncharted waters of #neuroscience. Read how: https://t.co/XWCO39Z8ss #ScientistsRock pic.twitter.com/FpGvRDW5ir

— AbbVie (@abbvie) July 28, 2020

New results from the third Phase 3 study on our investigational #dermatology treatment were just announced. Discover the latest: https://t.co/WdvXYc4leU pic.twitter.com/YwxRSUy6po

— AbbVie (@abbvie) July 28, 2020

Are data scientists really scientists? Chemist turned #datascience leader Phil Hajduk shared his perspective in a Q&A with CIO Mike Carlin: https://t.co/S4YV7tOUhn pic.twitter.com/xvSpmt827V

— AbbVie (@abbvie) July 17, 2020

BREAKING: Our research alliance with @harvardmed and @HarvardTechXfer will study and develop novel therapies against emergent #viral diseases to help prepare against future outbreaks, with a focus on #coronaviruses. More: https://t.co/24lWGfFl9R pic.twitter.com/UcBOtAJEzR

— AbbVie (@abbvie) August 25, 2020

Harvard Medical School and biopharmaceutical company AbbVie will launch a $30 million research alliance to combat viral infections, like the novel coronavirus tied, through the study and development of new therapies, the University announced Tuesday. https://t.co/LRLiFoliRL

— The Harvard Crimson (@thecrimson) August 26, 2020

https://twitter.com/LeukaemiaCareUK/status/1305870761886916608

#Atopic #Eczema is a genetic skin problem caused by a defect in the skin barrier. Food allergies may trigger flareups & make symptoms worse, but foods aren't the primary cause of atopic eczema. Learn more today on #AtopicEczemaDay at https://t.co/tzN3blF4CR #CareForAtopicEczema

— IrishSkin.ie (@ISFcharity) September 14, 2020

Thanks @AbbVie for being our national strategic partner! Your support is making a difference every day for students across the U.S. Learn more about our work together from City Year’s new digital annual report: https://t.co/lRORRS6KGg

#EdEquity

— CityYear (@CityYear) September 2, 2020

Announcing our Helix 51 biomedical incubator has gained support from AbbVie. The incubator and our new Innovation and Research Park are an investment in affordable, state-of-the-art wet lab space critical to a healthier future. https://t.co/vF3xDv8bps pic.twitter.com/3kblBnjLXE

— Rosalind Franklin U (@RFUniversity) July 23, 2020

We not only develop medicines, we help make sure patients can get them. Learn more about myAbbVie Assist and see if you’re eligible. https://t.co/51Sv66FP6z pic.twitter.com/520OV9zKBm

— AbbVie US (@AbbVieUS) September 1, 2020

Stress can be a factor in #IBD flare-ups. Check out these tips on ways to manage your #Crohns or #Colitis stress levels and be sure to talk to your doctor about it at your next appointment. https://t.co/YHUf7F2rHE pic.twitter.com/34WO0tymul

— AbbVie US (@AbbVieUS) September 15, 2020

#Psoriasis is a chronic, inflammatory condition that may occur at the same time as other diseases. Learn more about the symptoms of these diseases and speak with your doctor: https://t.co/biohRSsQH4 pic.twitter.com/ORrvHLGu3d

— AbbVie US (@AbbVieUS) September 12, 2020

https://twitter.com/AbbVieUS/status/1303790425614905344

If you have been diagnosed with #endometriosis, it may be helpful to hear from other people with endo and learn how to be an advocate for yourself and others: https://t.co/IU3ZvEtINb #SpeakENDO pic.twitter.com/YjgwrbS2M7

— AbbVie US (@AbbVieUS) September 9, 2020

Tim Richmond leads @abbvie ’s global human resources function, focused on employee engagement and driving business performance through culture.

Learn about the 5 pillars of what AbbVie call the “Ways We Work.” https://t.co/PcsZHodXAU pic.twitter.com/sJZnT18lLn

— Great Place to Work US (@GPTW_US) September 1, 2020

Illinois is where we call home – and @Forbes added us to their 2020 list of Best Employers here: https://t.co/iZAa7IoTMG

— AbbVie US (@AbbVieUS) August 27, 2020

This #TerryFoxDay marks the 40th anniversary of the #MarathonOfHope. Hats off to those helping to outrun #cancer with @TerryFoxCanada. https://t.co/5cCsAxZj3l

— AbbVie Canada (@abbviecanada) September 15, 2020

Many Canadians suffer from #atopicdermatitis, the most common type of #eczema. We need to do more to raise awareness. There is no rest from thinking about ezcema. #AtopicEczemaDay @IADPO @EczemaSocietyCA pic.twitter.com/F5sb63PHJi

— AbbVie Canada (@abbviecanada) September 14, 2020

#FACT: #CLL stands for Chronic Lymphocytic #Leukemia @LymphomaCanada @LLSCanada #bloodcancerawarenessmonth pic.twitter.com/UuKKwqY5CR

— AbbVie Canada (@abbviecanada) September 10, 2020

There are two kinds of back #pain: mechanical and inflammatory. #Ankylosingspondylitis is an autoimmune disease affecting the spine. Learn more": https://t.co/8wRqSnVdOr #arthritis pic.twitter.com/IiJWd4CW6d

— AbbVie Canada (@abbviecanada) September 7, 2020

https://twitter.com/abbvieuk/status/1305423560022863872

This #RAAwarenessWeek it is more important than ever to talk about emotional and physical wellbeing. Being open about the true impact of #RheumatoidArthritis is an important step in getting the right care and support. Teresa shares her RA story here:#RAAW2020

— AbbVie UK (@abbvieuk) September 12, 2020

It’s Blood Cancer Awareness Month and we’re partnering with @LeukaemiaAus to help break down barriers that stand before people with blood cancer.

To find out more, go to https://t.co/7Amss8SCh9 #breakingbarriers #BloodCancerAwarenessMonth #bloodcancer pic.twitter.com/qB9xNQcs7S

— AbbVie Australia (@AbbVie_AU) September 8, 2020

https://twitter.com/AbbVie_AU/status/1300697441533124608

#strokeweek2020 (Aug 31-Sept 6) and @strokefdn is urging Australians to become FAST heroes – anyone who can help save a life by simply knowing how to recognise the FAST (Face. Arms. Speech and Time) signs of stroke. Read about our own FAST hero Edwina: https://t.co/I9UQbkaeDe

— AbbVie Australia (@AbbVie_AU) August 31, 2020

AbbVie recognises the value in supporting individuals with true workplace flexibility. But don't take our word for it. Hear how AbbVie has made this a reality for Edwina and her family. #GPTW50 #BPTW20 https://t.co/cGNAUhXUSZ via @Sthn_Hland_News

— AbbVie Australia (@AbbVie_AU) July 29, 2020

Today is World Hepatitis Day. Listen to Kiah’s journey through hepatitis C and why being tested is important to “Finding the Missing Millions”. #LetsTalkHep @hepatitis_nsw @hepvic @hepatitisqueensland @kombiclinichttps://t.co/yTNrIlfUYd

— AbbVie Australia (@AbbVie_AU) July 28, 2020

Leukemia is cancer of the body's blood-forming tissues, including the bone marrow and the lymphatic system. There are a number of types of leukaemia.

Learn about the different forms of leukaemia here: https://t.co/J7ZmOAja5z

For more information, talk to your doctor. @LBCNZ pic.twitter.com/62ye1wzhFE

— AbbVie New Zealand (@AbbVie_NZ) September 1, 2020

Access to hep C treatments has improved over the last 3 years, helping to eliminate the disease. Despite this, there’s still a long road ahead if New Zealand wants to help achieve the WHO hep C elimination target by 2030.

For further info, visit @HepFoundationNZ or talk to a GP. pic.twitter.com/VR07bZxFHu

— AbbVie New Zealand (@AbbVie_NZ) October 21, 2019

In this industry, nothing is more important than assuring patient safety through a well-designed #QualitySystem. A robust system should consider every aspect of the #DrugDevelopment and manufacturing process to deliver a safe and efficacious product. https://t.co/kcW5skZPTv pic.twitter.com/4O5BQeWi5O

— AbbVie Contract Mfg (@AbbVieCM) September 14, 2020

#Lyophilization ensures drug stability, delivers an extended shelf-life, and enables long-term storage at room temperature. It is a pivotal operation in the manufacturing of unstable #BiologicDrugProducts https://t.co/0TN9vTdNfg pic.twitter.com/WhG5IBQ5Ge

— AbbVie Contract Mfg (@AbbVieCM) September 11, 2020

Why settle for an ASD process that limits your efficiency and extends project timelines?

Secure the flexibility you need while improving your drug solubility and bioavailability with hot melt extrusion (HME) https://t.co/L6OI7crIeR #SprayDrying #HME #ASD #Flexibility pic.twitter.com/wPU3BZ5gMg

— AbbVie Contract Mfg (@AbbVieCM) September 10, 2020

Learn about our latest supplemental New Drug Application to the U.S. #FDA for Waldenström's Macroglobulinemia #WM #RareDisease

— Pharmacyclics, an AbbVie Company (@Pharmacyclics) June 23, 2020

On this #RareDiseaseDay, we’d like to spotlight one of the pioneering researchers in Waldenström’s macroglobulinemia (WM), a rare form of #bloodcancer with which ~1,500 people in the U.S. are diagnosed each year. @rarediseaseday pic.twitter.com/mrIz28fXwj

— Pharmacyclics, an AbbVie Company (@Pharmacyclics) February 28, 2020

Chronic lymphocytic #leukemia (CLL) is a slow-growing blood cancer that occurs in a type of white blood cell known as a B cell. Learn more about this disease including the latest available treatment options via @USAToday. https://t.co/3wyScHhpe5

— Pharmacyclics, an AbbVie Company (@Pharmacyclics) January 21, 2020

New Jersey Vol.10 (corporations: Merck (Merck Sharp & Dohme (MSD) outside the U.S. & Canada))

From producing hard-to-find manufacturing parts ➡️ prototyping tissues and cells for testing, 3D technology can help make the impossible possible. Learn more about our labs worldwide that have become the hotbed for out-of-the-box solutions and game-changing innovation.

— Merck (@Merck) August 14, 2020

Our oncology portfolio and pipeline continue to expand with two collaborations announced today with @SeattleGenetics. See our latest news here: https://t.co/3Liez9BpnW $MRK pic.twitter.com/Tux4iBkgz0

— Merck (@Merck) September 14, 2020

Read our latest #pneumococcal disease news: https://t.co/JsT25Zgfrp $MRK pic.twitter.com/ypxFc1aLv1

— Merck (@Merck) September 9, 2020

Patients are our purpose. Science is our passion. Today, we stand united with biopharma colleagues around the world and reaffirm our long-standing commitment to ensuring that safety and rigorous science are our priorities in vaccine development. #InventingForLife

— Merck (@Merck) September 8, 2020

Check out our latest #respiratory update: https://t.co/kXMh76CdYW $MRK pic.twitter.com/BpRUoeF7Lt

— Merck (@Merck) September 8, 2020

Critical care pulmonologist, Dr. Stuart Green, is exploring ways to help people with #respiratory diseases: https://t.co/SaiP8y9Tpe pic.twitter.com/RP9Oa6Sr0y

— Merck (@Merck) September 7, 2020

We see the U.K. as a world leader in scientific development and look forward to being an active participant in the life sciences community. Learn about our new London Discovery Hub site: https://t.co/lmHZ1WbDjH #InventingForLife pic.twitter.com/REg3ENM0Mt

— Merck (@Merck) September 4, 2020

We’re sharing new data spanning more than 15 types of #cancer at the ESMO Virtual Congress 2020: https://t.co/2n1e2I68e0 $MRK pic.twitter.com/3SbKoqqiWc

— Merck (@Merck) September 2, 2020

We're committed to supporting patients with #cancer around the globe. Learn more about the progress we’ve made with our latest #oncology approvals in Japan: https://t.co/GrmsAF1u33 $MRK pic.twitter.com/igbsQMqufC

— Merck (@Merck) August 24, 2020

Follow Merck physician and medical volunteer, Dr. Mo Ali, through a day in the life on the front lines of treating #COVID19 patients. Watch here: https://t.co/H8fgpmw6QK pic.twitter.com/j9LHmMCI4g

— Merck (@Merck) August 20, 2020

We’re pleased to share our positive #clinicaltrial results in #esophagealcancer. Learn more about our latest news in this type of cancer: https://t.co/VqUZExlAIy $MRK pic.twitter.com/XqRMTpNvoT

— Merck (@Merck) August 19, 2020

In a #lungcancer survey, we found that at the time of diagnosis, 72% of people with advanced lung cancer felt they had brought their cancer on themselves. We’re partnering with @GO2Foundation to help patients across the country understand that they are #WorthTheFight.

— Merck (@Merck) August 18, 2020

Through our employee medical volunteer program, Kim Daly returned to nursing after 16 years to help those impacted by the #COVID19 pandemic. Learn more: https://t.co/3cjOAgIgns pic.twitter.com/ekk4TY8Gxs

— Merck (@Merck) August 12, 2020

Facing #cancer does not have to be a solo endeavor. Discover stories and strategies from Your Cancer Story to help you navigate a new landscape.

— Merck (@Merck) August 7, 2020

New technologies and going above and beyond to help a colleague's family — listen to the first-hand account from Craig Kennedy, head of supply chain, about how we are keeping our supply chain strong during #COVID19 and beyond: https://t.co/Q4gBkaou3E pic.twitter.com/stBHMx8FWc

— Merck (@Merck) August 6, 2020

We remain committed to supplying our medicines + vaccines, contributing our scientific expertise to the development of antiviral approaches + supporting our health care providers and the communities in which they serve. Learn more about our #COVID19 efforts ⬇️

— Merck (@Merck) August 3, 2020

Feeling overwhelmed during an advanced #lungcancer diagnosis is normal. Knowing how to communicate with your doctor can help. We’ve collaborated with @GO2Foundation on a doctor discussion guide to help you take action. #worldlungcancerday

— Merck (@Merck) August 1, 2020

Ken Frazier, Chairman & CEO, on our 2Q 2020 #earnings: https://t.co/ec5tJMSryV $MRK pic.twitter.com/3fI0B14Xws

— Merck (@Merck) July 31, 2020

We are pleased to announce that the #FDA has accepted two #oncology applications for the potential treatment of certain patients with #TNBC. Learn more about our latest pipeline advancement in #breastcancer: https://t.co/Ti5hYbB2gO $MRK pic.twitter.com/PEEgbDb4eI

— Merck (@Merck) July 30, 2020

For more than 125 years, we've worked to develop medicines and vaccines that have helped make important contributions in the fight against pandemics. Learn more about our efforts: https://t.co/wxd77PSins #InventingForLife pic.twitter.com/vJ1TARxBmC

— Merck (@Merck) July 29, 2020

Today’s Breakthrough Therapy designation recognizes the unmet need in certain patients with von Hippel-Lindau disease-associated renal cell carcinoma. Learn more about our latest #oncology update here: https://t.co/2BsMMxVy58 $MRK pic.twitter.com/WORsZOEB0T

— Merck (@Merck) July 29, 2020

Kurtis Oakley's phone rang – it was the #COVID19 task force in D.C. asking for his help. Read about his journey from Merck employee ➡️ Army microbiologist.

— Merck (@Merck) July 24, 2020

We believe that inclusivity is a key ingredient in resiliency. Hear from Don Watson about how making an inclusive environment for all benefits both employees and the company ⬇️ #PoweredByInclusion

— Merck (@Merck) July 22, 2020

Our colleague, Tom McGrew, directly helps to combat the #COVID19 pandemic in his community as a volunteer EMT. Learn more about his efforts ⬇️

— Merck (@Merck) July 20, 2020

Read about our colleague John Pratsinakis' triumphant battle with #COVID19 and how he fought not only for himself but for his family, friends, and co-workers.

— Merck (@Merck) July 17, 2020

For decades, we've known that a diverse & inclusive workforce inspires innovation. We are proud to be recognized by @DisabilityIN with the 2020 Employer of the Year Award. Learn how we strive to make our employees globally feel valued & empowered: https://t.co/h5laiaD92r pic.twitter.com/1p6ytkZ18t

— Merck (@Merck) July 16, 2020

We’re researching new paths forward for people with #heartfailure. Learn more about our latest #cardiovascular update: https://t.co/v8APDg5ss9 $MRK pic.twitter.com/ZCua84oDYW

— Merck (@Merck) July 16, 2020

Keelee Moseley, a @MerckforMothers ambassador, shares her story of survival and mission to advocate for soon-to-be-mothers: https://t.co/NOKmkvqc8I #MomEffect pic.twitter.com/Fxwk7vrCVl

— Merck (@Merck) July 15, 2020

We launched Your Cancer Story to support the #cancer community throughout their full experience with cancer. Explore resources, personal tips and heartfelt stories from the community.

— Merck (@Merck) July 14, 2020

"The way people have pulled together— I hope that is not forgotten. We are in this together, and we will get out of it together." Read more about how our own Karin Shanahan is helping our company and others return to optimal operations following #COVID19: https://t.co/xG9qsa4tYb pic.twitter.com/teoY5Tmvi9

— Merck (@Merck) July 13, 2020

To address #AMR, it is imperative that together, we continue to push the boundaries of science. https://t.co/ykJXnBOmb1

— Merck (@Merck) July 10, 2020

Our contribution to @AMRActionFund is an important step in fighting emerging resistant organisms. We’re committed to investing our expertise and resources alongside our partners to get much-needed antibiotics to those who need them most. Learn more: https://t.co/FMgRX1yuTx pic.twitter.com/3HiBZ7IAPh

— Merck (@Merck) July 10, 2020

The challenge of AMR is multifaceted and we must keep working to stay a step ahead. Learn why we’ve committed to investing $100 million over 10 years in the new @AMRActionFund with our industry partners to bring forward new treatment options for patients: https://t.co/FMgRX1yuTx pic.twitter.com/FaXj54LdI4

— Merck (@Merck) July 9, 2020

Just as we have a long legacy in fighting #HIV, we’re committed to being a significant player in the global effort to confront #COVID19. Learn more from our own Dr. Julie Gerberding on the parallels she sees between the two pandemics: https://t.co/2epskjhN1A pic.twitter.com/SodmQPZiPx

— Merck (@Merck) July 9, 2020

Learn more about our recent #bloodcancer update: https://t.co/S9e4abtFBY $MRK pic.twitter.com/JXluCWPYog

— Merck (@Merck) July 9, 2020

See here for our recent #pancreaticcancer update: https://t.co/koEcsO3okX $MRK pic.twitter.com/uxZhRoLbRa

— Merck (@Merck) July 8, 2020

See our latest oncology news here: https://t.co/YJhrD94kG9 $MRK pic.twitter.com/JaXbc2A3Mi

— Merck (@Merck) July 8, 2020

“I just couldn’t sit home every day not doing anything, not contributing to the community, with the knowledge I’ve been blessed to have." Learn more about how nurse & employee volunteer Brenda Fisher is lending her medical expertise to Houston Food Bank during #COVID19.

— Merck (@Merck) July 7, 2020

Innovating in #HIV remains crucial to our work. Learn more about our latest data released: https://t.co/uN7QN10MtE $MRK pic.twitter.com/mRs2mi9PFi

— Merck (@Merck) July 6, 2020

We have decided to stop our advertising on Facebook and Instagram. We are assessing the responses from Facebook and will be monitoring the actions they take, and will do the same across other media platforms. Read more in our latest statement: https://t.co/f3qbAFpm0M pic.twitter.com/ijo2wWlR6c

— Merck (@Merck) July 2, 2020

Thanks to our manufacturing teams who are working tirelessly to ensure the continuity of supply of our medicines + vaccines throughout #COVID19. Learn more about our company’s efforts: https://t.co/tyGI5S4tBK pic.twitter.com/uyvvd4WYTM

— Merck (@Merck) July 2, 2020

During the #COVID19 pandemic, our global clinical trials team works to ensure that our #clinicaltrials continue with a high degree of safety, quality and compliance, as always. Read about the incredible stories that continue to inspire us: https://t.co/BJJzf0032b pic.twitter.com/xhXkJVH7P0

— Merck (@Merck) July 1, 2020

#COVID19 has posed many challenges for the #cancer community. Together with @KatieCouric, we’re sharing real-life experiences like Janet’s in hopes of helping others impacted by cancer during the pandemic feel just a little less alone. Read about her story ⬇️ https://t.co/sfFILCm6RM

— Merck (@Merck) June 30, 2020

Learn more about our latest #FDA approval in #colorectalcancer: https://t.co/VqIMAausrA $MRK pic.twitter.com/QS5LESMbTJ

— Merck (@Merck) June 29, 2020

Today we celebrate the 90th birthday of Nobel Prize winner, Dr. William Campbell, who strengthened our company’s resolve to combat infectious diseases and serve patients around the world. Read about Dr. Campbell’s achievements: https://t.co/SPa0uC1snS pic.twitter.com/e7J1gdB5Ld

— Merck (@Merck) June 28, 2020

We are proud to have collaborated with our partners to help end the #ebola outbreak in the eastern region of the Democratic Republic of the Congo. As a global community we are committed to improving public health together. Read more about this news: https://t.co/Sm4YElIlN8 pic.twitter.com/blkt1eq5ev

— Merck (@Merck) June 26, 2020

Announcing our latest #oncology #FDA approval in advanced cutaneous squamous cell carcinoma (cSCC) #skincancer: https://t.co/fyDOpNndT7 $MRK pic.twitter.com/MfsEPB26PN

— Merck (@Merck) June 24, 2020

We’re committed to helping address unmet needs for the #HIV community. Follow along as we share our latest data during the AIDS 2020 Virtual Conference: https://t.co/tch4WG0KnK $MRK pic.twitter.com/Mc8rEXGFWA

— Merck (@Merck) June 24, 2020

Thanks to our manufacturing teams for their continued hard work ensuring continuity of supply of our medicines and vaccines to support patients globally. Learn more about our efforts: https://t.co/tyGI5S4tBK pic.twitter.com/kBr5OWzI7F

— Merck (@Merck) June 22, 2020

Read our latest #pneumococcal disease news: https://t.co/eT3yyEyAQj $MRK #ISPPD pic.twitter.com/qotjPXumpS

— Merck (@Merck) June 22, 2020

Learn more about our newest update in #esophagealcancer: https://t.co/8Wocb7y7Gk $MRK pic.twitter.com/cwvGpbkCMQ

— Merck (@Merck) June 22, 2020

According to the @CDCgov, efforts to reduce transmission of #COVID19, such as stay-at-home and shelter-in-place orders, have led to decreased use of routine preventive medical services, including vaccination. Learn more: https://t.co/EChAjSx14f pic.twitter.com/ZcyLYD5a4N

— Merck (@Merck) June 18, 2020

“Science found a way before, and science will find a way today.” Read more from Dr. Nick Kartsonis on how #COVID19 underscores the imperative for our company + industry to continue investing in research to help combat the world’s greatest health threats: https://t.co/2StgOr6Koo pic.twitter.com/sj3fm7BDMj

— Merck (@Merck) June 18, 2020

Every #cancer survivorship story is unique. We encourage everyone to help support the cancer community by listening and sharing these important stories. #NationalCancerSurvivorMonth pic.twitter.com/1eOTqMjZ9l

— Merck (@Merck) June 18, 2020

Our commitment to helping expand options for cancer patients continues. Learn more about our latest #FDA approval: https://t.co/6jPrwHGUqt $MRK pic.twitter.com/IJGXBS3KCH

— Merck (@Merck) June 17, 2020

Click to see our latest research in #type2diabetes: https://t.co/d6ijDxz6Iz $MRK pic.twitter.com/Q2BdNaSf9M

— Merck (@Merck) June 16, 2020

Check out our latest #HPV news: https://t.co/orBm6xund9 $MRK pic.twitter.com/lKOta4qcIl

— Merck (@Merck) June 12, 2020

See our recent #bladdercancer update: https://t.co/zUbWDaUmIF $MRK pic.twitter.com/jJu5rXbtkN

— Merck (@Merck) June 9, 2020

Proud to share our latest news in #infectiousdiseases: https://t.co/lRw9yDVsfu $MRK pic.twitter.com/beUEmmymdT

— Merck (@Merck) June 5, 2020

Our own John Markels on our recent announcement continuing our commitment in being a major supplier of HPV vaccines to @Gavi from 2021-2025. Learn more: https://t.co/JEtaRnkO6s pic.twitter.com/HfemyqET2Z

— Merck (@Merck) June 4, 2020

Our CEO Ken Frazier calls for unity on @CNBC: https://t.co/jrxmaWVO5y pic.twitter.com/GHqrU5FmvP

— Merck (@Merck) June 2, 2020

See here for a recent #pancreaticcancer update: https://t.co/r0pKF91L8D $MRK pic.twitter.com/Z1XlwE6Ulp

— Merck (@Merck) June 1, 2020

Everyone knows someone who has been touched by cancer. That’s why we’re fighting with all we have to deliver more, sooner. #ASCO20

— Merck (@Merck) May 30, 2020

Thank you @katiecouric and @habibtisarah for helping bring to light the real-life complexities of coping with #cancer during #COVID19. https://t.co/DDUUJLdUN9

— Merck (@Merck) May 29, 2020

Through collaboration with @EisaiUS, we’re exploring new options for patients living with #kidneycancer and those with #livercancer. Learn more about our data at #ASCO20: https://t.co/GQD2gqO6aZ $MRK

— Merck (@Merck) May 28, 2020

We're unwavering in our commitment to the #cancer community to bring new options to patients. Check out our latest #oncology update: https://t.co/CmqWeTOgKe #ASCO20 $MRK

— Merck (@Merck) May 28, 2020

LIVE: Merck CEO Ken Frazier joins David Rubenstein to discuss leadership during a crisis https://t.co/6D50wHFNrU

— Bloomberg (@business) July 8, 2020

#IamBIO features the men and women in the biotechnology industry that are working to change the world every day, in every way.

Meet Dr. Muhammed “Mo” Ali of @Merck – a physician volunteering his efforts on the frontlines of #COVID19.

Learn More: https://t.co/T5R0chf45g pic.twitter.com/hE8P8GKrYV

— I Am Biotech (@IAmBiotech) June 25, 2020

#TBT to August 2019 as health care professionals in the Democratic Republic of the Congo worked to save lives & stop the spread of Ebola.

On Thursday, @WHO announced the end of the one of the longest & deadliest outbreaks in Ebola history. https://t.co/5ANQbz52d3 pic.twitter.com/uTU0oqMeJ3

— United Nations (@UN) June 25, 2020

How can we help prevent COVID-19 from exacerbating maternal health inequities? Executive Director @MEtiebetMD weighs in on @MilkenInstitute’s #PowerofIdeas series on elevating the voices, experiences & solutions of birthing people to #EndMaternalMortality: https://t.co/0Ra5eq3Sax pic.twitter.com/72ltwN150q

— Merck for Mothers (@MerckforMothers) August 19, 2020

Veterinarians are our heroes. Today & every day, we stand behind the veterinary profession & support their important contributions to animal health. #BeUnconditional

— Merck Animal Health (@MerckAH) September 10, 2020

Choose #biosimilars to help build a future with the potential for more patient options and cost savings to the health care system. #ConsiderBiosimilarAdoption https://t.co/5UL4ySDr7p pic.twitter.com/2cJFzBhUF7

— US Merck Products (@USMerckProducts) July 22, 2020

New York Vol.35 (corporations: Pfizer)

As states open up and stay-at-home orders are lifted this summer, experts offer advice on limiting your risk of exposure to the coronavirus. Learn more:

— Pfizer Inc. (@pfizer) September 8, 2020

We now have more than 25,000 participants dosed in our #COVID19 vaccine clinical trial. Learn more about our progress in developing a potential #COVID19 vaccine, here: https://t.co/bd9DdEyQc6 pic.twitter.com/VniUFPsTSb

— Pfizer Inc. (@pfizer) September 5, 2020

We’re leaving no stone unturned in the fight against #COVID19. Watch the full video featuring our top scientists for a behind-the-scenes look at the scientific frontlines during this pivotal time. #ScienceWillWin #PfizerProud

— Pfizer Inc. (@pfizer) September 2, 2020

We have committed to developing our #COVID19 vaccine candidate with unprecedented speed, without sacrificing safety. Hear from our Chief Medical Officer Dr. Mace Rothenberg what that means and the progress we have made: https://t.co/sp9NQw7FYq

— Pfizer Inc. (@pfizer) September 1, 2020

Pfizer is sharing a gastroenterologist’s perspective on #telemedicine for people living with #UC during the pandemic.

— Pfizer Inc. (@pfizer) August 31, 2020

We can all have a role to play in the #clinicaltrials process. Jason, Vivian, Julia and Bryce discuss their roles and invite you to play an even more important one: helping to make new medicines possible. Learn more #clinicaltrial

— Pfizer Inc. (@pfizer) August 30, 2020

.@AlbertBourla joins @BizRoundtable to reflect on the year so far & how Pfizer is responding to the #COVID19 health crisis: https://t.co/r8DfIGRhfP pic.twitter.com/o1KksYqCmD

— Pfizer Inc. (@pfizer) August 26, 2020

As the role of #telemedicine evolves in 2020, #rheumatologist Dr. Ara Dikranian shared three tips to keep in mind when preparing for virtual medical appointments. Visit to learn more.

— Pfizer Inc. (@pfizer) August 24, 2020

Want to learn more about the fight against #COVID19? #TheANTIGEN podcast is here to help.

We deep dive into:
➡️ past global health emergencies
➡️ the quest for a potential vaccine
➡️ how #COVID19 is being addressed in the meantime
➡️ life after a crisis

— Pfizer Inc. (@pfizer) August 10, 2020

Today we announced a multi-year agreement to #manufacture & supply @GileadSciences investigational #antiviral for treatment of #COVID19: https://t.co/v7JysQSt2L pic.twitter.com/DWs1IbsJWr

— Pfizer Inc. (@pfizer) August 7, 2020

#Genetherapy is one of the most innovative areas in science today. Learn how we are working to pioneer breakthroughs that have the potential to change patients’ lives:

— Pfizer Inc. (@pfizer) August 6, 2020

Today we announced an agreement with the Government of @Canada to supply our BNT162 mRNA-based #vaccine candidate against SARS-CoV-2, subject to clinical success and Health Canada approval.#COVID19 @BioNTech_Group @PfizerCA pic.twitter.com/FtWQRpg5zJ

— Pfizer Inc. (@pfizer) August 5, 2020

Today we announced an agreement with the Ministry of Health, Labor and Welfare in #Japan to supply 120M doses of our #COVID19 #vaccine candidate in collaboration with @BioNTech_Group, subject to regulatory approval: https://t.co/FBbQN3ciRF pic.twitter.com/U402NeO6WA

— Pfizer Inc. (@pfizer) July 31, 2020

We’re thrilled to be recognized on the 2020 list of @FastCompany’s Best Workplaces for Innovators. See the full list here: https://t.co/ImyuDrKiGk #FCBestWorkplaces

— Pfizer Inc. (@pfizer) July 30, 2020

UPDATE: $PFE $BNTX mRNA-based #vaccine candidate against SARS-CoV-2 (BNT162b2) is moving into Phase 2/3 clinical development and enrollment.

➡️ Read the release: https://t.co/9PmDiChTCs #COVID19 @BioNTech_Group pic.twitter.com/LQiOVlzlP3

— Pfizer Inc. (@pfizer) July 27, 2020

UPDATE: We're proud to announce an agreement with @HHSGov @SecAzar under Operation #WarpSpeed for up to 600M doses of our #COVID19 vaccine candidate currently in development with @BioNTech_Group.@BARDA @JPEOCBRND @PHEgov

— Pfizer Inc. (@pfizer) July 22, 2020